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Abstract 
This is retrospective descriptive study which was conducted in the 
radiation and isotopes center-khartoum and sudan national lab during 
the period January2000-december 2004,to determine the patteren of 
malignant diseases in the sudan. 
Out of 14521 patients regestered in the R.I.C-KRT,56.6%were female 
and 43.4% were male and the commonest malignant diseases was 
found to be ca-breast =22.4% the least commonest malignant disease 
was found to be male ca-breast =0.27%,and the commonest region 
was found to be Khartoum region =32.1% , the most commonly 
affected age group was found to be >50 years =47.3% and the least 
commonly affected age group was found to be < 20 years =10.3% . 
Also it document that ther is remarkable increase in the number of 
patients with milgnant diseases from the year 2000(=15.1%)  
,2001(=18.1%),2002(=19.4%),2003(21.5%),2004(=25.8%). 
The data from S.N.lab showed the fallowing; 
  Total number of patients = 2180. 71.2% were female and 28.8% 
were male.  
The most commonly affected age was found to be the age group of 
(40-50) = 19.6%, the least commonly affected age group was found to 
be the age group<20 = (5.9%), the common region was found to be 
Khartoum region = 88.2%, the most common malignant disease was 
found to be ca-breast= (25.1%). 
  ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ
اﻟﺨﺮﻃﻮم واﻟﻤﺨﺘﺒﺮ -هﺬﻩ اﻟﺪراﺳﺔ ﺧﻠﻔﻴﺔ وﺻﻔﻴﺔ أﺟﺮﻳﺖ ﻓﻲ اﻟﻤﺮآﺰ اﻟﻘﻮﻣﻲ ﻟﻠﻌﻼج ﺑﺎﻷﺷﻌﺔ واﻟﻄﺐ اﻟﻨﻮوي
   .4002 ﺣﺘﻲ دﻳﺴﻤﺒﺮ0002- ﺮﻳاﻟﻘﻮﻣﻲ اﻟﻤﺮآﺰي ﻓﻲ اﻟﻔﺘﺮة ﻣﺎﺑﻴﻦ ﻳﺎﻧﺎ
 هﺪﻓﺖ اﻟﺪراﺳﺔ ﻟﻌﻤﻞ ﻣﺴﺢ ﻹﻧﺘﺸﺎر اﻷﻣﺮاض اﻟﺴﺮﻃﺎﻧﻴﺔ ﺣﺴﺐ اﻟﻔﺌﺎت اﻟﻌﻤﺮﻳﺔ ﻟﻠﻤﺮﺿﻰ واﻟﺠﻨﺲ وأﻗﺎﻟﻴﻢ
  .اﻟﺴﻮدان اﻟﺴﺘﺔ
  :أﺛﺒﺘﺖ اﻟﺪراﺳﺔ اﻷﺗﻲ
 12541 اﻟﺨﺮﻃﻮم ان اﻟﻌﺪد اﻟﻜﻠﻲ ﻟﻠﻤﺮﺿﻲ اﻟﻤﺴﺠﻠﻴﻦ -ﻓﻲ اﻟﻤﺮآﺰ اﻟﻘﻮﻣﻲ ﻟﻠﻌﻼج ﺑﺎﻻﺷﻌﺔ واﻟﻄﺐ اﻟﻨﻮوي
وآﺎن ﺳﺮﻃﺎن اﻟﺜﺪي ﻟﺪي اﻻﻧﺎث هﻮ % 4.34ﺑﻴﻨﻤﺎ ﻧﺴﺒﺔ اﻟﺬآﻮر % 6.65ﻣﺮﻳﺾ وآﺎﻧﺖ ﻧﺴﺒﺔ اﻻﻧﺎث 
ﺮﻃﺎن اﻟﺜﺪي ﻟﺪي اﻟﺬآﻮر هﻮ اﻻﻗﻞ ﺷﻴﻮﻋﺎ وﺑﻠﻐﺖ ﺑﻴﻨﻤﺎ آﺎن ﺳ% 4.22اﻻآﺜﺮ ﺷﻴﻮﻋﺎ اذ ﺑﻠﻐﺖ ﻧﺴﺒﺘﻪ 
اآﺜﺮ اﻟﻔﺌﺎت % .1.23وآﺎن اﻗﻠﻴﻢ اﻟﺨﺮﻃﻮم اآﺜﺮ ﻧﺴﺒﺔ ﻣﻦ ﺑﺎﻗﻲ اﻻﻗﺎﻟﻴﻢ اذ ﺑﻠﻐﺖ ﻧﺴﺒﺘﻪ % 72.0ﻧﺴﺒﺘﻪ
واﻟﻔﺌﺔ اﻻﻗﻞ اﺻﺎﺑﺔ آﺎﻧﺖ اﻟﻔﺌﺔ اﻻﻗﻞ ﻣﻦ % 3.74=اﻟﻌﻤﺮﻳﻪ اﺻﺎﺑﺔ آﺎﻧﺖ اﻟﻔﺌﺔ اﻻآﺜﺮ ﻣﻦ ﺧﻤﺴﻴﻦ ﺳﻨﺔ 
  %.3.01=ﻋﺸﺮﻳﻦ ﺳﻨﺔ
  :ﺑﻴﻨﻤﺎ اﺛﺒﺘﺖ اﻟﺪراﺳﺔ زﻳﺎدة ﻣﻄﺮدة ﺑﻌﺪ آﻞ ﺳﻨﺔ اذ آﺎﻧﺖ ﻧﺴﺒﺔ اﻟﻤﺮﺿﻲ ﻟﻠﺨﻤﺲ ﺳﻨﻮات آﺎﻻﺗﻲ
  %1.51=0002ﺳﻨﺔ 
  %1.81=1002ﺳﻨﺔ 
  %4.91=2002ﺳﻨﺔ 
  % 5.12=3002ﺳﻨﺔ 
  %8.52 =4002ﺳﻨﺔ 
  :اﻷﺗﻲ( ﺳﺘﺎك)اﻇﻬﺮت إﺣﺼﺎﺋﻴﺔ اﻟﻤﺨﺘﺒﺮ اﻟﻤﺮآﺰي اﻟﻘﻮﻣﻰ 
% 8.82ﺑﻴﻨﻤﺎ آﺎﻧﺖ ﻧﺴﺒﺔ اﻟﺬآﻮر % 2.17ﺴﺒﺔ اﻻﻧﺎث  وآﺎﻧﺖ ﻧ0812  ان اﻟﻌﺪد اﻟﻜﻠﻲ ﻟﻠﻤﺮﺿﻲ اﻟﻤﺴﺠﻠﻴﻦ 
واﻟﻔﺌﺔ اﻻﻗﻞ ﺗﻜﺮارا  ﻣﻦ ﻋﺸﺮﻳﻦ ﺳﻨﺔ %( 6.91)وآﺎﻧﺖ اﻟﻔﺌﺔ اﻟﻌﻤﺮﻳﺔ اﻻآﺜﺮ ﺗﻜﺮارا ﻓﺌﺔ اﻟﺨﻤﺴﻴﻦ ﺳﻨﺔ 
  %( .2.88)واﻻﻗﻠﻴﻢ اﻻآﺜﺮ ﺗﻜﺮارا هﻮ اﻗﻠﻴﻢ اﻟﺨﺮﻃﻮم ﺣﻴﺚ ﺑﻠﻐﺖ ﻧﺴﺒﺘﻪ %( 9.5)
  %(.1.52)هﻮ ﺳﺮﻃﺎن اﻟﺜﺪياﺛﺒﺖ اﻟﺪراﺳﺎت ان اﻟﻤﺮض اﻟﺴﺮﻃﺎﻧﻲ اﻻآﺜﺮ ﺗﻜﺮارا 
  .ﻋﻨﻴﺖ هﺬﻩ اﻟﺪراﺳﺔ اﻷﺧﻴﺮة ﺑﺎﻟﺘﺸﺨﻴﺺ اﻟﻨﺴﻴﺠﻲ اﻟﺘﺄآﻴﺪي
Abbreviation 
HCC= hepatocellular carcinoma. 
R.IC=radiation and isotopes center. 
S.N.Lab=Sudan national lab. 
KRT=Khartoum. 
F.M.O.H=federal ministry of health. 
<=less than. 
>=more than. 
=means equal. 
%=percent. 
ALL=acute lymphoblastic leukemia . 
AML=acute myelocytic leukemia. 
CLL= chronic lymphoblastic lymphoma. 
CML= chronic myolocytic lymphoma. 
NHL=non Hodgkin lymphoma  
HD=Hodgkin lymphoma  
EB=Epstein bar 
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Chapter I 
Introduction 
 
1.1. Background 
The term malignancy, neoplasia and cancer are usually used interchangeably in both the 
technical and popular literature.  Human cancer is probably as old as the human race. It 
is obvious that cancer did not suddenly start appearing after modernization or industrial 
revolution. The oldest known description of human cancer is found in an Egyptian 
seven papyri as “Edwin smith” and “George Eber’s” papyri; they found a writing 
written between 3000-1500 BC. Both of them contain details of conditions that are 
consistent with modern description of cancer.  The oldest available specimen of human 
cancer is found in the remains of skull of a female who lived during the Bronze Age 
1900-1600 BC. The tumor in the women skull is a suggestive of head and neck cancer. 
 
World wide, there are over 10 million new cases of cancer and more than 6 million 
deaths from cancer annually. Two decades ago, these figures were 6 million and 4 
million.  Of the 10 million new cancer cases each year, 4.7 million are in the more 
developed countries and nearly 5.5 million are in the less developed countries. Although 
the disease has often been regarded as a problem principally of the developed world, in 
fact, more than half of all cancers occur in the developing countries. In developed 
countries cancer is the second most common cause of death, and epidemiological 
evidence points to the emergence of a similar trend in developing countries. Cancer is 
currently the cause of 12% of all deaths world-wide. In approximately 20 years time, the 
number of deaths annually due to cancer will increase from about 6 million to 10 
million. 
 
Hippocrates, the great Greek physician 460-370 B.C who is considered the father of 
medicine is thought to be the first person to clearly recognize difference between benign 
and malignant tumors this writing include description of cancers involving various body 
sites.  Hippocrates noticed that the blood vessel around malignant tumor looked like the 
claws of crab. He named the disease karkinos “the Greek name for crab” to describe 
tumor that may or may not progress to ulceration. In English this term translated to 
carcinos or carcinoma.  Later in the course of history, Constantinople became the 
intellectual headquarter of medicine. During this period the cause of cancer was 
explained as a result of excess of black bile. During 18th century Jean Astruc and 
2 
 
chemist Bernard conducted research to confirm current theories related to the origin of 
cancer. These efforts were the very first step of experimental oncology, the art of 
science of seeking better diagnosis, treatment and understanding of the causes of cancer.  
Discovery of anesthesia in 1844 allowed surgery to flourish and the classic cancer 
operations such as radical mastectomy were developed.  The20th century saw great 
progress in understanding of microscope structure and functioning of living cells. 
 
Worldwide there are over 10 million new cases of cancer and more than 6 million 
deaths from cancer annually. Two decade ago, these figures were 6 million and 4 
million respectively. Of the 10 million new cancer cases each year 4.7 million are in the 
more developed countries and nearly 5.5 million are in the less developed countries. 
Although the disease has often has been regarded as a problem principally of the 
developed world, In fact, more than half of all cancers occur in the developing 
countries. 
 
In developed countries cancer is the second most common cause of death, and 
epidemiological evidence point to the emergence of a similar trend in developing 
countries. Cancer is currently the cause of 12% of all deaths world wide. In 
approximately 20 year’s time, the number of deaths annually due to cancer will increase 
from about 6 million to 10 million. There are four principle reasons for increase in 
cancer mortality: deaths from cardiovascular diseases are declining in developed 
countries,  More people are surviving to old age when cancer is more likely to occur, 
Increasing tobacco use in recent decade has led to grater incidence of cancer of the lung 
and certain other sites, and Changes in diet, decreasing physical activity and increasing 
obesity have most likely contributed to an increase in various form of cancer. 
 
In developed countries, cancer generally accounts for about one-fifth of all deaths with 
mortality figures second only to those for cardiovascular disease. Currently infections 
and perinatal problems together account for less than7% of the total mortality in 
developed countries and the proportion is dropping. In these countries, of all major 
conditions that result in death, cancer is one of the very few for which the proportion is 
rising significantly.  In developing countries, cancer is now responsible for about one in 
10 deaths. But Incidence of the disease is increasing. As living standard improves and 
life expectancy is extended, the incidence of communicable disease declines and non-
communicable disease such as cancer assume greater importance. 
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1.2. The scope of the research 
In developed countries, cancer is now responsible for about one in 10 deaths, but 
incidence of the disease is increasing. As living standards improve and life extended, 
the incidence of communicable diseases declines and non-communicable diseases such 
as cancer assume greater importance.  The starting premise of this study is to tackle the 
issue of cancer with respect to prevalence, distribution according to geographic 
locations, age groups and gender.  Among men, lung and stomach cancer are the most 
common cancer worldwide, while prostate is largely seen in more developed countries.  
For women, the most common cancer worldwide are breast and cervical cancer, 
although cervical cancer primarily seen in less developed countries. Lung, colorectal 
and stomach cancer are among the five most common cancer for more both men and 
women, in both more developed and less developed countries.  Therefore, this study 
attempts to highlight the significance of cancer incidence among age groups and sex.  
Moreover, the study explores the prevalence of the disease across the country. 
 
1.3. Problem statement 
There is a tremendous increase of cancer incidents in the country.  Each year the trend 
and pattern of the disease increases.  Several factors contribute to the wide spread of the 
disease and the increase of mortality.  For men, cancer of the oral cavity is particularly 
common as consequence of chewing tobacco, which has become common among 
males.  In sudan there is no accurate figure reflecting the actual incidence of the disease 
either due to lack of diagnosis of the disease which is in turn influenced by the level of 
poverty and remoteness from the capital.  However, as living standards improve and life 
extended, the incidence of non-communicable diseases such as cancer assume greater 
importance. 
 
The economic burden of cancer is the most obvious in health care cost, such as those for 
hospital, other health services, and drugs. Indirect costs arise from loss of productivity 
as a result of illness and premature death of those affected.  A diagnostic of cancer in 
one of the adults in family may lead not only to the loss of a source of income, but also 
all too frequently to exhausting the family’s remaining income and resources in seeking 
treatment. Perhaps saddest of all are the futile frantic searches and large amount of 
money paid by the family for treatments that cannot prolong the life of the family 
member with advanced cancer.  Most of Sudan’s rural areas are classified as marginal 
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areas where the socio-economic index of poverty indicated that most of the rural areas 
of greater Kordofan and Greater Darfur are classified as ultra-poverty.  Detection of 
cancer incidence is not affordable to the majority of local people in the rural areas.  
Therefore, prevalence of cancer needs to be investigated for sake of heightening the 
main causes of the disease in attempts to mitigate the trend of spreading. 
 
1.4. Objectives of the research 
The broad objective of the research is to highlight the level and trends of distribution of 
malignant diseases in the country, more specifically; 
- To explore the trend of malignant diseases in the Sudan for the period 2000-2004. 
- To investigate prevalence of malignant diseases according to gender during the 
above-mentioned period. 
- To determine the age group that susceptible to malignant diseases incidence. 
- To investigate the prevalence of the malignant diseases among the different 
geographical regions of the country (east, west, north, central and south) 
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Chapter II 
Literature Review 
 
2.1. Introduction 
Cancer is a term that is used to describe a wide variety of malignant diseases, the 
management of which requires several medical disciplines.  Malignant disease is 
involving multidiscipline in malignant. Cancer encompasses two categories:       
Hematological malignancy such as leukemia and Non hematological malignancy such 
as solid tumor like breast cancer.  Cancer has four characteristic:-  
- Clonality: it originates from single stem cells which proliferate to form colons 
of malignant cells. 
- Autonomy: uncontrolled growth.  
- A naplasia: lack of normal coordination cell differentiation. 
- Metastasis: dissemination to other parts of body 
 
However, cancer is responsible for the mortality of great proportion of human beings.  
Table (1) shows different causes of mortality due to different diseases and other factors. 
 
Table (2.!): global and regional patterns of annual deaths, by cause, 2000  
 World total causes 
(000) 
Infection & 
parasitic  
Cancer Circulatory 
diseases  
Prenatal   Injury  Other 
causes 
 55694 25.9 12.6 30 4.4 9.1 18 
Developed C. 13594 6 21.6 47.9 0.7 7.9 15.9 
Underdeveloped 
C. 
42100 32.3 9.8 24.2 5.6 9.5 18.7 
Africa 10572 61.7 5.1 9.2 5.5 7.1 11.5 
S&central 
America 
3097 14.6 14 28.5 4.3 12.3 26.2 
North America 2778 6.3 23.8 41 0.6 6.4 21.9 
Middle east 4036 32 6.1 26.9 7.5 8.4 19 
South-east Asia 14157 29.9 8 28.9 7.1 9.7 16.4 
Western pacific  11390 10.6 18.6 31.2 2.8 10.7 26 
Europe  9664 5.4 19.8 51.5 0.8 8.5 14.1 
Source: WHO (1) 
 
 
 
 
 
6 
 
Table (2.2): shows SEER Cause of Death Recode 1969+ (9/17/2004) in the United 
States of America.  
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2.2. Cancer of various sites 
Among men, lung and stomach cancer are the most common cancers worldwide, while 
prostate cancer is largely seen in more developed countries.  For women the most 
common cancers worldwide are breast and cervical cancers, although cervical cancer is 
primarily seen in less developed countries.  Lung, colorectal and stomach cancers are 
among the five most common cancers for both men and women, in both developed and 
less developed countries.  Further insight may be gained by considering the incidence of 
cancer of various parts of the body in different countries (see table 3, 5).  In the Sudan 
the relationship between aflatoxin and hepatocellular carcinoma. The study included 
west of the Sudan – area of high incidence – and central of the Sudan – area of low 
incidence of HCC, during the period (May–November 1995). The study investigated 
whether aflatoxin contamination of product contribute to the incidence of (HCC) in 
Sudan. Thirty– seven peanut butter and peanut samples were collected from local 
markets.  Alfatoxin concentration were significantly higher in west Sudan {8.7 +\- 
197.3(SD) mg\kg}, a high risk area, than in central Sudan {8.5 +\- 6.8 mg\kg}, a low–
risk area. In west Sudan, humid local storage conditions of peanut products were related 
to high aflatoxin concentrations. In a small case – control study of HCC patients (n=24) 
and controls (n=34), an odds ratio of 7.5 (95% confidence interval =1.4-40.2) was 
observed for humid vs. dry local storage conditions. Development of index of individual 
HCC exposure was less successful in food. These preliminary findings justify further 
research into the rule of aflatoxins and hepatitis in HCC incidence in Sudan.  Fig (2.1) 
shows the trends of different cancer in the united States for the period 1979 – 2003. 
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Source: (2) 
 
2.3. Factors of malignant diseases 
Some individuals are known to be at high risk for cancer, such as those with a personal 
history of cancer or a strong family history of cancer (in 2 or more first-degree 
relatives); increasingly, as genetic mutations and polymorphisms are found to be 
associated with specific cancers, high-risk individuals will be identified through genetic 
testing. The type, periodicity, and commencement of screening in high-risk populations 
for most cancers reflect the judgment of practitioners rather than evidence from 
scientifically conducted studies. Physician judgment is needed in such circumstances to 
determine the most appropriate application of available screening methods. Prudence 
suggests increased vigilance in the higher-risk populations. At a minimum, this means 
that the high-risk person is identified, is counseled appropriately, and regularly 
undergoes those screening procedures that have been shown to be of benefit to the 
general population (3).  Etiology of most malignant disease is still unknown, though 
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various factors have been identified as being associated with development of malignant 
disease.  Some of these factors are; 
- Geographical factors: It was found that lung cancer is most prevalent in 
England, Scotland and Ireland, whereas cancer of the prostate, breast and 
colon has high incidence in Asian countries.  Liver cancer has high incidence in 
African countries but low incidence in Europe And USA.  Japan has increased 
incidence of stomach cancer but low incidence of pancreas Cancer.  As 
southeast Africa, Iran and China have an increase in the incidence of the 
esophageal cancer most probably due to cocking process.  It was noted that 
most of the geographical difference were due to environmental factors but not 
due to genetic factors, because people move from one country to another 
eventually they acquire the cancer incidence of the country to which they have 
moved. 
- Age factors: Most of the cancers incidences increase with advance of age.  It 
was noted that above 60 years old of age, males are more affected than 
females whereas between 30-40 females are commonly affected than male.  
Children have a peak incidence between 3-13 years most commonly by acute 
lymphoblastic leukemia (ALL). Some cancers have bimodal age distribution e.g. 
Hodgkin’s disease.  
- Environmental factors: Pollution with Asbestos, Radon and Nickel, was 
found to be associated with lung cancer, laryngeal cancer, bladder cancer and 
mouth cancer. Abu U.V light is associated with increase in the incidence of all 
types of skin cancer e.g. melanoma that is particular common in Australia, New 
Zealand and South Africa. 
- Alcohol: Is associated with hepatocellular carcinoma, cancer of esophagus and mouth. 
- Diet: it was found that dietary fibers is associated with low incidence of cancer of the 
colon, on the other hand refined food has high incidence of carcinoma of the colon. 
Dietary fat is associated with increase incidence of G.I.T ca. 
- Infective agents: It has been shown that some infective agent are related to certain 
malignancies E.g. specific type of T-cell leukemia and retrovirus human T-cell 
leukemia virus, hepatocellular carcinoma and hepatitis B and C virus, ca- stomach and 
Helicobacter pylori, Burkilt`s Lymphoma and nasopharyngeal ca. with EBV, Kaposi 
sarcoma and HIV, ca cervix and papillovirus. 
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- Oncogenes: the fact that viral information can be integrated into the genome of a 
human cell and thereby transform it into a malignant cell so there are regulatory genes 
known as: tumor suppressor genes (whose function is to prevent this malignant 
transformation triggered by carcinogens like tobacco or spontaneous Mutation). The 
other gene is growth-promoting known as protooncogen, which are triggered, by 
carcinogen or spontaneous mutation. 
- Drugs: certain drugs have been incriminated as being associated with some 
malignancy e.g. estrogens and endometrium and vaginal malignancies, Cytotoxic drugs 
and acute Myelogenic leukemia. 
- Biological factors: Breast cancer incidence was found to be associated   positively 
with early menarche and late menopause and late first pregnancy. Lactation has 
protective role against ca-breast. On the other hand ca-cervix has positive association 
with early and multiple sexual practice as well as sexually transmitted disease.  
- Occupational factors: there are some types of malignant diseases that have a direct 
relationship with the types of occupation.  Table (2.2) shows the relationship between 
the occupation type and the incidences of cancer. 
 
Table (2.1): Relationship between occupation and malignant disease 
Occupation             Agent Site of malignant 
disease 
Dye Manufacture  
Rubber worker 
 Aromatic 
  Amines 
Bladder 
Asbestos mining and Handling   Asbestos  Lung 
Cadmium worker Cadmium Prostate 
Uranium miners Ionizing 
Radiation  
Lung 
Coal gas manufacture   asp halter and other Poly cyclic  
Hydrocarbon 
Skin 
Lung 
Farmer, sailors Ultra violet  
Light  
Skin 
Lip 
Hard wood furniture  
Manufacture 
Unknown  Nasal sinuses 
 
2.4. Burden of cancer 
There are four principal reasons for the increase in cancer mortality:  
- deaths from cardiovascular diseases are declining in developed countries; 
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- more people are surviving to old age , when cancer is more likely to 
occur; 
- increasing tobacco use in recent decades has lead to greater incidence of 
cancer of the lung and certain other sites; 
- Change in diet, decreasing physical activity and increasing obesity has 
most likely contributed to an increase in various forms of cancer.  
 
In developed countries, cancer generally accounts for about one-fifth of all deaths with 
mortality figures second only to those for cardiovascular diseases (Table (2.2). 
Currently, infections and perinatal problems together account for less than 7% of the 
total mortality in developed countries, and the proportion is dropping. In these 
countries, of all major conditions that result in death, cancer is one of the very few for 
which the proportion is rising significantly (Table (2.3).  In developed countries, cancer 
is now responsible for about one in 10 deaths (see table 1), but incidence of the disease 
is increasing. As living standards improve and life extended, the incidence of 
communicable diseases declines and non communicable diseases such as cancer assume 
greater importance.            
 
Table 2 numbers of cancer deaths and new cancer cases in the world as estimated for 
2000 and predicated for 2020 (based on population projections) 
 
Year  Region New cases (million)         Death (million) 
2000 More developed countries  
Less developed countries. 
All countries  
4.7 
5.4 
10.1 
2.6 
3.6 
6.2 
2020 More developed countries  
Less developed countries  
All countries  
6.0 
9.3 
15.3 
3.5 
6.3 
9.8 
Source: (4)  
 
Cancer of the oral cavity is particularly common in India and adjacent areas as 
consequence of chewing tobacco. Stomach cancer is more common in china, Japan and 
some countries of south and Central America and Eastern Europe. Colorectal (large 
bowel) cancer is common in western societies, but has also become increasingly 
common in Japan. liver cancer ,though rare in most parts of the world , occurs more 
commonly in parts of Africa ,eastern Asia ,and the western pacific .the incidence of 
lung cancer is high in north America and Europe and in shanghai (china) ,but low in 
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Africa .epidemic levels of cigarette smoking account for the very high incidence of lung 
cancer in most of the developed countries , and recently this has become increasingly 
true of other parts of the world (5) .breast cancer , the commonest female cancer in the 
world , is very high in the west ,cervical cancer is more common in the developed 
countries , and in many developing countries in the most frequent form of cancer in 
women . Prostate cancer is also common in the west. In high largely as a result of early 
detection through screening. 
In 2006, an estimated 1,399,790 people in the United States will be diagnosed with 
cancer, and 564,830 will die of cancer (6). Last accessed December 14, 2006. .  
Estimates of the premature deaths that could have been avoided through screening vary 
from 3% to 35%, depending on a variety of assumptions. Beyond the potential for 
avoiding death, screening may reduce cancer morbidity since treatment for earlier-stage 
cancers is often less aggressive than that for more advanced-stage cancers (7).  Several 
potential harms must be considered against any potential benefit of screening for 
cancer] Although most cancer screening tests are noninvasive or minimally invasive, 
some involve small risks of serious complications that may be immediate (e.g., 
perforation with colonoscopy) or delayed (e.g., potential carcinogenesis from radiation). 
Another harm is the false-positive test result, which may lead to anxiety and 
unnecessary invasive diagnostic procedures. These invasive diagnostic procedures carry 
higher risks of serious complications. A less familiar harm is overdiagnosis, i.e., the 
diagnosis of a condition that would not have become clinically significant had it not 
been detected by screening. This harm is becoming more common as screening tests 
become more sensitive at detecting tiny tumors. Finally, a false-negative screening test 
may falsely reassure an individual with subsequent clinical signs or symptoms of cancer 
and thereby actually delay diagnosis and effective treatment. 
In developing the cancer screening summaries, the PDQ Screening and Prevention 
Editorial Board uses the following definitions:  
- Screening is a means of detecting disease early in asymptomatic people.  
Positive results of examinations, tests, or procedures used in screening are usually not 
diagnostic but identify persons at increased risk for the presence of cancer who warrant 
further evaluation.  
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- Diagnosis is confirmation of disease by biopsy or tissue examination in the work-up 
following positive screening tests. (Following a positive screening result, cancer can 
often be ruled out by procedures other than biopsy or tissue examination.)  
 
2.5. Economical impacts of cancer 
The economic burden of cancer is the most obvious in health care cost, such as those for 
hospital, other health services, and drugs. Indirect costs arise from loss of productivity 
as a result of illness and premature death of those affected. Direct cost may be estimated 
fairly readily in situations where the nature and extent of services provide to cancer 
patient are known. Calculation of indirect costs, however, involves making assumptions 
concerning both expected future earning and a discount rate to convert potential earning 
in to a current amount one estimate of direct cancer care costs in the united state of 
America in 1990 was US$ 27.5 BILLION, the corresponding indirect costs of 
premature mortality from cancer amounting to almost US$ 59BILLION. 
 
Beyond these numbers, the common reality, especially in poor area, is a profound 
economic family crisis. A diagnostic of cancer in one of the adults in family may lead 
not only to the loss of a source of income, but also all too frequently to exhausting the 
family’s remaining income and resources in seeking treatment. Perhaps saddest of all 
are the futile frantic searches and large amount of money paid by the family for 
treatments that can-not prolong the life of the family member with advanced cancer. If 
families feel abandoned by their formal health care system, they may spend their 
remaining resources seeking assistance from well-meaning or unscrupulous individuals 
who falsely promise to help. 
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Table 4 incidence of most common cancer, 2000 
                 Males        Female          
Rank cancer new cases (thousand)     Rank cancer new cases  (000)      
1- lung                          902    1-  breast               1050 
2-  stomach                   558 2-  cervix                  471 
3-  prostate                    543 3-  colon/rectum      446  
4-    colon/rectum         499 4-  lung                    337  
World  
5-  liver                         398 5-  stomach              318 
1-  lung                         471    1-  breast                  579 
2-   prostate                  416 2-  colon/rectum      292 
3-   colon/rectum         319 3-  lung                    175 
4 -  stomach                 208  4-  stomach              125 
More developed 
countries  
5-  Bladder                   164 5-  corpus uteri        114 
1-  lung                         431 1-  breast                  471 
2-   stomach                 350 2-  cervix                 379  
3-  liver                        325 3-  stomach              193 
4-  Oesophagus            224 4-  lung                    162 
Less developed 
countries  
5-  colon/rectum          180 5-  colon/rectum       154 
2.6. Psychosocial and Economic impacts of cancer; 
Regardless of prognosis ,the initial diagnosis cancer still perceived by many patients as 
a life-threatening event .over one-third of patients experience clinical range anxiety and 
\or depression. Surprisingly, dieses severity, prognosis, and type of treatment do not 
seem to have a large impact on psychosocial adjustment to cancer. However, patients 
who can achieve mastery over their illness adjust well to their cancer. 
 
Cancer can be equally, if not more, distressing for family and friend. Family income 
loss, social isolation, family tensions, and adverse effects on daily functioning in the 
family may follow closely on the occurrence of cancer. Similarly, health care providers 
are not immune to the psychosocial effects of caring for people with cancer. Workers 
who frequently see sick and dying patients, or who can not provide assistance to their 
patients in the manner they want, are at risk for “staff burn-out”. This syndrome is 
characterized by emotional exhaustion and de-personalization of the patient, and has 
been linked to job absenteeism, insomnia, substance abuse and physical complaints.                          
      
2.7. Approaches to cancer control:  
Disease-specific mortality has been the most widely accepted endpoint in randomized 
clinical trials of cancer screening; however, the validity of this endpoint rests on the 
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fundamental assumptions that the cause of death can be accurately determined and that 
the screening and subsequent treatment have negligible effects on other causes of death. 
Recent reviews of randomized clinical trials of cancer screening suggest that 
misclassification in cause of death has been a major problem and that misclassification 
has led to an overestimation of the effectiveness (or an underestimation of the harms) of 
screening (8 - 9).  In contrast to disease-specific mortality, all-cause mortality depends 
only on an accurate ascertainment of deaths and when they occur and therefore is not 
affected by misclassification in cause of death. One major limitation of the all-cause 
mortality endpoint however is that it is unlikely to reveal a statistically significant effect 
of cancer screening because this intervention is usually targeted to a disease that causes 
only a small proportion of all deaths. Nevertheless, all-cause mortality should be 
considered in conjunction with disease-specific mortality to reduce the possibility that a 
major harm (or benefit) from screening is hidden by misclassification in cause of death.  
 
The four principal approaches to cancer control are:  
- Prevention: prevention means eliminating or minimizing exposure to the causes of 
cancer, and includes reducing individual susceptibility to the effect of such causes. This 
approach offers the greatest public health potential and the most cost-effective long –
term method of cancer control.  tobacco is the leading single cause of cancer worldwide 
and the fight against cancer every country should give highest priority to tobacco 
control. 
- Early detection: increasing awareness of the signs and symptoms of cancer 
contributes to early detection of the disease.  Where tests for cancer of specific sites are 
available, and facilities are appropriate, screening of apparently healthy individuals can 
disclose cancer in early or precursor stage, when treatment may be most effective. Early 
detection is only successful when linked to effective treatment.  
- Diagnosis and treatment:   cancer diagnosis cells for a combination of careful 
clinical assessment and diagnostic investigation. Once diagnosis is confirmed, it is 
necessary   to ascertain cancer staging to evaluate the extension of the disease and be 
able to provide treatment accordingly. Cancer treatment aims at curing, prolonging use 
full life and improving quality of life. Treatment services should give priority to early 
detectable tumors and potentially curable cancers. In addition, approaches should 
include psychosocial support, rehabilitation and close coordination with palliative care 
to ensure the best possible quality of life for cancer patients.  
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- Palliative care: in most of the world, the majority of the cancer patients present with 
advanced disease. For them, the only realistic treatment option is pain relief and   
palliative care. Effective approaches to palliative care are available to improve the 
quality of life for cancer patients. 
 
However, cancer control can be adopted through preventive measure.  It is possible to 
mitigate the spread of malignant diseases by:                                                     
- tobacco control;  
- healthy diet ; 
- physical activities and avoidance of obesity ; 
- reducing alcohol use , 
- reducing carcinogenic occupational and environment exposures; 
- immunization against hepatitis B virus ; 
- avoidance of prolonged exposure to the sun; 
- Health education, relating to sexual and reproductive factors associated with 
cancer. 
 
Action on tobacco use is universally needed, but the priorities accorded to other 
components of the programmer will depend on the results of a situation analysis of the 
country concerned, covering the actual and forecast burden of cancer cases in the 
country; and the estimated proportion of potentially preventable cases. A broad range of 
health promotion activates are appropriate to cancer control and these are examined in 
detail at the end of this chapter. 
 
 
2.8. Diagnosis and treatment of cancer 
Most malignant diseases present with common constitutional symptoms e.g. fever, loss 
of appetite, loss of energy and loss of weight, and also they may present with specific 
symptoms depending on the anatomical and physiological nature of the disease.  
Diagnosis could be confirmed by peripheral blood picture, bone marrow aspirate or 
biopsy, histopathological biopsy plus or minus imaging.  At least 2 requirements must 
be met for screening to be efficacious (10):  
- A test or procedure must be available to detect cancers earlier than if the cancer 
were detected as a result of the development of symptoms.  
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- Evidence must be available that treatment initiated earlier as a consequence of 
screening results in an improved outcome.  
 
These requirements are necessary but not sufficient to prove the efficacy of screening, 
which requires a decrease in cause-specific mortality. For example, these two criteria 
are met in the case of screening for childhood neuroblastoma by assessment of urinary 
catecholamine metabolites. On the basis of these criteria, a mass screening program was 
conducted in Saitama Prefecture, Japan, from 1981 to 1992 for 6-month-old infants 
(11).   Over that 12-year period, the annual incidence of neuroblastoma in children 
younger than 1 year increased from about 28 per million to 260 per million but without 
a significant reduction in incidence in children older than 1 year. Because there also was 
no reduction in mortality for the disease, this experience provided strong evidence of 
overdiagnosis—diagnosis of some neuroblastomas detectable by screening, which 
would not have been clinically diagnosed later. Similar experiences have been reported 
elsewhere in Japan (12) and in the Quebec Neuroblastoma Screening Project (QNSP) in 
Canada. The history of screening for neuroblastoma also provides a useful illustration of 
the benefit of undertaking well-designed evaluations of emerging screening 
technologies before implementing screening programs. Although such studies are very 
costly, it has been shown that the QNSP itself averted unnecessary morbidity for 
thousands of children and did so while returning a yield plausibly estimated at a cost 
savings 64.5 times the investment in the study (13).   
 
The cancer screening summaries are based on various levels of published scientific 
evidence and collective clinical experience. The highest level of evidence is taken as 
mortality reduction in controlled, randomized clinical trials. The results of clinical 
studies, case-control studies, cohort studies, and other information are also considered 
in formulating the summaries. In addition, the incidence of cancer, stage distribution, 
treatment, and mortality rates are considered. The summaries are subject to modification 
as new evidence becomes available (14).  
 
Cancers can be diagnosed at different stages in their development. Stage of cancer 
diagnosis may be expressed as numbers (I, II, III, or IV, for example) or by terms such 
as "localized," "regional," and "distant." The lower the number or the more localized the 
cancer, the better a person's chances of benefiting from treatment and being cured.  
Tracking the rates of distant, or late, cancers is a good way to monitor the impact of 
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cancer screening. When more cancers are detected in early stages, fewer should be 
detected in late stages. 
 
2.9. Observed Patterns of Cancer Stage at Diagnosis  
National Cancer Institute gathers cancer incidence data from 11 geographic areas, 
covering approximately 14% of the US population. These population-based data of long 
duration (1973-present) are a unique and important resource in monitoring stage-related 
survival. Interpreting Changes in Relative Survival Over Time.   Increases in survival 
over time, however, even when based on data from tumor registries, such as SEER that 
include all cases in a given population, are difficult to interpret. They may reflect the 
benefits of early detection or improved treatment or both, but they may also result from 
lead-time bias and overdiagnosis, both of which occur commonly with screening (15).  
 
Lead-time bias will result in longer estimated survival of people with cancers that have 
been identified through screening because the time before the cancer would have been 
diagnosed clinically is included in the calculation of survival. 
 
Overdiagnosis may result from finding cancers that would never have become manifest 
clinically. By definition, these cancers have a good prognosis. For example, autopsy 
series have shown a high percentage of occult early prostate carcinomas in elderly men 
who died of causes unrelated to prostate cancer (16).  The discovery of these cancers 
through screening could increase the number of cases and give the appearance of stage 
shift, and of increases in survival or cure rates, without necessarily reducing mortality. 
An analysis of data reported by the SEER program for 1950 to 1996 found that changes 
over time in 5-year relative survival rates for 20 major cancers were essentially 
unrelated to trends in mortality rates for those cancers over the same period (17).] The 
authors suggest that changes in 5-year survival rates are largely due to earlier diagnosis 
and to detection of subclinical cases that might never have surfaced clinically. They 
conclude that inferences about the effectiveness of early diagnosis or treatment should 
not be drawn from temporal changes in 5-year survival rates, but rather should be based 
on changes in mortality rates. Thus, changes in 5-year survival rates or stage shifts are 
not appropriate measures of the effectiveness of screening for early disease. Reductions 
in incidence rates for late-stage tumors represent a better measure of progress due to 
screening than 5-year survival trends, although such evidence is less compelling than 
reductions in mortality.  
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2.10. Treatment of cancer 
For nearly all cancers, treatment options and survival are related to stage, which is 
generally characterized by the anatomic extent of disease. On this basis, it is assumed 
that early detection of cancer, at an earlier stage, may yield better outcomes. In the 
1940s, a generalized staging classification of localized, regional, and distant disease was 
developed to show long-term trends, and it is still useful. In the more detailed TNM 
system, which has been periodically modified, the Tumor size, the status of the lymph 
Nodes, and the status of distant Metastases are also categorized. These elements are 
grouped into stages 0-IV according to their association with survival. In general, larger 
primary malignant tumors have a higher incidence of metastasis to regional lymph 
nodes and to distant sites. Stage has such a profound effect on outcome that all 
randomized treatment trials require the comparison of similar stages in evaluating 
differences in outcome. Shifts in stage may also herald improved survival and decreased 
mortality, though stage shift alone does not establish benefit.  
 
Biologic cellular characteristics of cancer, such as grade, hormone sensitivity, and gene 
overexpression are recognized as important predictors of cancer behaviors. For 
example, high-grade cancer may be fast growing and quick to metastasize regardless of 
stage at the time of diagnosis. Therefore, detection of these cancers when small may not 
affect outcome. Randomized controlled trials with survival outcomes are necessary to 
prove screening benefits.  The treatment of cancer is mainly palliative and in small 
minority it is curative. It is provided in the form of radiotherapy, chemotherapy, surgery 
or combination of these.  Generally, prognosis is poor and mortality is high. This 
depends on the nature, stage, metastasis and differentiation of cells.  Direct or assisted 
visual observation is the most widely available examination for the detection of cancer. 
It is useful in identifying suspicious lesions in the skin, retina, lip, mouth, larynx, 
external genitalia, and cervix.  The second most available detection procedure is 
palpation to detect lumps, nodules, or tumors in the breast, mouth, salivary glands, 
thyroid, subcutaneous tissues, anus, rectum, prostate, testes, ovaries, and uterus and 
enlarged lymph nodes in the neck, axilla, or groin.  Internal cancers require procedures 
and tests such as endoscopy, x-rays, magnetic resonance imaging, or ultrasound. 
Laboratory tests, such as the Pap smear or the fecal occult blood test have been 
employed for detection of specific cancers (15).  
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The performance of screening tests is usually measured in terms of sensitivity, 
specificity, and positive-predictive values (PPV) and negative-predictive values (NPV). 
Sensitivity is the chance that a person with cancer has a positive test. Specificity is the 
chance a person without cancer has a negative test. PPV is the chance that a person with 
a positive test has cancer. NPV is the chance that a person with a negative test does not 
have cancer. PPV and, to a lesser degree, NPV are affected by the prevalence of disease 
in the screened population. For a given sensitivity and specificity, the higher the 
prevalence, the higher the PPV.  
 
Experimental trials are designed to correct for or eliminate selection, lead-time, length, 
healthy volunteer, and other biases when prospectively testing a detection procedure to 
determine its effect on health outcome. The highest level of evidence and greatest 
benefit from screening is mortality reduction in a randomized controlled trial. For most 
sites, such evidence is not available. Theoretically it is possible to conduct randomized 
trials for most interventions, but the sample size that is needed, the expense, and the 
duration of such trials for most cancers, frequently make this approach impractical. 
Therefore, evidence obtained by other methods is often used.  
 
Case-control and cohort studies provide indirect evidence for the effectiveness of 
screening, but it is difficult to eliminate the contribution of selection bias and healthy 
volunteer biases evident in these studies.  Ecological studies can demonstrate 
association between the use of screening and a stage shift in cancer that can provide 
indirect evidence of the value of screening. Such evidence is particularly compelling for 
the effectiveness of screening for cervical cancer (18). Ecological correlation of 
mortality and intensity of screening has been used in this context. Such studies do not 
prove a mortality-reduction effect, and the potential for bias to invalidate inferences 
from nonexperimental studies or to give misleading results can be substantial (19 - 20). 
Descriptive uncontrolled studies based on the experience of individual physicians, 
hospitals, and nonpopulation-based registries may yield some information about 
screening. The performance characteristics of various detection tests, such as sensitivity, 
specificity, and PPVs, are generally first reported in such descriptive studies. The first 
evidence that screening may be successful is an increase in the incidence of early 
cancers as well as a decreased incidence of late-stage metastatic cancers (stage shift); 
later, a reduction in deaths may occur. These descriptive studies do not establish 
efficacy because of the absence of an appropriate control group. 
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Chapter III 
Methodology 
 
3.1. Source of data 
In this study secondary data was used to attain the objectives of the study.  The 
secondary data was obtained from patients’ information registry of the Federal Ministry 
of Health (FMOH), Sudan National lab (STAC), and Radiation and Isotopes Center 
(RIC) for the period Januay,1-2000 –December, 31- 20004 (five years).  The number of 
registered patients from the registry of RIC was  patients, and 4154 patients from the 
registry of Sudan national Lab (STAC).  The secondary data obtained from these two 
sources were raw data, while the data of the F.M.O.H 13855 patients from the registry 
of S.N. lab was obtained as summary sheet of cases.  The data of RIC and STAC were 
obtained as raw data (directly from the registry information handbook), while the data 
of FMOH was obtained as a summary data (results).  The data of the FMOH was used 
to provide a chance of making comparison between the findings of STAC and RIC. 
 
3.2. Data processing 
The raw data of STAC and RIC were subjected to processing.  Patients were stratified 
according to their source of origin into six categories based on their geographic 
locations (north, east, west, south, central and Khartoum).  All the patients from greater 
Kordofan and Darfur were considered as from western Sudan, and all the patients of the 
southern states were considered as from south region.  The same criterion was applied 
for the states of northern Sudan (north region) and eastern Sudan (east Sudan).  The 
White Nile State and Gezira State was considered as central Sudan.  Khartoum State 
was considered as independent region because the bulk of the patients were from the 
state.  Moreover, the age of patients was stratified on 10 years basis.  There were some 
patients of age less than ten years and some other above ninety years.  Between the two 
extremes the rest of the patients distributed among the different age classes.  Table (3.1) 
shows the actual registered patients and the valid number of patients. Patients, whose 
information was incomplete in the registry (missing age or diagnosis) were excluded 
from the study. 
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Table (3.1): Patients information registry of STAC and RIC 
STAC 
RIC Year  
Registered data 
Valid 
data 
% Registered data Valid 
data 
% 
2000 928 425 19.5 2316 2193 15.1 
2001 650 227 10.4 2826 2642 18.2 
2002 736 274 12.6 2896 2817 19.4 
2003 1052 685 31.4 3205 3122 21.5 
2004 788 569 26.1 3681 3747 25.8 
Total  4154 2180 100 14924 14521 100 
 
3.3. Data entry and analysis 
Data coding was made first followed by data entry in excel spreadsheet computer 
program.  Prior to data analysis, the data was transferred to SPSS (Statistical Package 
for Social Science).  Different analyses were made mainly; descriptive statistics 
(frequency and cross tabulation) and ANOVA analysis for sake of examine the 
significance of cancer in relation to gender, age groups and source of origin.  The SPSS 
program provided the chance of organizing the data into histograms and tables.  
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Chapter IV 
Results 
 
 
4.1. Malignant diseases in the Sudan 
The material under study consists of more than sixteen thousand cancer cases for the 
period 2000 – 2004 (five years) according to the records of Radiation and Isotopes 
Centre and Stac laboratories (14521 and 2180, respectively).    These cases were 
grouped into neoplasms of the oral cavity and pharynx (lip, tongue, salivary gland, 
mouth, oropharnx, nasophrynx and hypopharynx); neoplasms of digestive organs 
(oesophagus, stomach,bowel, liver, gall bladder and pancreas); neoplasms of respiratory 
system (nasal sinuses, larynx, and lung); bone and connective tissue tumors (bone 
neoplasms, connective tissue, Kaposi sarcoma); skin neoplasms (malignant melanoma, 
other skin); breast; neoplasms of female genital organs (cervix, chorion carcinoma, 
body utrus, ovary and other female genital organs); neoplasms of male genital organs 
(prostate, testis, and penis); urinary tract neoplasms (bladder and  kidney); lymphoma 
(Non Hodgkin's lymphoma); Leukemia (lymphatic leukemia and Meyloid leukaemia) 
other malignant neoplasms (eye, central, nervous system, thyroid).   
 
In this chapter the pattern of malignant neoplasms in Sudan were explored according to 
the frequency of incidences, age groups, sex and geographical distribution of malignant 
neoplasms.   Moreover, the malignant neoplasm were grouped into two categories, 
namely; high and low frequency malignant diseases 
 
4.1.1. Pattern of malignant neoplasms in Sudan 
According to the records of RIC the number of malignant neoplasm recorded for the 
period 2000 – 2004 is about 14521 cases.  Table 4.1 shows the main malignant 
neoplasms and their frequency.  The findings of the above-mentioned table reveals that 
the neoplasms of the digestive organs represent the main cases of malignant neoplasms 
according to the records of RIC where 21.5% (3136 cases) of the registered cases 
showed incidence of neoplasms of digestive organs followed by breast cancer (18.2%).  
A neoplasm of female genital organs is also relatively high compared to other malignant 
diseases where 11% of the cancer cases belong to this group according to RIC records.  
Incidence of leukemia represents 8.9% of the registered malignant neoplasm, while 
neoplasms of the oral cavity and pharynx represent 7.8%.  Lymphoma accounts for 
6.5% of the cases while head and neck malignant neoplasms represent 6.1% of the 
registered cases.  The first ranked malignant neoplasm (neoplasms of digestive organs, 
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breast, neoplasms of female genital organs, leukemia, neoplasms of the oral cavity and 
pharynx, lymphoma and head and neck) represent the high frequency malignant 
neoplasms (80%) according to the records of RIC for the period 2000 – 2004. 
 
Table (4.1): Malignant neoplasms in Sudan (RIC 2000 – 2004) 
Cumulative % Percent  Patients  
21.5 21.5 3136 Neoplasms  of digestive organs 
39.7 18.2 2640 Neoplasms of breast  
50.7 11 1602 neoplasms of female genital organs 
59.6 8.9 1293 Leukemia 
67.4 7.8 1137 neoplasms of the oral cavity and pharynx 
73.9 6.5 937 lymphoma  
80 6.1 887 Head and neck 
84.7 4.7 683 other malignant neoplasms  
88.8 4.1 583 Musculoskeletal  
92.8 4.0 581 neoplasms of male genital organs 
95.2 2.4 351 neoplasms of respiratory system 
97.4 2.2 313 urinary tract neoplasms 
99 1.6 239 skin neoplasms 
100 1 149 bone and connective tissue tumours 
 100 14521 Total  
 
The low frequency malignant neoplasms is represented by musculoskeletal, neoplasms 
of male genital organs, neoplasms of respiratory system, urinary tract neoplasm, skin 
neoplasms, bone and connective tissue tumor and other malignant neoplasms which 
collectively represent 20% of the registered cancer incidences for the period 2000 – 
2004 (Table (4.1)). 
 
4.1.2. Geographical distribution of malignant neoplasms in Sudan 
According to the records of RIC, almost all the country witness cases of malignant 
neoplasms.  Table (4.2) shows the incidences of malignant neoplasms for the period 
2000 – 2004.  From the above-mentioned table it is evident that Khartoum State 
represents the main source of malignant neoplasms where 32.1% of the patients of 
malignant neoplasms in the country were from the state followed by patients from 
Central Sudan (29.3%).  Khartoum State and Central Sudan represent the bulk of 
malignant neoplasm incidences in the Sudan according to the records of RIC for the 
period 2000 – 2004 where they collectively represent 61.4% of all the cases of 
malignant neoplasms.  This finding could be verified by the fact that spatial distribution 
of patients is behind the high registered cases in RIC.  The number of malignant 
neoplasms in Western Sudan is relatively high compared to other regions were 2351 
patients (16.2%) were registered in RIC records for malignant neoplasm compared to 
25 
 
1752 patients (12.1) from Northern Sudan.  This variation might be attributed to the fact 
that western Sudan in this study encompasses devastated areas (greater Kordofan and 
Darfur Regions). 
 
Table (4.2): Geographical distribution of malignant neoplasms in Sudan  
Cumulative Percent Valid Percent Percent Frequency  
32.1 32.1 32.1 4664  Khartoum 
61.4 29.3 29.3 4255  Central Sudan 
73.5 12.1 12.1 1752  Northern Sudan 
89.7 16.2 16.2 2351  Western Sudan 
98.1 8.4 8.4 1223  Eastern Sudan 
100.0 1.9 1.9 276  Southern Sudan 
 100.0 100.0 14521 Total 
 
Incidence of malignant neoplasms in Eastern and southern Sudan is relatively low 
compared to the other regions.  Patients from Eastern Sudan represent 8.4% of the 
registered cases compared to 1.9% from southern Sudan. 
 
It is clear from the above finding that there is significant variation in malignant 
neoplasms among the different regions.  Table (4.3) showed that there is significant 
variation in malignant neoplasms at probability level 0.000 where the F-value is 7.829.  
 
Table (4.3): ANOVA table for malignant neoplasms among different regions 
Sig. F Mean Square df Sum of Squares . 
.000 7.829 15.153 13 196.988 Between Groups 
  1.936 1450728079.758 Within Groups 
   1452028276.746 Total 
 
The post Hoc test (Duncan test) for the distribution malignant neoplasms revealed that 
there is insignificant difference (p = 0.073) in breast, neoplasms of male genital organs 
and neoplasms of respiratory orgasm among the different regions (Table (4.4)), and the 
incidence of these malignant neoplasms is significant difference from the other 
malignant neoplasms.   Also there is insignificant difference at probability level 0.081 in 
the incidences of neoplasms of oral cavity and pharynx, neoplasms of female genital 
organs, musculoskeletal, neoplasms of digestive organs and Leukemia among the 
different regions.  The rest of the malignant neoplasms (skin neoplasms, urinary tract 
neoplasms, other malignant neoplasms, bone and connective tissue tumors, lymphoma 
and neoplasms of head and neck) are insignificantly different at probability 0.081. 
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Table (4.4): Duncan test for the distribution of malignant neoplasms in regions 
 Subset for alpha = .05  
3  2 1 
N  
  2.2379 2640  Neoplasms of breast 
  2.3391 581  Neoplasms of male genital organs 
  2.4017 351  Neoplasms of respiratory organs 
 2.4371  1137  Neoplasms of oral cavity and pharynx 
 2.4482  1602  Neoplasms of female genital organs 
 2.4700  583  Musculoskeletal neoplasms 
 2.5086  3126  Neoplasms of digestive organs 
 2.5143  1293  Leukemia 
2.5481   239  Skin neoplasms 
2.5495   313  Urinary tract neoplasms 
2.5520   683  Other malignant neoplasms 
2.5839   149  Bone and connective tissue tumors 
2.5912   937  Lymph 
2.5998   887  Neoplasms of head and neck 
.058 .081 .073  Sig. 
 
4.1.3. Patterns of malignant neoplasms according to age group 
It seems that all age groups are liable to malignant neoplasms.  The percent of incidence 
in children of 1 – 10 years old is low where only 4.5% were registered for malignant 
neoplasms.  The percentage increase with age, 5.8% of patients lies within the range of 
11 – 20 years and 9% lies with the age range of 21 – 30 years.  The three age groups 
represent 19.4% of all the reported cases in CIR records (Table (4.5 )).  The incidences 
of malignant neoplasms increase dramatically with the advance of age.  Patients of 
malignant neoplasms above 31 years represent 80.6% of the total sample.  The age 
group between 31 – 70 years represents the bulk of the cancer cases according to the 
records of CIR for the period 2000 – 2004. 
 
Table (4.5): Malignant neoplasm in different age groups 
Cumulative Percent Valid Percent Percent Frequency Age  group 
4.5 4.5 4.5 660 1-10 
10.4 5.8 5.8 846 11-20 
19.4 9.0 9.0 1307 21-30 
35.1 15.7 15.7 2282 31-40 
52.7 17.6 17.6 2561 41-50 
72.0 19.3 19.3 2800 51-60 
90.4 18.4 18.4 2668 61-70 
100.0 9.6 9.6 1397 >70 
 100.0 100.0 14521 Total 
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Although the findings of the above table furnishes variations of malignant neoplasms 
incidence among different age groups, ANOVA test revealed that there is insignificant 
variation regarding the incidence of malignant neoplasms among the different age 
groups at significance level 0.000 where F-value is 255.267 between groups, and there 
is insignificant difference within the age groups at the same level of significance within 
the age group.  Table (4.6) shows ANOVA table regarding the significance of malignant 
neoplasms among different age groups. 
 
Table (4.6): ANOVA test for malignant neoplasm among age groups 
Sig. F- value Mean Square df Sum of Squares  
.000 255.267 77.051 13 3318.468 Between Groups 
 3.313 14507  48060.969 Within Groups 
 1452 0   51379.437 Total 
 
Duncan test classified the distribution of malignant neoplasms among different age 
groups into three groups.  The first group indicates there is insignificant difference in 
the incidences at significance level 0.473 (subset for alpha = 0.05) of musculoskeletal, 
urinary tract neoplasms, neoplasms of digestive organs, lymphoma, leukemia and 
neoplasms of respiratory organs.  The second group includes cancer incidences of 
breast, skin neoplasms, other malignant neoplasms, neoplasms of head and neck and 
neoplasms of female genital organ.  Cancer incidences of this group are significantly 
different from cancer incidence of the first group regarding age groups, but there is 
insignificant difference among them.   
 
Table (4.7): Duncan test for malignant neoplasms among age groups 
Subset for alpha = .05 
3 2 1 
 Breast 
  3.1904 583  Musculoskeletal 
  3.2716 313  Urinary tract neoplasms 
  3.7649 3126  Neoplasms of digestive organs 
  3.8613 937  Lymphoma 
  3.9698 1293  Leukemia 
  3.9972 351  Neoplasms of respiratory organs 
 4.1405   2640  Breast 
 4.2050  239  skin neoplasms 
 4.2196   683  other malignant neoplasms 
 4.5265  887  Neoplasms of head and neck 
 4.6248  1602  Neoplasms of female genital organs 
4.7599   1137  Neoplasms of oral cavity and pharynx 
4.7785   149  Bone and connective tissue tumors 
5.4458   581  Neoplasms of male genital organs 
.056 .060 .473 14520 Sig. 
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Neoplasms of oral cavity and pharynx, bone and connective tissue tumors are also 
insignificantly different regarding the age groups at probability level 0.056, and they are 
significantly different from cancer incidence of the other two groups (Table (4.7)). 
 
4.1.4. Pattern of malignant diseases according to sex 
 
The distribution of malignant neoplasms according to sex can be used as a monitor to 
trace the disease.  Some diseases are sex specific like neoplasms of male and female 
genital organs.  Generally, it seems that females are more susceptible to cancer diseases 
compared to males.  According to the records of RIC the number of females affected by 
cancer represents 56.6% of all registered cases.  The rest of patients are male (43.4%).  
Fig (4.1) shows the frequency of malignant neoplasms according to sex. 
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Fig. (4.1): Incidence of malignant neoplasm according to sex 
 
According to ANOVA test the F-Value at significance level 0.000 (372.408) indicates 
differences in incidences of malignant neoplasms according to sex (Table (4.8)).  
 
Table (4.8): ANOVA test for malignant neoplasms according to sex 
Sig. F-value Mean 
Square 
df Sum of Squares  
.000 372.408 68.656 13 892.524 Between Groups 
  .184 14507 2674.457 Within Groups  
   14520 3566.981 Total  
 
Duncan test showed four different levels of malignant neoplasms according to sex 
(Table (4.9)).  Neoplasms of male genital organs are significantly different as far as sex 
concerned at significant level 1.000.  This finding is logical since neoplasms of male 
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genital organ are a gender neoplasm.  The bulk of the malignant neoplasms are 
insignificantly different, at significance level 0.071, as far as sex is concerned (skin 
neoplasms, bone and connective tissue tumors, neoplasms of digestive organs, other 
malignant neoplasms, leukemia, neoplasms of oral cavity and pharynx, urinary tract 
neoplasms, musculoskeletal and lymphoma).  Neoplasms of female genital organs and 
breast are insignificantly different (p = 0.230) as far as sex is concerned, and they are 
significantly different from the other group.  Neoplasms of head and neck are 
significantly different from all the other malignant neoplasm at probability level 0.053.  
 
Table (4. 9): Duncan test for malignant neoplasms according to sex 
  Subset for alpha = .05  
4 3 2 1 
N    
   1.0396 581   Neoplasms of male genital organs 
  1.3724  239  Skin neoplasms 
  1.3758  149  Bone and connective tissue tumors 
  1.3887  3126  Neoplasms of digestive organs 
  1.3909  683  Other  malignant neoplasms 
  1.4246  1293  Leukemia 
  1.4274  351  Neoplasms of respiratory organs 
  1.4345  1137  Neoplasms of oral cavity and pharynx 
  1.4601  313  Urinary tract neoplasms 
  1.4837  583  Musculoskeletal 
  1.5005  937  Lymphoma 
 1.7684   1602  Neoplasms of female genital organs 
 1.7724   887  Neoplasms of breast 
1.9682   2640  Neoplasms of head and neck 
.053 .230 .071 1.000   
 
4.1.5. Incidence of cancer in the five years (2000 – 2004) 
The time trend of cancer diseases in the Sudan, according to RIC records, shows 
considerable variation in the number of patients.  The general trend indicates that the 
incidences of cancer diseases increase year by year.  The number of cancer cases 
recorded for the year 2000 is about 2190 cases representing 15.1% of all the cases 
recorded in the RIC for the period 2000 – 2004.  in year 2001 the percentage of 
malignant neoplasms incidences increased to 2627 (18.1% of the total sample).  The 
trend of cancer cases showed a continuous increase year after year.  In 2002 the number 
of malignant neoplasm patients raised to 2824 cases (19.4% of the total sample for the 
period 2000 – 2004) and in year 2003 the number of patients increased to 3128 (21.5%). 
18.1year 2001 (398 cases more than the record of year 2000).  The number of cases for 
year 2002 showed 2002 cases, while in 2003 the number of cancer incidences raised to 
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2186 and the last year (2004) witnessed the peak of the cancer cases (2315).  Fig (4.2) 
shows the time trend for the cancer incidences for the period 2000 – 2004. 
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Fig (4.2): Pattern of malignant neoplasms for the period 2000 – 2004 
 
From the above figure it is clear that malignant neoplasms incidences increase annually.  
Accordingly there is significant difference in cancer incidences according to the records 
of RIC for the period 2000 – 2004.  this finding is supported by ANOVA test (Table 
(4.10) showing that there is significant difference in malignant neoplasms incidence 
among the five years at significance level 0.000 where the F-value is 15.303. 
 
Table (4.10 ): ANOVA test for malignant neoplasms for five years (RIC) 
Sig. F-value Mean Square df Sum of Squares  
.000 15.303 29.779 13 387.133 Between Groups 
  1.946 14507 28230.928 Within Groups  
   14520 28618.061 Total  
 
4.2. Main malignant neoplasm according to RIC (2000 – 2004) 
As mentioned earlier, the malignant neoplasms were classified into two groups 
according to their prevalence (high incidence and low incidence cancer diseases).  Table 
(4.11) shows the main malignant neoplasms according to the records of RIC for the 
period 2000 – 2004 (five years). 
 
Table (4.11): Main malignant neoplasms in the Sudan (RIC 2000 – 2004) 
Cumulative % Valid % % N Malignant neoplasm 
22.7 22.7 22.7 2640  Breast 
49.6 26.9 26.9 3126  Neoplasms of digestive organs 
57.7 8.1 8.1 937  Lymphoma 
68.8 11.1 11.1 1293  Leukemia 
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78.6 9.8 9.8 1137  Neoplasms of oral cavity and pharynx 
86.2 7.6 7.6 887  Neoplasms of head and neck 
100.0 13.8 13.8 1602  Neoplasms of female genital organs 
 100.0 100.0 11622Total 
 
Ranking of the malignant neoplasms revealed that the neoplasms of digestive organs are 
the most common cancer diseases.  More than quarter (26.9%) of the patients of the 
main malignant neoplasm complains from neoplasms of the digestive organs and this 
represent 21.5% of the total cases of registered patients in the RIC records.   Neoplasms 
of breast are the second (22.7%) and represent 18.2% of the total cancer cases.  The 
third malignant neoplasms is neoplasms of female genital organs (13.8%) representing 
11% of the total sample followed by Leukemia (11.1%).  Neoplasms of the oral cavity 
and pharynx, lymphoma and neoplasms of head and neck come next in ranking with 
9.6, 8.1 and 7.6%, respectively. 
 
4.2.1. Neoplasms of digestive organs 
Neoplasms of digestive organs are not an age group or sex specific diseases.  All the age 
groups are liable for cancers of digestive organs, and the same is true for the sex.  The 
total number of patients of malignant neoplasms of the digestive organs is about 3126 
patients 21.5% of the total cancer cases according to the records of RIC for the period 
2000 – 2004.  Table (4.12) shows the distribution of neoplasms of digestive organs 
according to sex and age groups.  The trend of neoplasms of digestive organs among 
different age groups shows a continuous rise in the level of incidence of the diseases 
being low in lower age group (1 – 10 years) and increase steadily up to the age of 70 
years after which the percent of cancer of digestive organs drop.   Nine per cent of the 
neoplasms of the digestive organs fall with the age range of 1 – 10 years, while the 
percent for the age group 11 – 20 years is 9.7%.  The number of cases of neoplasms of 
the digestive organs starts to be apparent starting from age 20 years.  The percent of 
patients of age 21 – 70 years represent about 73% of the cases and the most liable age 
group to incidence of neoplasms of the digestive organs is between 51 – 60 years.  The 
level of neoplasms of digestive organs is lowest after 70 years (8.4%).   
 
As far as sex is concerned, the incidence of neoplasms of digestive organs is much 
higher in males compared to females where males' cancer cases represent 61.1% of the 
total sample.  The level of cancer incidence among males is relatively high in age group 
41-50, 51-60 and 61-70 years.  The trend of incidence of neoplasm of digestive organs 
among males shows a fluctuating pattern being lowest at age groups 21 – 30 and above 
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70 years.  For females, incidences of neoplasms of digestive organs show a considerable 
increase in the cancer incidences with the advance in age up to 60 years of age, after 
that it starts to decline.   
 
Table (4.12): Distribution of digestive organs cancer among sex and age  
Male Female Total  
 N % N % N %  
1-10 190 6.1 92 2.9 282 9.0 
11-20 189 6.0 115 3.7 304 9.7 
21-30 185 5.9 133 4.3 318 10.2 
31-40 224 7.2 186 6.0 410 13.1 
41-50 291 9.3 212 6.8 503 16.1 
51-60 315 10.1 215 6.9 530 17.0 
61-70 336 10.7 180 5.8 516 16.5 
>70 181 5.8 82 2.6 263 8.4 
Total  1911 61.1 1215 38.9 3126 100 
 
 
ANOVA table revealed that there is insignificant difference among age groups 
regarding neoplasms of digestive organs at significant level 0.000 where the F-value is 
76.826 (Table (4.13 )). 
 
Table (4.13): ANOVA table of digestive orgasm cancer among age groups 
Sig. F  Mean Square df Sum of Squares  
.000 76.826 248.931 6 1493.584 Between Groups 
  3.240 1161537634.944 Within Groups  
   1162139128.528 Total  
 
The cross tabulation of age group and sex for the neoplasms of digestive organs showed 
Pearson X2 value as 26.131 (p = 0.000) and indication of significant differences in 
neoplasm of digestive organs and sex and the linear-by-linear association is 1.043 at 
significance level 0.307 (Table (4.14)). 
 
Table (4.14): Pearson X2 for age groups and gender cross tabulation 
Asymp. Sig. (2-sided) df value  
.000 7 26.131  Pearson Chi-Square 
.000 7 26.321  Likelihood Ratio 
.307 1 1.043  Linear-by-Linear Association 
  3126  N of Valid Cases  
 
Regarding the geographical and time trend of the neoplasms of the digestive organs, 
most of the registered cases were from Khartoum State (30.2%), Central Sudan (29.6%) 
and Western Sudan (17%).  The percentage of patients from these three regions account 
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for 76.8% of patients registered for neoplasms of digestive organs.  Incidences of 
neoplasms of digestive organs are also high in patients from Northern Sudan (12.5%), 
while the percentages of patients from Easter and Southern Sudan is relatively low 
compared with the other regions (8.1 and 2.6%, respectively (Table (4.15)). 
 
Table (4.15): Incidence of digestive organs cancer in the Sudan (RIC) 
 N 2000 2001 2002 2003 2004 Total  
Khartoum 945 7.3 9.4 7.7 4.9 .9 30.2 
Central Sudan 925 3.4 4.2 5.1 6.5 10.5 29.6 
Western Sudan  530 1.7 2.6 3.7 4.2 4.9 17.0 
Northern Sudan 392 1.7 2.0 2.1 3.8 3.0 12.5 
Eastern Sudan 253 .9 1.9 1.4 1.7 2.1 8.1 
Southern Sudan 81 .2 .2 .3 1.1 .9 2.6 
 3126 15.1 20.3 20.3 22.1 22.3 100 
 
ANOVA test revealed significant variation in incidences of neoplasms of digestive 
organs at significance level 0.000 where the F value for neoplasm of digestive organs 
among the different region is 14.850.  this finding is supported by the great differences 
in the incidence of cancer cases among the different region (Table (4.16)). 
 
Table (4.16): Test of significance of digestive organs cancers among regions 
 F Mean Square df Sum of Squares  
.000 14.850 28.915 6 173.488 Between Groups 
   1.947 11615 22616.186 Within Groups 
    11621 22789.674 Total 
 
As far as time trend of neoplasms of digestive organs is concerned, there is subtle 
variation in the percentages of incidence for the period 2000 – 2004.  the general trend 
shows a continuous increase in the percentages of cancer incidences except for the years 
2001 and 2002 which showed similar percentages of cancer incidence.  The pattern of 
incidences in Khartoum State, Eastern Sudan and Southern Sudan shows a fluctuating 
pattern, while for the rest of the regions (Central Sudan, Western Sudan and Northern 
Sudan the trend of neoplasms of digestive organs shows a steady increase of incidences 
with advance of years.  However, the ANOVA test (Table (4.17)) shows significant 
variation in neoplasms of digestive organs regarding the time trend of the incidences. 
 
Table (4.17): Test of significance of time trend of digestive organs cancer 
 F Mean Square df Sum of Squares 
.000 16.564 32.009 6 192.052  Between Groups 
   1.932 11615 22444.468  Within Groups 
    11621 22636.520  Total 
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Different types of neoplasms of digestive organs were registered in the records of RIC 
for the period 2000 – 2004.  the main malignant neoplasms affecting the digestive 
organs are Oesphagus (25.7%), Stomach (13.9%), Gall bladder (12.3%), Large bowel 
(10.6%), Rectum (10.5%), Sarcoma (9.2%), Colon (7%), Liver (5.1%), and other 
neoplasms of digestive organs (Pancreas, Carcinoma, Characinoid and anal) represent 
5.4% of the neoplasms of digestive organs patients.  Appendix (1) shows the different 
neoplasms of digestive organs.  The first five neoplasms of the digestive organs 
(Oesphegus, Stomach, Gall bladder, large bowel and Rectum) account for about three 
quarters (73%) of neoplasms of the digestive organs.  More that half (73%) of the 
patients of the neoplasms of the digestive organs, and the rest of the diseases (Sarcoma, 
Colon, Liver, Pancreas, Carcinoma, Carcinoid and anal) represent 27% of the registered 
cases.  From this finding it is clear that the first group of neoplasms of the digestive 
organs is the most common compared to the others. 
 
Fig (4.3) shows the time trends of the main neoplasms of the digestive organs 
(Oesphagus, Stomach, Gall bladder, Large Bowel and rectum).  Almost all the 
incidences of the main neoplasms of the digestive organs are increasing with advance of 
years except the neoplasms of large bowel which shows increase and start to diminish in 
years 2003 and 2004. 
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Fig. (4.3): Time trends for the main neoplasm of digestive organs (RIC) 
4.2.2. Breast cancer disease 
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Breast cancer is the second most dominant disease that prevails almost in the whole 
country.  About 2640 patients were registered in the records of the RIC during the 
period 2000 – 2004.  breast cancer patients represents 22.7% of the patients of main 
malignant neoplasms, and 18.2% of the total sample of patients (14521).  The 
prevalence of the disease is not site specific where all the regions of the country 
witnessed incidence of breast cancer.  However, there is significant variation in breast 
cancer incidences in the different regions being higher in Khartoum where 38.3% of the 
breast cancer diseases are from Khartoum State (10% of all the cancer cases for the 
period 2000 – 2004) followed by patients from Central Sudan (28%).  The number of 
breast cancer incidence in the Northern Region is also high (364 cases) representing 
13.8% of all the breast cancer cases for the period of 2000 – 2004.  In southern, western 
and eastern Sudan the percent of breast cancer incidence is relatively low compared to 
the above-mentioned regions.  In western Sudan the percent of breast cancer incidence 
is 12.2 compared to 6.7 and 1% for eastern and southern Sudan, respectively. 
As far as sex is concerned, incidence of female breast cancer disease is the most 
dominant where 96.7% of the patients of this disease are females while the male breast 
diseases account for 3.3% of all the cases of breast cancer disease in the whole country 
during the period 2000 – 2004 (RIC records).  Table (4.18) shows the distribution of 
breast cancer diseases according to sex in the different region of the country. 
Table (4.18): Breast cancer disease according to sex in the different regions 
Male female  
% N % N  
2.8 28 97.2 983  Khartoum 
3.6 27 96.4 713  Central Sudan 
3.0 11 97.0 353  Northern Sudan 
4.3 14 95.7 308  Western Sudan 
2.8 5 97.2 171  Eastern Sudan 
3.8 1 96.2 25  Southern Sudan 
3.3 86 96.7 2553 Total  
Female breast cancer disease is higher in Khartoum, Central Sudan, Northern Sudan and 
Western Sudan, and low in Eastern and Southern Sudan.  The male breast disease 
follows the same trend. Table (4.18) shows the significant difference in the breast 
cancer diseases among the different regions where Pearson X2 is 2.526 at significant 
level 0.773.    
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Table (4.18): Chi-square test for breast cancer disease in the regions 
Asymp. Sig. (2-sided) Value df  
.773 2.526 5 Pearson Chi-Square 
.785 2.446 5 Likelihood Ratio 
.426 .634 1 Linear-by-Linear Association 
  2639   N of Valid Cases 
The time trend of breast cancer diseases shows that the percentage of incidences 
increases year after year (Fig. 4.4).  The percentage of breast cancer incidence in 2000 
represent 15.4 of the total patients and the percentage increased to 18.7 in 2001 and 18.8 
in 2002.  In 2003 the number of breast cancer patients increased dramatically ( 22.2%  
of the patients), and in 2004 they represent 24.9% of all breast cancer diseases. 
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Fig. (4.4): Time trend of breast cancer disease in the Sudan (2000 – 2004) 
 
Comparing male and female breast cancer disease, male breast cancer disease shows 
fluctuating pattern and not increased steadily as in the case of all breast cancer diseases.  
Fig. (4.5) shows the time trend of males and females in the sudan for the period 2000 – 
2004. 
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Fig. (4.5): Males and females breast cancer diseases for the period 2000 - 2004 
 
4.2.3. Neoplasms of female genital organs 
Neoplasms of female genital organs as the name applied are a sex specific malignant 
disease.  The incidence of malignant neoplasms is relatively high compared to other 
malignant diseases where 1602 females consulted the RIC in the period 2000 – 2005 
representing 13.8% of the patients of the above-mentioned main malignant diseases and 
11% of the total sample.  The distribution of the neoplasms of female genital organs 
distributed among the different age groups except for the age class 1 – 10 years where 
none of the patients complaint from the neoplasms of the genital organs.  Table (4.19) 
shows the distribution of neoplasms of female genital organs among different age 
groups.  The percent of cancer incidence of female genital organs in the second age 
class (11 – 20) is relatively low (2.5%) compared to other age classes.   
 
Table (4.19): Distribution of female genital organs cancer among age groups 
Age 
groups 
Frequency  Percent  Valid percent Cumulative % 
1-10 21 0 0 0 
11-20 52 2.5 2.5 2.5 
21-30 105 6.6 6.6 9.1 
31-40 205 14.8 14.8 23.9 
41-50 292 18.2 18.2 42.1 
51-60 371 23.2 23.2 65.3 
61-70 383 23.9 23.9 89.2 
>70 173 10.8 10.8 100 
Total 1602 100 100  
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Starting from the age class 21 – 30 years, the level of the neoplasm increase, where 
6.6% of the malignant neoplasms of female genital organs belong to this age class. 
After thirties, the level of cancer incidence increase dramatically.  More specifically, 
about 80.1% of the patients of neoplasms of female genital organs fall with the age 
range of 31 – 70 years being highest in the age 51 – 70 years (47.1%) of the patients. 
 
The cross tabulation of age groups to incidences of neoplasms of female genital organs 
showed that there is significant differences in the incidence of cancers among the 
different age classes where X2 value is 23.641 at significance level 0.001and the 
likelihood ration is 22.797 at significance level 0.002 (Table (4.20)). 
 
Table (4.20 ): X2  test for neoplasm of female genital organs for age classes 
Asymp. Sig. (2-sided) 
 
Df Value  
.001 7 23.641  Pearson Chi-Square 
.002 7 22.797  Likelihood Ratio 
.145 1 2.127  Linear-by-Linear Association 
  1602  N of Valid Cases 
 
The significance difference in the neoplasms of female genital organs is apparent in the 
ANOVA test which revealed that there is significant variation among age groups 
regarding neoplasms of female genital organs at significance level 0.000 where the F 
value is 76.826 (Table (4.21)). 
 
Table (4.21): ANOVA test of female genital organs cancer for age classes 
Sig. F Mean Square df Sum of Squares  
.000 76.826 248.931 6 1493.584 Between Groups 
  3.240 1161537634.944 Within Groups 
   1162139128.528 Total 
 
Regarding the time series of neoplasms of female genital organs in the different regions, 
the level of cancer incidence is higher in Khartoum State (34.1%) of the patients of 
neoplasms of female genital organs followed by Central Sudan Region (27.8%), while 
patients from western Sudan represent 15.5%.  Incidences of neoplasm of female genital 
organs are almost similar in patients from Northern and Eastern Sudan (10.7 & 9.9%, 
respectively), while patients from southern Sudan represent just a fraction of the total 
sample (1.8%). Table (4.22) shows the cross tabulation of the time series of neoplasms 
of female genital organs among the different regions. 
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Table (4.22): Neoplasms of female genital organs in the Sudan (RIC) 
Total 2004 2003 2002 2001 2000 N  
34.1 .9 5.7 9.4 8.9 9.2 547 Khartoum 
27.8 9.1 6.9 4.2 3.9 3.6 445 Central Sudan 
10.7 2.1 2.5 2.3 2.4 1.4 171 Northern Sudan 
15.7 3.8 4.0 3.2 2.7 2.1 252 Western Sudan 
9.9 1.4 2.2 1.7 2.2 2.2 158 Eastern Sudan 
1.8 .4 .7 .6 .1 0.0 29 Southern Sudan 
100 17.7 22.1 21.4 20.3% 18.5 1602 Total  
 
From the above table it is clear that there are variations in neoplasm of female genital 
organs in the different regions.  This finding is supported by the finding of ANOVA test 
which revealed that there is significant difference in the incidences of neoplasms of 
female genital organs in the different region at significance level 0.000 where the F 
value is only 14.85 (Table (4.23)). 
 
Table (4.23): ANOVA of female genital organs cancer in regions 
Sig F df Mean Square Sum of Squares . 
.000 14.850 6 28.915 173.488  Between Groups 
  11615 1.947 22616.186  Within Groups 
  11621  22789.674  Total 
 
As far as the time trend is concerned, the percentages of incidence of neoplasms of 
female genital organs in general showed a steadily increase in cancer cases.  In year 
2000 the percent of patients is 18.5% which increased to 20.3% in 2001 and continue to 
rise in 2002 to 21.4%.  In 2003 the number of cases registered represents the peak in 
comparison with the rest of the years where the percent of patients jumped to 22.1% 
before declining to 17.7% in 2004.  regarding the different region the trend is not 
similar to the general trend where in Khartoum State, Northern Sudan, Western Sudan 
and Eastern Sudan showed a fluctuating pattern, while the percent of incidence of 
neoplasms of female genital organs of patients from Central Sudan and Southern Sudan 
follow that same trend of general neoplasms of female genital organs.  This variation is 
clearly revealed by ANOVA test which showed a low F – value (16.564) for neoplasms 
of female genital organs across time series of the five years (2000 – 2004) at 
significance level 0.000 (Table (4.24)). 
 
Table (4.24): ANOVA test for female genital organs cancer (RIC 2000 – 2004) 
Sig F Mean Square df Sum of Squares . 
.000 16.564 32.009 6 192.052 Between Groups 
  1.932 11615 22444.468 Within Groups 
   11621 22636.520 Total 
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Different malignant neoplasms were registered for female genital organs in RIC for the 
period 2000 – 2004.  About 1602 patients were registered for neoplasms of female 
genital organs.  More than half of the patients (52.1%) suffer from Cervix and this 
represent 5.75% of the total patients registered for malignant neoplasms in RIC.  
Incidence of ovary cancer is also high among patients of neoplasms of female genital 
organs where 32.3% of the patients of female genital organs suffer from this disease 
followed by uterus cancer (11%).  While chorion carcinoma cases is relatively low 
compared to the above mentioned diseases, and only 12 patients were registered for this 
disease.  Other neoplasm of female genital organs includes vagina and vulva (3.7% of 
neoplasms of female genital organs).  Appendix (2) shows the different types of 
neoplasms of female genital organs, their frequency and their percentages. 
 Fig (4.6) shows the distribution of the main female genital organs neoplasm for the 
period 2000 – 2004 according to the records of RIC.   For uterus and cervix neoplasms 
the figure clearly shows the increase of cancer incidences with the advance of years.  
While for the ovary cancer the trend of the disease follow a fluctuating pattern showing 
an increase in years 2001 and 2002 and declined in 2003 after which in year 2004 it rise 
again. 
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Fig. (4.6): Pattern of main neoplasms of female genital organs (2000–004) 
 
 
4.2.4. Leukemia 
Leukemia is one of the most serious diseases and its trend reached an alarming level.  In 
the past few incidences were reported for Leukemia.  Recently the level of its incidence 
is far beyond expectations.  Incidences of Leukemia represent 11.1% of the main 
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malignant neoplasms and 8.9% of all cancer cases according to CIR records for the 
period 2000 – 2004.  All the age groups are susceptible to Leukemia and the same is 
true for the sex.  Table (4.25) shows the distribution of Leukemia according to the 
records of RIC for the period 2000 – 2004.  The cross tabulation of the two variables 
(age groups and sex) indicated that the incidence of Leukemia is higher in males in 
comparison with females where 57.5% of the registered cases is for males.  Females 
incidence of Leukemia is 42.5% of the total patients registered for this disease.  In the 
age range of 51 – 70 years, the incidence of Leukemia is relatively high in males 
compared to other ages where 22.9% of patient males belong to this age range.  The 
same is true for females where the same age range represent the crest of Leukemia 
incidence.   
Table (4.25): Incidences of Leukemia according to sex and age groups 
Male Female Total  
N % N % N % 
1-10 75 5.8 36 2.8 111 8.6 
11-20 62 4.8 30 2.3 92 7.1 
21-30 73 5.6 42 3.2 115 8.9 
31-40 92 7.1 89 6.9 181 14.0 
41-50 93 7.2 88 6.8 181 14.0 
51-60 135 10.4 115 8.9 250 19.3 
61-70 149 11.5 98 7.6 247 19.1 
>70 65 5.0 51 3.9 116 9.0 
Total  744 57.5 549 42.5 1293 100 
It is logic to find that the age groups of the total sample of Leukemia patients fall within 
the age range of 51-70 since this range represent the climax of Leukemia incidences in 
both male and females.  Therefore, 38.4% of the patients fall within the age range of 51 
– 70.  in early ages (1 – 10 and 11 – 20 years) the percent of patients is relatively low 
(15.7%), but the level of Leukemia incidences increase after age 20 years.  The percent 
of patients of age class 31 – 40 is similar to that of age class 41 – 50 years (14% for 
each). 
Pearson X2 show that there is significant difference for the relationship between age 
groups and sex regarding incidence of Leukemia at significance level 0.011  where the 
value of X2 is 18.203 and the likelihood ratio for this relationship for Leukemia is 
18.396 (Table (4.26)). 
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Table (4.26 ): Cross tabulation of sex and age group for Leukemia (RIC) 
Asymp. Sig. (2-sided) 
 
Df Value  
.011 7 18.203 Pearson Chi-Square 
.010 7 18.396 Likelihood Ratio 
.045 1 4.005 Linear-by-Linear Association 
  1293 N of Valid Cases 
The geographical distribution and the time series of Leukemia indicates the increase of 
the percentages of incidence in the different regions of the Sudan according to the 
records of RIC for the period 2000 – 2004.  Table (4.27) shows the geographical 
distribution of Leukemia incidences in relation to time series of the incidences.  As far 
as the geographical distribution is concerned, Central Sudan showed the highest 
percentage (32%) of Leukemia followed by Khartoum State (28.2%).   There is subtle 
difference in the percentages of Leukemia incidence in Northern and Western Sudan 
(13.9 & 14.1%, respectively.  The level of Leukemia incidences in Eastern and Southern 
Sudan is relatively low (9.8 & 2%, respectively. 
Table (4.27): Distribution of Leukemia in regions and its time series (RIC) 
Region N 2000 2001 2002 2003 2004 Total 
Khartoum 364 8.6 7.6 5.5 4.9 1.6 28.2 
Central Sudan 414 2.9 2.4 2.9 6.0 17.9 32.0 
Northern Sudan 180 2.2 1.5 1.8 2.6 5.8 13.9 
Western Sudan 182 1.5 1.4 1.5 3.6 6.0 14.1 
Eastern Sudan 127 .9 .9 .9 1.8 5.3 9.8 
Souther Sudan 26 .1 .2 .2 .4 1.2 2.0 
Total 1293 16.2 14.0 12.8 19.3 37.8 100 
The incidences of Leukemia is not similar to other malignant neoplasms, the other 
diseases showed increase of incidence with advance of years, Leukemia disease oppose 
this trend.  The percentage of Leukemia in 2000 is higher than that of 2001 and 2002.  
in 2004 cases of Leukemia showed a dramatic increase in the percentage of the patients 
(37.8%), and the patients of 2003 and 2004 represent 57.1% of Leukemia patients.  The 
Pearson X2 for the relationship of geographical distribution and time series of 
incidences of Leukemia shows insignificant difference at significance level 0.000 
(Table (4.28)). 
Table (4.28): X2 for geographical distribution and time series of Leukemia 
Asymp. Sig. (2-sided) Df value  
.000 20 303.158  Pearson Chi-Square 
.000 20 340.090  Likelihood Ratio 
.000 1 112.475  Linear-by-Linear Association 
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  1293  N of Valid Cases 
Leukemia is one of the common cancer cases in the Sudan.  According to the records of 
the RIC, 1293 patients were registered for Leukemia from different region of the 
country.  The main diseases of Leukemia include lymphatic leukemia, Meyloid 
leukemia, CML, CLL, AML and ALL with different frequencies.  The main diseases of 
this group are AML (37.3%), ALL (25.5%), CLL (18.8%) and CML (15.5%).  The 
other Leukemia diseases are Lymphatic leukemia and Meyloid leukemia which have 
lesser weight compared to the other diseases of Leukemia.  Appendix (3) shows the 
main diseases of Leukemia according to the records of RIC for the period 2000 – 2004. 
CLL and AML percentages of incidences increase year after year till reach the climax 
(5.2 and 8.8%, respectively) in 2004, while CML and ALL showed a fluctuating 
pattern.  Year 2003 witnessed the highest percent of CML incidence, while the highest 
percent for ALL was year 2002.  Fig (4.7) shows the pattern of the main Leukemia 
diseases in the Sudan according to the records of RIC for the period 2000 – 2004. 
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Fig (4.7): Trends of main Leukemia diseases in the Sudan (RIC 2000 - 2004 
 
4.2.5. Neoplasms of the oral cavity and pharynx 
Neoplasms of oral cavity and pharynx represent 9.8% of the main malignant neoplasm 
and 7.8% of the total cancer cases.  The neoplasms of oral cavity and pharynx are higher 
in males compared to females.  The percent of patient males is 56.6% compared to 
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43.4% for female.  Males of age 51 – 70 years represent 29.5% of the patients.  The 
percent of patient females for the same age group is much higher compared to males 
(49%).  Table (4.29) shows the distribution of neoplasms of the oral cavity and pharynx 
according to age groups and sex.  For both, males and females, the incidences of 
neoplasms of oral cavity and pharynx are very low. 
Table (4.29): Relationship between sex and age groups for Neoplasms of oral cavity 
and pharynx 
 Male  Female  
 N % N % N % 
1-10 3 .3 5 .4 8 .7 
11-20 16 1.4 10 .9 26 2.3 
21-30 42 3.7 51 4.5 93 8.2 
31-40 56 4.9 53 4.7 109 9.6 
41-50 104 9.1 93 8.2 197 17.3 
51-60 177 15.6 109 9.6 286 25.2 
61-70 158 13.9 113 9.9 271 23.8 
>70 87 7.7 60 5.3 147 12.9 
Total  643 56.6 494 43.4 1137 100 
 
The incidences of malignant neoplasms of oral cavity and pharynx increase with the 
advance of age.  Only 0.7% of the patients fall within the age class of 1 – 10 years and 
the percentages of incidence increase continuously with the advance of age up to age 
group 51 – 60 years after which it start to decline.  Perason X2 shows that the trend of 
neoplasms of oral cavity and pharynx for sex and age group is significantly different at 
significance level 0.079 where the value of X2 is 12.745 (Table (4.30)). 
 
Table (4.30): X2 of age group and sex in relation to neoplasms of oral cavity and 
pharynx 
Asymp. Sig. (2-sided) df Value  
.079 7 12.745  Pearson Chi-Square 
.080 7 12.708  Likelihood Ratio 
.014 1 6.038  Linear-by-Linear Association 
  1137  N of Valid Cases 
   
Regarding the geographical distribution of the neoplasms of the oral cavity and the 
pharynx, the percentages of incidences varies among the different regions being high in 
Khartoum State (31.6%) and Central Sudan (30%), while the percentage of incidence is 
relatively low in Southern and Eastern Sudan (7.6 & 1.7%, respectively).  Moreover, 
like all the other malignant neoplasms, the percentage of patients is higher in Western 
Sudan (16.7%) compared to patients from Northern Sudan (12.5%), (Table (4. 31)).  
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Table (4.31): Distribution of oral cavity cancer in regions over years 
 N 2000 2001 2002 2003 2004 Total 
Khartoum 359 7.2 9.4 9.8 3.0 2.2 31.6 
Central Sudan 341 2.0 2.1 4.1 6.8 15.0 30.0 
Northern Sudan 142 1.4 1.8 2.0 3.3 4.0 12.5 
Western Sudan 190 1.4 2.5 4.4 3.8 4.7 16.7 
Eastern Sudan 86 1.6 1.0 1.0 1.4 2.6 7.6 
Southern Sudan 19 0.0 0.2 0.4 0.7 0.4 1.7 
Total 1137 13.6 16.9 21.6 18.9 28.9 100 
The trend of the incidence of neoplasms of oral cavity and pharynx in the different 
regions showed significant variations.  In Khartoum the peak of incidences recorded in 
year 2002 and for Central Sudan the peak was 2004 where more than half of the patients 
registered in RIC for this disease were from Central Sudan. Generally, 2004 showed the 
high incidences of neoplasms of oral cavity and pharynx in patients of all the regions 
except Khartoum State. 
The relationship between regions and time trend of neoplasms of oral cavity and 
pharynx  (Table (4.32)) show insignificant difference at probability level 0.000 where 
the X2 value is very high 276.264 an indication of good relationship between 
geographical distribution of neoplasm of oral cavity and pharynx over time series (2000 
– 2004). 
Table (4.32): Relationship between regions and time series for neoplasms of oral 
cavity and pharynx 
Asymp. Sig. (2-sided) df Value  
.000 20 276.264  Pearson Chi-Square 
.000 20 296.533  Likelihood Ratio 
.000 1 44.726  Linear-by-Linear Association 
  1137  N of Valid Cases 
The main neoplasms of the oral cavity and pharynx according to the records of RIC for 
the period 2000 – 2004 are Lip, Tongue, Salivary gland, Mouth, Oropharynx, 
Nasophrynx and hypopharynx.  The total number of cases registered for these 
neoplasms is 1137 cases.  The there is a clear variation in the level of incidences of the 
above mentioned cancers being higher for Nasophrynx (429 cases) and lower for 
Salivary gland (67).  The numbers of incidences of the other cancer cases fall within the 
range of Nasophrynx and Salivary gland.  Appendix (4) shows the different neoplasm of 
oral cavity ad pharynx. 
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 The main incidences of the neoplasms of the oral cavity and pharynx include 
Nasophrynx (36.9%) of the total neoplasm of the oral cavity and pharynx cases 
followed by Oropharynx cancer (20.6%) and hypopharynx ranked third with 13.8% 
followed by neoplasms of lip (10.6).  The main neoplasms of the oral cavity and the 
pharynx account for 82.3% of the cases of the neoplasms of the oral cavity and pharynx.  
The other neoplasm of the oral cavity and pharynx include Tongue (7.7%), Salivary 
gland (5.9%) and Mouth, and they collectively account for 17.7% of the cases of the 
neoplasms of the oral cavity and the pharynx.  
Fig. (4.8) shows the trend of the main oral cavity and pharynx neoplasms for the period 
2000 – 2004.  neoplasms of the lip is increased steadily starting from year 2000 and 
reach its peak on 2004 the other main diseases (Oropharynx, Nasophrynx and 
Hypopharynx) showed a fluctuating pattern.  The Nasopharynx reached its peak in 2002 
where the percent of patients account for 8.7% of all the neoplasms of Nasopharynx, 
while the peak of the Oropharynx is in 2003 (4.9% of the Oropharynx cases). 
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Fig (4.8): Trends of main of oral cavity and pharynx cancer (RIC 2000 – 2004) 
 
4.3.6. Lymphoma 
Lymphoma is one of the main malignant neoplasms in the Sudan.  According to the 
records of RIC for the period 2000 – 2004, Lymphoma represent 8.1% of the main 
malignant neoplasms (6.7% of the total cases of malignant negoplasms).  Almost there 
is no difference in the percent of females and males registered for Lymphoma (50.1 and 
49.9%, respectively.  Female of age group 41 – 60 represent the bulk of the Lymphoma 
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patients, while for male incidences of Lymphoma is high in age group 51 – 70 years).  
Table (4.33) shows the distribution of Lymphoma according to sex and age groups.   
 
Table (4.33): Incidence of lymphoma according to sex and age (RIC 2000 – 200$ 
 Male  Female Total 
 N % N % N % 
1-10 57 6.1 20 2.1 77 8.2 
11-20 64 6.8 23 2.5 87 9.4 
21-30 55 5.9 27 2.9 82 8.8 
31-40 48 5.1 72 7.7 120 12.8 
41-50 63 6.7 102 10.9 165 17.6 
51-60 73 7.8 97 10.4 170 18.1 
61-70 72 7.7 83 8.9 155 16.5 
>70 36 3.8 45 4.8 81 8.6 
Total  468 49.9 469 50.1 937 100 
 
As far as the age group is concern the trend of lymphoma shows a fluctuating trends 
being very low in age class 1 – 10 (8.2%) and increased in age class 11 – 20 (9.4%) and 
declined to 8.8* in age class 21 – 30. after thirties, the incidences of lymphoma start to 
rise continuously until it reached its climax at age class 51 – 60 (18.1% of the total 
sample) and started to decline age in the old age classes. However, the relationship 
between sex and age groups for lymphoma (X2) shows that there is a strong relationship 
between age groups and sex as far as lymphoma is concerned at significance level 0.000 
where X2 value is 65.848 (Table (4.34)). 
 
Table (4.34): Pearson X2 for lymphoma regarding sex and age group 
Asymp. Sig. (2-sided df value  
.000 7 65.848  Pearson Chi-Square 
.000 7 67.722  Likelihood Ratio 
.000 1 35.654  Linear-by-Linear Association 
  937  N of Valid Cases 
 
The incidences of Lymphoma in the different regions for the five years are shown in 
Table (4.35).  Khartoum State and Central Sudan showed the highest percentages of 
Lymphoma patients (30.4 & 27.7%, respectively) i.e. about 58.1% of the cases.  
Incidences of Lymphoma in Western Sudan are also high (21.3%).  Patients form 
Northern Sudan (8.2%) showed lower percentage than that of patients from Eastern 
Sudan (9.2%).  As usual Lymphoma patients from Southern Sudan showed the least 
percentage (2.7%). 
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Table (4.35): Distribution of Lymphoma in the different regions for the five years 
 N 2000 2001 2002 2003 2004 Total % 
Khartoum  285 6.7 9.0 9.2 4.9 .6 30.4 
Central Sudan 260 2.5 4.1 5.1 4.7 11.4 27.7 
Northern Sudan 81 1.7 1.3 1.1 2.0 2.6 8.6 
Western Sudan 200 1.7 3.0 5.1 4.9 6.6 21.3 
Eastern Sudan 86 .9 1.9 2.0 1.0 3.4 9.2 
Southern Sudan 25 .1 .1 .6 .6 1.2 2.7 
Total  937 13.6 19.3 23.2 18.1 25.8 100 
 
The time trend of Lymphoma incidences over the five years showed a steady increase of 
percentages where in year 2000 the percent of patients is 13.6% and in 2001 increased 
to 19.3% before reaching 23.2% in year in 2002.  In 2003 the percent of Lymphoma 
patients dropped to 18.1% and increased dramatically in 2004 to 25.8%.  However, the 
Pearson X2 shows strong relationship between the different regions during the five 
years (X2 = 170.919regarding Lymphoma at significance level 0.000 (Table (4.36 )). 
 
Table (4.36): X2 for Lymphoma in different regions for period 2000-2004 
Asymp. Sig. (2-sided) df Value  
.000 20 170.919 Pearson Chi-Square 
.000 20 209.173 Likelihood Ratio 
.000 1 60.979 Linear-by-Linear Association 
  937 N of Valid Cases 
The main diseases of neoplasm of lymphoma are Non Hodgkin's lymphoma, Hodgkin's 
lymphoma and Axillary LN.  the first two diseases represent the bulk of the incidences 
of neoplasms of lymphoma where 684 patients were registered in the RIC records 
during the period 2000 – 2004 for neoplasm of Non Hodgkin's lymphoma representing 
73% of the patients of Lymphoma and 4.7% of all the cancer cases for the above 
mentioned periods according to the records of RIC.  Hodgkin's lymphoma also gained 
weight where 215 patients were registered during the same period and represent 22.9% 
of the Lymphoma patients and 1.48% of all cancer cases.  Neoplasm of Axillary Lymph 
node is relatively very low where only 38% of the patients belong to this group.  
Appendix (5) shows the main diseases of lymphoma, and Fig. (4.9) shows the time 
trend of the Non Hodgkin's lympomah and Hodgkin's lymphoma 
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Fig. (4. 9):Main Lymphoma diseases (RIC 2000 – 2004) 
4.2.7. Neoplasms of head and neck 
Neoplasm of head and neck lies in the bottom of the list of the main malignant 
neoplasm in the Sudan according to the records of RIC for the period 2000 – 2004.  it 
represent 7.6% of the main malignant neoplasms and 6.1% of the total patients of 
malignant neoplasms.  There are variations of incidences of neoplasms of head and neck 
among sex.  Neoplasms of head and neck is very high among females (78.2% of the 
patients), while the incidences of neoplasms of head and neck among males is 21.8%.  
Table (4.37) shows the distribution of Neoplasms of head and neck among sex and age 
groups 
 
Table (4.37): Distribution of neoplasms of head and neck among sex and age  
Male Female Total   
N % N % N % 
1-10 5 .6 6 .7 11 1.2 
11-20 8 .9 10 1.1 18 2.0 
21-30 7 .8 41 4.6 48 5.4 
31-40 22 2.5 117 13.2 139 15.7 
41-50 34 3.8 159 17.9 193 21.8 
51-60 53 6.0 173 19.5 226 25.5 
61-70 41 4.6 141 15.9 182 20.5 
>70 23 2.6 47 5.3 70 7.9 
Total  193 21.8 694 78.2 887 100 
 
However, the highest percentage of female incidences of neoplasms of head and neck 
was 51 – 60 and 41 – 50 age groups (19.5 & 17.9%, respectively), while for the male 
the incidences of neoplasms of head and neck is high in age groups 51 – 60 and 61 – 70.  
as far as the cross tabulation of sex and age groups for the neoplasms of head and neck 
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is concerned, Pearson X2 showed low relationship between the age groups and sex at 
significance level 0.004 where X2 = 20.847 (Table (4.38)). 
 
Table (4.38): X2 for the relationship between sex and age groups 
Asymp. Sig. (2-sided) df Value  
.004 7 20.847 Pearson Chi-Square 
.007 7 19.366 Likelihood Ratio 
.226 1 1.465 Linear-by-Linear Association 
  887 N of Valid Cases 
 
Table (4.39) shows the trend of neoplasms of head and neck in the different regions for 
the period 2000 – 2004.   There is no difference in the ranking of the malignant 
neoplasms of head and neck from the other types of main malignant diseases as far as 
regions are concerned.   Khartoum State, Central Sudan and Western Sudan represent 
the main regions for the incidences of neoplasms of head and neck (31.9, 25% and 21%, 
respectively) i.e. the bulk of the patients of neoplasms of head and neck were from these 
regions (76.9%).  For this neoplasm, the percent of patients from Eastern Sudan (9.7%) 
is higher than the cases from Northern Sudan (9.6%).  The percent of patients from 
Southern Sudan, as usual, is lowest compared to other regions. 
 
 
 
Table (4.39): Distribution of neoplasms of head and neck in different regions (2000 
– 2004)  
 N 2000 2001 2002 2003 2004 Total 
Khartoum 283 4.6 7.8 11.7 6.5 1.2 31.9 
Central Sudan 222 2.6 3.6 4.7 7.6 6.5 25.0 
Northern Sudan 85 1.4 1.7 2.3 2.9 1.4 9.6 
Western Sudan 186 1.8 2.9 3.7 7.2 5.3 21.0 
Eastern Sudan 86 1.8 1.2 2.4 1.9 2.4 9.7 
Southern Sudan 25  .8 .7 .6 .8 2.8 
 887 12.2 18.0 25.5 26.7 17.6 100 
The time trend of the neoplasms of head and neck for the period 2000 – 2004 shows a 
steady increase in the incidences of neoplasms of head and neck.  In 2000 the patients 
represent 12.2% of the patients and the percentage increased to 18% in 2001 and 
continued to increase to 25.5% in 2002.  Year 2003 represent the peak of the incidences 
of neoplasms of head and neck (26.7%).  From these findings it is clear that the 
incidences of neoplasms of head and neck of years 2002 and 2003 represent the bulk of 
the incidences of the disease (52.2%).  However, the Pearson X2 (X2 = 106.479)for the 
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distribution of the neoplasms of head and neck in the different regions for the period 
2000 – 2004 showed a strong relationship at significance level 0.000 (Table (4.40)). 
 
Table (4.40): X2 for the distribution of Neoplasms of head and neck in different 
regions for the period 2000 - 2004 
Asymp. Sig. (2-sided) df Value  
.000 20 106.479  Pearson Chi-Square 
.000 20 119.932  Likelihood Ratio 
.000 1 23.870  Linear-by-Linear Association 
  887  N of Valid Cases 
The neoplasms of head and neck include a prolong list of diseases (Buccal, Cheek, Ear, 
Eye, Face, Gingira, Jaw, Mandible, Maxillary, neck, Nose, Palate, Parotid, Post cricoids 
and tonsil) which varies in their frequencies. The most common cancer diseases are; eye 
(209 patients), Parotid (114 patients), Mandible (98 patients) and maxillary (90 
patients), and collectively they represent more than half (57.6%) the cases of neoplasm 
of head and neck which consists of 13 diseases (Appendix 6). 
The trend of the main neoplasms of head and neck follow different patterns, for the 
neoplasms of the eye the incidences increases steadily with years where in 2000 the 
patients represent 3.8% of the patients of this disease and continued to increase until it 
reached its climax in the last year (2004).  The other neoplasms of head and neck 
(Parotid, Mandible and Maxillary) showed fluctuating pattern.  Year 2002 witnessed the 
highest percentage of incidence of Parotid and Mandible, while year 2004 showed the 
highest incidences of eye and Maxillary neoplasms (Fig (4.10)). 
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Fig (4. 10): Trends of the main neoplasms of head and neck 
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4.3. Low incidence malignant neoplasms in the Sudan (RIC 2000 – 2004) 
The low incidence malignant neoplasms includes; musculoskeletal, neoplasms of male 
genital organs, neoplasms of respiratory organs, neoplasms of urinary tract, neoplasms 
of skin, neoplasms of bone and connective tissues, and other malignant diseases.  Table 
(4. 41) shows the frequencies and percentages of low incidence malignant diseases. 
 
Table (4. 41): Low frequency malignant neoplasms (RIC 2000 – 2004) 
Cumulative %Valid % % N  
20.1 20.1 20.1 583  Musculoskeletal neoplasms 
40.2 20.0 20.0 581  Neoplasms of male genital organs 
52.3 12.1 12.1 351  Neoplasms of respiratory organs 
63.1 10.8 10.8 313  Neoplasms of urinary tract 
71.3 8.2 8.2 239  Neoplasms of skin 
76.4 5.1 5.1 149  Neoplasms of bone and connective tissues 
100.0 23.6 23.6 683  Others malignant diseases 
 100.0 100.0 2899  Total 
 
4.3.1. Musculoskeletal 
The most common disease of the low incidences neoplasm of malignant diseases is 
musculoskeletal diseases; about 2899 patients were registered for this disease in the RIC 
records representing 4% of all neoplasms of malignant diseases registered for the period 
2000 – 2004, and 20.1% of the low incidence neoplasms. 
Different proportions of males and females of different age classes were subjected to 
this neoplasm.  The incidence of the disease is relatively higher in males (51.6%) 
compared to females (48.4%).  Females of age class 21 – 30 showed the peak of the 
incidences during the period 2000- 2004, while for the males the peak of the incidences 
occurred among age class 11 – 20.  Table (4.42) shows the distribution of the disease 
according to sex and age classes.   
Table (4.42): Distribution of musculoskeletal diseases according to sex and age  
Males Females Total  
N % N % N % 
1-10 10 1.7 11 1.9 21 3.6 
11-20 71 12.2 49 8.4 120 20.6 
21-30 45 7.7 66 11.3 111 19.0 
31-40 43 7.4 55 9.4 98 16.8 
41-50 34 5.8 32 5.5 66 11.3 
51-60 43 7.4 31 5.3 74 12.7 
61-70 36 6.2 25 4.3 61 10.5 
>70 19 3.3 13 2.2 32 5.5 
Total  301 51.6 282 48.4 583 100 
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Neoplasms of musculoskeletal showed a different trend compared to other malignant 
diseases where the incidences are higher in lower age classes compared to higher age 
classes.  About 56.4% of the patients (males and females) fall within the age range of 11 
-40 years.  In other malignant diseases the incidence is higher in high age classes. 
 
The Pearson X2 test for the relationship of sex and age classes regarding the incidences 
of musculoskeletal disease (Table (4.43)) revealed low relation between the two 
variables at significance level 0.051 (X2 = 14.034). 
 
Table (4.43 ): X2 of musculoskeletal for sex and age groups 
Asymp. Sig. (2-sided) df Value  
.051 7 14.034  Pearson Chi-Square 
.049 7 14.096  Likelihood Ratio 
.204 1 1.615  Linear-by-Linear Association 
  583  N of Valid Cases 
 
The time trend of musculoskeletal diseases shows a fluctuating pattern during the period 
2000 – 2004 being low (15.4%) in 2000 and raised to 20.9% in 2001 and continued to 
increase in 2002 (24.2%) before dropping to 16% in 2003.  in 2004 the incidence of the 
disease increased again to 23.5% (Table (4.44).  
 
Table (4.44): distribution of musculoskeletal diseases in the sudan (RIC)  
 2000 2001 2002 2003 2004 Total 
Khartoum 6.3 9.4 11.5 3.9 .9 32.1 
Central Sudan 3.8 4.1 5.0 5.3 11.3 29.5 
Northern Sudan 1.7 2.9 1.4 1.2 2.6 9.8 
Western Sudan 2.2 2.6 3.8 4.5 5.7 18.7 
Eastern Sudan 1.2 1.9 1.9 .9 2.1 7.9 
Southern Sudan .2  .7 .2 1.0 2.1 
 15.4 20.9 24.2 16.0 23.5 100 
 
The geographical distribution of the disease showed great variations among the regions 
being high in Khartoum (32.1%) followed by patients from Central Sudan (29.5%).  
Like most of the incidences of neoplasm of malignant diseases, patients from Western 
Sudan occupy the third position in the ranking of percentages of patients where 18.7% 
of musculoskeletal are from Western Sudan.  Northern Sudan and Eastern Sudan there 
are almost similar as far as the percentages of musculoskeletal diseases are concerned ( 
9.8 and 7.9%, respectively).  The percentage of patients from Southern Sudan, as usual, 
is very low compared to other regions (2.1%). 
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Table (4.45) shows the relationship between the geographical distribution of 
musculoskeletal diseases for the period 2000 – 2004.  the Pearson X2 indicated the 
strong relationship between the geographical distribution of the musculoskeletal 
diseases and the time trend of the incidences at significant level (0.000) where the X2 
value is 105.031. 
 
Table (4.45 ): X2 of musculoskeletal geographical distribution and time trend 
Asymp. Sig. (2-sided df  Value  
.000 20 105.031  Pearson Chi-Square 
.000 20 124.708  Likelihood Ratio 
.000 1 22.506  Linear-by-Linear Association 
  583  N of Valid Cases 
The main diseases of musculoskeletal, according to the records of the RIC are; Thigh, 
Arm, Back, Chromo sarcoma, Fib sarcoa, Knee, Hand, Leg, Leomyosarcoma, Osteag 
solcoma and shoulder.  Appendix (7) shows the different diseases of musculoskeletal 
neoplasm according to the records of RIC.  The most common musculoskeletal 
neoplasm are Fib sarcoma (28.8%), Osteag solcoma (24%), leg (14.9%) and Cromo 
sarcoma (9.6%), and they collectively accounts for 77.3% of musculoskeletal neoplasm.  
4.3.2. Neoplasms of male genital organs 
 
Neoplasm of male genital organs is a sex specific disease, all the age classes are liable 
to infection by this disease. However the incidences of this disease become apparent 
with the advance of the age.  Before fifties of age, the incidences of neoplasms of male 
genital organs are relatively low (19.8%).  After the fifties, the incidences of neoplasms 
of male genital organs start to occur at alarming rate.  In age class 51 – 60 the 
percentage of patients is 16.5% of the whole patients.  This percentage is more than 
double in the age class 61 – 70 (34.9%), and the percentage of patients of age more than 
seventies is 28.7% (4.46).. 
Table (4.46): Neoplasms of male genital organs for age classes  
Males   
N % Cumulative % 
1-10 12 2.1 2.1 
11-20 16 2.8 4.9 
21-30 18 3.1 8 
31-40 31 5.3 13.3 
41-50 38 6.5 19.8 
51-60 96 16.5 36.3 
61-70 203 34.9 71.2 
>70 167 28.7 100 
Total  581 100  
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The time trend of the incidence of neoplasms of male genital organs for the period 2000 
– 2004 showed a steady increase for the period 2000 – 2002 where the percentage of 
patients reached 19.4% in 2002.  In 2003 the percentage of patients dropped to 17.6 
before rising to 32.7% in 2004.  Generally, the percentages of patients from the different 
regions are higher in 2004 except Khartoum State where the peak of the percentage of 
patients recorded for the year 2002.  Table (4.47) shows the distribution of neoplasms of 
male genital organs for the period 2000 – 2004 according to the records of the RIC 
 
Table (4.47): Distribution of neoplasms of male genital organs (RIC 2000 – 2004) 
 2000 2001 2002 2003 2004 Total 
khartoum 7.2 8.4 10.7 4.8 1.4 32.5 
Central Sudan 3.4 2.2 3.8 6.0 17.2 32.7 
Northern Sudan 1.0 1.9 1.4 2.8 4.6 11.7 
Western Sudan 1.7 1.9 2.6 2.6 6.5 15.3 
Eastern Sudan .5 1.7 .9 1.0 2.8 6.9 
Southern Sudan .2  .2 .3 .2 .9 
 14.1 16.2 19.4 17.6 32.7  
 
the incidences of neoplasms of male genital organs is higher in patients from Central 
Sudan (32.7%) followed by patients from Khartoum State (32.5%).  Therefore, the bulk 
of the patients of the neoplasms of male genital organs are from these two regions.  The 
incidence of the disease is higher in patients from Western Sudan (15.3%) compared to 
patients from Northern Sudan (11.7%).  The other regions (Eastern Sudan and Southern 
Sudan), showed low percentages of incidence (6.9 and 0.9%, respectively). 
 
The X2 test showed a strong relationship between the geopgraphical distribution of 
patients of neoplasms of male genital organs and the time series of incidences at 
significant level 0.000 where the X2 value is 143.827 and the likelihood ratio is 
167.098.  Table (4.48) shows the relationship of the geographical distribution of the 
patients of neoplasms of male genital organs and the time trend (2000 – 2004) of the 
incidences. 
 
Table (4.48): X2 of the geographical distribution of neoplasms of male genital 
organs and time trend 
Asymp. Sig. (2-sided df Value  
.000 20 143.827 Pearson Chi-Square 
.000 20 167.098 Likelihood Ratio 
.000 1 31.693 Linear-by-Linear Association 
  581 N of Valid Cases 
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The main diseases of the neoplasms of male genital organs are Prostate, Testis and 
Penis.  Appendix (8) shows the main neoplasms of males genital organs for the period 
2000 – 2004 according to RIC.  The incidences of Prostate represent the bulk of the 
cases (93.8%), while the rest of the diseases (Testis and Penis) account for 6.2%. 
4.3.3. Neoplasms of respiratory system 
This neoplasm is one of the low frequency of the neoplasms of malignant diseases.  The 
number of patients registered for these neoplasms in the records of the RIC is about 351 
representing 12.1% of the cases of low frequency neoplasm of malignant diseases and 
2.4% of whole neoplasms of malignant diseases. 
 
All the age groups and sex were registered in the records of RIC for the neoplasms of 
respiratory system for the period 2000 – 2004.  However, the percentage of males 
(57.3%) is higher compared to the incidence of the disease among females (42.7).  in 
females the peak of the incidence of the disease occurred in age class 51 – 60, while for 
males the peak of incidence took place in age class 61 – 70.  Table (4. 49) shows the 
distribution of neoplasms of respiratory system among the different age classes.  
 
 
Table (4.49 ): Distribution of neoplasms of respiratory system according to age 
(RIC 2000 – 2004) 
Males Females Total  
N % N % N % 
1-10 30 8.5 27 7.7 57 16.2 
11-20 6 1.7 5 1.4 11 3.1 
21-30 11 3.1 10 2.8 21 6.0 
31-40 17 4.8 17 4.8 34 9.7 
41-50 23 6.6 21 6.0 44 12.5 
51-60 38 10.8 35 10.0 73 20.8 
61-70 45 12.8 25 7.1 70 19.9 
>70 31 8.8 10 2.8 41 11.7 
Total  201 57.3 150 42.7 351 100.0 
The above table showed that the incidence of neoplasms of respiratory system is 
relatively high among children of age class 1 – 10 years (16.2%).  In old age classes (51 
– 60 and 61 – 70) the incidences of neoplasms of respiratory system is very high (20.8 
and 19.9%, respectively.  In the other age classes the percentage of incidence is 
relatively low compared to the above mentioned age classes. 
Table (4.50) shows the relationship of age classes and sex for the neoplasms of 
respiratory system.  The cross tabulation of the age classes and sex showed poor 
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relationship for neoplasms of respiratory system at significance level 0.202 where the 
X2 is only 9.777 and the likelihood ration is 10.153. 
 
Table (4.50): X2 test for neoplasm of respiratory system in relation to age and sex 
Asymp. Sig. (2-sided) df Value  
.202 7 9.777 Pearson Chi-Square 
.180 7 10.153 Likelihood Ratio 
.037 1 4.373 Linear-by-Linear Association 
  351 N of Valid Cases 
 
As far as the geographical distribution of the neoplasm is concerned, there is no 
variation in the percentage of incidences compared with the other neoplasms of 
malignant diseases.  Table (4.51) shows the distribution of the incidences of neoplasms 
of respiratory system in the Sudan.  Khartoum State showed the higher percentage of 
incidences of neoplasms of respiratory system (34.2%) followed by patients from 
Central Sudan (28.8%) and Western Sudan (17.1%), respectively.  The percentages of 
incidence in Northern and Eastern Sudan are 10.3 and 8.8%, respectively, while the 
level of incidence among patients from Southern Sudan is very low (0.9%) 
 
 
 
Table (4.51): Incidence of neoplasm of respiratory system (RIC 2000–2004) 
 2000 2001 2002 2003 2004 Tota 
khartoum 5.4 6.6 6.8 14.0 1.4 34.2 
Central Sudan 2.8 3.1 3.1 11.1 8.5 28.8 
Northern Sudan .6 .9 1.1 4.0 3.7 10.3 
Western Sudan .6 2.3 2.3 8.0 4.0 17.1 
Eastern Sudan .9 .9 2.0 4.0 1.1 8.8 
Southern Sudan    .6 .3 .9 
 10.3 13.7 15.4 41.6 19.1 100 
 
The time series of the disease showed a steadily increase during the first three years 
(2000 – 2002) and in 2003 the incidences showed a marked increase in the percentage 
of the incidences (41.6%) and in the fifth year (2004) the percentage of incidence 
dropped to 19.1.  Therefore, year 2003 represented the bulk of incidences of neoplasms 
of respiratory system in all the regions. 
 
Pearson X2 of the neoplasms of respiratory system for geographical distribution of the 
patients over the period 2000 – 2004 showed a medium relationship at significance level 
0.001 where the X2 value is 45.526 and the likelihood ration is 51.666 (Table (4.52 )). 
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Table (4.52): X2 test of neoplasms of respiratory system for regions and years 
Asymp. Sig. (2-sided df Value  
.001 20 45.526  Pearson Chi-Square 
.000 20 51.666  Likelihood Ratio 
.000 1 12.744  Linear-by-Linear Association 
  351  N of Valid Cases 
The main diseases of neoplasms of respiratory system, according to the records of RIC 
for the period 2000 – 2004 include Nasal sinuses, Larynx and lung.  The larynx 
incidence represented the bulk of the (cases 57.5%), while the lung and Nasal sinuses 
were 30.2 and 12.3%, respectively.  Appendix (9) shows the main diseases of 
neoplasms of respiratory organs. 
4.3.4. Urinary tract neoplasms 
This is one of the lowest neoplasms of malignant diseases where only 313 patients were 
registered for this disease in the RIC records for the period 2000 – 2004.  This 
represents 2.2% of the malignant diseases.  This disease is not a sex specific where both 
males and females are liable for this disease. 
According to the records of RIC for the period 2000 – 2004, the incidences of 
neoplasms of urinary system is higher in males (54%) compared to females (46%).  For 
both, males and females, the age class 31 – 40 represents the climax of the incidence of 
neoplasms of urinary system.  Table (4.53) shows the incidences of neoplasms of 
urinary system in the different age classes and sex. 
Table (4.53 ): Incidences of urinary tract neoplasms among sex and age classes 
Males Females Total  
N % N % N % 
1-10 12 3.8 5 1.6 17 5.4 
11-20 23 7.3 22 7.0 45 14.4 
21-30 30 9.6 24 7.7 54 17.3 
31-40 35 11.2 35 11.2 70 22.4 
41-50 25 8.0 14 4.5 39 12.5 
51-60 21 6.7 20 6.4 41 13.1 
61-70 13 4.2 16 5.1 29 9.3 
>70 10 3.2 8 2.6 18 5.8 
Total  169 54.0 144 46.0 313 100.0 
 
All the age groups were subjected to the incidence of neoplasms of urinary system with 
variant extend.  The age class 31 – 40 showed the peak of the incidences (22.4%) 
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followed by age class 21 – 30 (17.3%) and 11 – 20 (14.4%), respectively.  The other 
percentages are distributed for the other five age classes (Table (4.53)). 
 
The cross tabulation of sex and age classes of the neoplasms of urinary tract system 
revealed a poor relationship between the age classes and sex at significance level 0.627 
where the X2 value is only 5.268 and the likelihood ratio is 5.364 (Table (4.54)). 
 
Table (4.54): X2 of sex and age classes for  urinary tract neoplasms 
Asymp. Sig. (2-sided) df Value  
.627 7 5.268  Pearson Chi-Square 
.616 7 5.364  Likelihood Ratio 
.476 1 .509  Linear-by-Linear Association 
  313  N of Valid Cases 
The geographical distribution of neoplasms of urinary tract system revealed that the 
incidences of the diseases are higher in patients from Central Sudan (33.2%) followed 
by patients from Khartoum State (26.8%).  As in most of neoplasms of malignant 
diseases, patients from Western Sudan ranked third according to their percentage 
(17.6%).  The percentage of patients from Northern Sudan and Eastern Sudan is almost 
similar (10.9 and 10.2%, respectively).  Percentage of patients from Southern Sudan 
occupied the bottom of the list with 1.3% (Table (4.55)). 
 Table (4.55): geographical distribution of urinary tract neoplasms (RIC) 
 2000 2001 2002 2003 2004 Tota 
khartoum 13.4 3.5 4.8 4.8 .3 26.8 
Central Sudan 4.5 2.6 .6 6.1 19.5 33.2 
Northern Sudan 1.9 1.3 1.9 2.6 3.2 10.9 
Western Sudan 3.2 1.6 .6 5.4 6.7 17.6 
Eastern Sudan 2.2 1.9 .6 2.6 2.9 10.2 
Southern Sudan   .6  .6 1.3 
 25.2 10.9 9.3 21.4 33.2 100 
 
The time series of urinary tract neoplasms for the five years showed V-shape being high 
(25.2%) in the first year (2000) and declined to 10.9% in the second year (2001) and 
continue to decline in 2002 (9.3%) before rising to 21.4% in 2003 and reached the 
climax in 2004 (33.2%).  In 2000, 2001 and 2003 there is no any patient of urinary tract 
neoplasm from southern Sudan. 
 
The cross tabulation of the relationship between the geographical distribution of urinary 
tract and their time of incidences showed a strong relationship at significance level 
0.000 (X2 = 109.356).  Table (4.56) shows the relationship between the geographical 
distribution of urinary tract neoplasms and the period of the incidences. 
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Table (4.56): X2 of urinary tract neoplasms geographical distribution (2000 – 
2004)  
Asymp. Sig. (2-sided df Value  
.000 20 109.356  Pearson Chi-Square 
.000 20 123.255  Likelihood Ratio 
.000 1 13.845  Linear-by-Linear Association 
  313  N of Valid Cases 
 
The main diseases of urinary tract neoplasms are kidney, which represent the bulk of the 
urinary tract neoplasms incidence (86.3%) and Bladder (13.7%).  Table (4.57) shows 
the main diseases of urinary tract neoplasms. 
 
Table (4.57): main diseases of urinary tract neoplasms 
0.3 
1.9 
13.7 
86.3 
43 
270 
Bladder 
Kidney  
urinary tract neoplasms 
2.2  313   
4.3.5. Skin neoplasms 
 
Skin neoplasms are one of the low frequency malignant diseases.  The percentage of 
patients registered in the records of RIC for the period 2000 – 2004 is only 1.65 (239 
patients). 
 
Regarding the incidences of skin neoplasms for sex, the incidences is relatively higher 
among males (62.8%) compared to females (37.2%).  Table (4.58) shows the 
distribution of skin neoplasms among different age classes and sex.  However, the 
incidence of the disease among males is high among age class 61 – 70, while for the 
females the age class 31 – 40 showed the higher incidence of skin neoplasms. 
 
Table (4.58): Distribution of skin neoplasms among sex and age groups 
Males Females Total  
N % N % N % 
1-10 2 .8   2 .8 
11-20 5 2.1 4 1.7 9 3.8 
21-30 24 10.0 14 5.9 38 15.9 
31-40 21 8.8 23 9.6 44 18.4 
41-50 25 10.5 16 6.7 41 17.2 
51-60 21 8.8 13 5.4 34 14.2 
61-70 30 12.6 13 5.4 43 18.0 
>70 22 9.2 6 2.5 28 11.7 
Total  150 62.8 89 37.2 239 100.0 
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The incidence of skin neoplasm is low in lower age classes (1 – 10 and 11 – 20 years, 
0.8 and 3.8%, respectively).  There is no big variation in the percent of incidence among 
the age classes 31 – 40 (18.4%), 61 – 70 (18%) and 41 -50 (17.2%).  In the young youth 
(21 -30 years) the percentage of patients is 15.9% (Table (4.58)). 
The cross tabulation of age classes and sex for the skin neoplasm revealed a poor 
relationship between the age classes and sex at significance level 0.212 (X2 = 9.612) 
and the likelihood ratio is 10.415.  Table (4.59) shows the cross tabulation of skin 
neoplasms for sex and age classes. 
Table (4.59):X2 of skin neoplasms for sex and age classes 
Asymp. Sig. (2-sided) df Value  
.212 7 9.612  Pearson Chi-Square 
.166 7 10.415  Likelihood Ratio 
.069 1 3.309  Linear-by-Linear Association 
  239  N of Valid Cases 
The geographical distribution of skin neoplasms showed subtle variation in the 
incidence of skin neoplasms for Khartoum State and Central Sudan (28.9 and 28%, 
respectively).  The percentage of patients from Western Sudan is 18.4 while for the 
patients from Northern Sudan is 14.6%.  As usual, the percentages of patients from 
Eastern Sudan and Southern Sudan are very low (7.9 and 2.1%, respectively).  Table 
(4.60) shows the geographical distribution of skin neoplasms for the five years (2000 – 
2004). 
Table (4.60): Geographical distribution of skin neoplasms (2000 – 2004) 
 2000 2001 2002 2003 2004 Total 
Khartoum 5.0 6.7 11.3 5.4 .4 28.9 
Central Sudan 1.7 1.7 4.2 6.3 14.2 28.0 
Northern Sudan 1.7 2.5 3.8 2.1 4.6 14.6 
Western Sudan 1.3 4.2 2.5 2.9 7.5 18.4 
Eastern Sudan .4 1.3 .8 1.7 3.8 7.9 
Southern Sudan    .8 1.3 2.1 
 10 16.3 22.6 19.2 31.8 100 
The time trend of skin neoplasms showed a steadily increase in the percentages of 
patients for the period 2000 – 2002 where it reached 22.6% after which it dropped to 
19.2% in 2003 before rising to the maximum level of percentages (31.8%).  The highest 
incidences of skin neoplasm took place in 2004 in all the regions except in Khartoum 
State where the peak of the incidence occurred in 2002. 
The Pearson X2 for the relationship of geographical distribution and the time trend of 
the skin neoplasms showed good relation at significance level 0.000 (X2 = 62,373) and 
the likelihood ratio is 78.617 (Table (4.61)). 
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Table (4. 61: X2 for the geopgraphical distribution of skin neoplasms (2000 – 2004) 
Asymp. Sig. (2-sided df Value  
.000 20 62.373  Pearson Chi-Square 
.000 20 78.617  Likelihood Ratio 
.000 1 15.583  Linear-by-Linear Association 
  239  N of Valid Cases 
The main diseases of skin neoplasms are Malignant melanoma (49%) and other skin 
diseases (51%).  Table (4.62) shows the main diseases of skin neoplasms. 
Table (4.62): Main diseases of skin neoplasms (RIC 2000 – 2004) 
    
0.8 
0.8 
49 
51 
117 
122 
Malignant  melanoma 
Other  skin 
1.6 100 239  
4.3.6. Bone and connective tissue tumors 
Few cases were registered in the records of the RIC for bone and connective tissue 
tumors during the period 2000 – 2004 where only 149 cases were registered (1% of 
neoplasms of malignant diseases).   
The incidences of bone and connective tissue tumors among males and females vary 
considerable.  The incidence among males is higher (62.4%) compared to females 
(37.6%).  There is no case of bone and connective tissue tumors were registered for 
females in age class 1 – 10 years.  All the other age classes (males and females) showed 
cases of bone and connective tissue tumors.  However, the peak of the bone and 
connective tissue tumors occurred in age class 61 – 70 for the males, while for the 
females the peak of the incidence occurred in the age class 51 – 60 (Table (4.63)). 
Table (4.63): Distribution of bone and connective tissue tumors according to sex 
and age classes 
Males Females Total  
N % N % N % 
1-10 2 1.3   2 1.3 
11-20 4 2.7 3 2.0 7 4.7 
21-30 4 2.7 4 2.7 8 5.4 
31-40 8 5.4 4 2.7 12 8.1 
41-50 19 12.8 12 8.1 31 20.8 
51-60 12 8.1 16 10.7 28 18.8 
61-70 27 18.1 11 7.4 38 25.5 
>70 17 11.4 6 4.0 23 15.4 
Total  93 62.4 56 37.6 149 100.0 
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As far as the age classes are concerned, the incidences of bone and connective tissue 
took a serious trend starting from the age class 41 – 50 years (20.8%) passing through 
51 – 60 (18.8%) to age class 61 – 70 years (25.5%).  The incidences are also high in 
patients above 70s, while for the lower age classes (1 – 10, 11 -20, 21-30 and 31 – 40) 
the incidences of bone and connective tissue are very low (Table (4.)). 
 
Table (4.64) shows the relationship between sex and age classes for bone and 
connective tissue.  X2 test showed that the relationship between the two variables is 
poor (8.993) at significance level 0.253. 
 
Table (4.64 ): X2 for bone and connective tissue in relation to sex and age classes 
Asymp. Sig. (2-sided) df Value  
.253 7 8.993  Pearson Chi-Square 
.213 7 9.592  Likelihood Ratio 
.397 1 .718  Linear-by-Linear Association 
  149  N of Valid Cases 
 
The geographical distribution of the incidences of bone and connective tissue tumors 
revealed that the incidences of the disease is higher in patients from Central Sudan 
(34.9%), while there is subtle difference between patients from Khartoum State and 
Western Sudan (24.8 and 24.2%, respectively).  There is no any case of incidence 
reported from Northern Sudan and Western Sudan in 2000.   Incidences of bone and 
connective tissue tumors for Southern Sudan were reported only in the last two years 
(2003 and 2004).  Moreover, there is no case of bone and connective tissue tumors 
registered for Eastern Sudan (Table (4.65)). 
 
Table (4.65): Geographical distribution of bone and connective tissue tumor (2000 
– 2004) 
 2000 2001 2002 2003 2004 Total 
khartoum 2.7 3.4 4.0 12.8 2.0 24.8 
Central Sudan 1.3 .7 4.0 8.7 20.1 34.9 
Northern Sudan  1.3 .7 2.7 3.4 8.1 
Western Sudan  2.0 2.7 6.7 12.8 24.2 
Eastern Sudan .7  .7  4. 5.4 
Southern Sudan    .7 2.0 2.7 
Total  4.7 7.4 12.1 31.5 44.3 100 
 
The time trend of the incidences of bone and connective tissue tumors showed a steadily 
increase in the incidences year by year.  The last two years (2003 and 2004) showed a 
sharp increase in the incidences of neoplasms of bone and connective tissue tumors 
(31.5 and 44.3%, respectively). 
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The cross tabulation of the geographical distribution and the time trend for bone and 
connective tissue tumors (Table (4.66) revealed a low relationship at significance level 
0.008 (X2 = 38.268).  
 
Table (4.66): X2 for bone and connective tissue tumors in relation to geographical 
distribution and time trend (2000 – 2004) 
The main disease of bone and connective tissue tumors includes; bone neoplasms, 
connective tissue and Kaposi sarcoma.  Table (4.67) shows the main diseases of bone 
and connective tissue tumors. 
Table (4.67): main diseases of bone and connective tissue tumors 
    
0.3 
0.45 
0.25 
27.5 
43.6 
28.9 
41 
65 
43 
Bone  neoplasms 
connective tissue 
Kaposi sarcoma 
1.0  149  
 
 
4.3.7. Other malignant neoplasms 
 
There are some malignant neoplasms which were not categorized among the above 
mentioned malignant neoplasms, these mainly includes Central nervous system, 
Thyroid and Unknown primary.  These diseases were registered for 683 patients during 
the period 2000 – 2004. 
 
The relationship of sex and group age for other malignant neoplasms is shown in table 
(4.67).  Incidences of other malignant neoplasms is higher in males (60.9%) compared 
to females (39.1%).  Higher incidences of other malignant neoplasms among males 
occurred in the age classes 51 – 60 and 61 – 70 (12.4 and 13.3%, respectively), while 
for females the high incidences occurred in the age class 31 – 40 years (7.6%).   
 
 
 
 
 
 
 
Asymp. Sig. (2-sided) df Value  
.008 20 38.268  Pearson Chi-Square 
.000 20 47.901  Likelihood Ratio 
.002 1 9.404  Linear-by-Linear Association 
  149  N of Valid Cases 
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Table (4.67): Other malignant neoplasms among sex and age groups 
Males Females Total  
N % N % N % 
1-10 21 3.1 9 1.3 30 4.4 
11-20 15 2.2 19 2.8 34 5.0 
21-30 39 5.7 30 4.4 69 10.1 
31-40 53 7.8 52 7.6 105 15.4 
41-50 64 9.4 44 6.4 108 15.8 
51-60 85 12.4 46 6.7 131 19.2 
61-70 91 13.3 43 6.3 134 19.6 
>70 48 7.0 24 3.5 72 10.5 
Total  416 60.9 267 39.1 683 100.0 
 
All the age classes (males and females) showed incidences of other malignant 
neoplasms and the incidences increase steadily with the advance of age starting from the 
age class 1 – 10 (4.4%) up to 61 – 70 years (19.6%) after which (above seventies) the 
incidences dropped to 10.5%. 
The relationship between sex and age group for other malignant neoplasms is poor at 
significance level 0.048 (X2 = 15.653) and the likelihood ration is 15.896 (Table (4.68)). 
 
Table (4.68): X2 of sex and age group for other malignant neoplasms 
Asymp. Sig. (2-sided) df Value  
.048 8 15.653  Pearson Chi-Square 
.044 8 15.896  Likelihood Ratio 
.013 1 6.213  Linear-by-Linear Association 
  683  N of Valid Cases 
 
The geographical distribution of other malignant neoplasms revealed higher percentages 
of incidences among patients from Central Sudan (32.5%) followed by Khartoum State 
(26.8%).  There is subtle difference in the incidences of other malignant neoplasms 
among patients from Western Sudan and Northern Sudan (14.1 and 13.9%, respectively.  
Patients from Southern Sudan showed the least percent of incidences (Table (4.69)). 
 
Table (4.69): Geographical distribution of other malignant neoplasms (2000 – 
2000) 
 2000 2001 2002 2003 2004 Tota 
khartoum 7.5 7.5 5.9 4.4 1.6 26.8 
Central Sudan 2.9 3.1 3.2 6.3 17.0 32.5 
Northern Sudan 1.9 3.5 1.6 1.6 5.3 13.9 
Western Sudan 1.6 1.3 1.3 3.5 6.3 14.1 
Eastern Sudan .4 1.0 .9 2.0 6.6 11.0 
Southern Sudan    .3 1.5 1.8 
 14.3 16.4 12.9 18.2 38.2 100 
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The time trend of other malignant neoplasms shows high incidence in 2004 (38.2%), 
while in the other four years (2000 – 2003) the percentages of incidences is relatively 
low compared with 2004 (Table (4.68 )).  However, there is no any case reported for 
patients from Southern Sudan in 2000, 20001 and 2004. 
 
The relationship between the geographical distribution of other malignant neoplasms 
and the time trend revealed a strong relation at significance level 0.000 (X2 = 168.633) 
and the likelihood ratio is 192.463 (Table (4.69)). 
Table (4.69): X2 for geographical distribution of other malignant neoplasms and 
time 
Asymp. Sig. (2-sided) df Value  
.000 20 168.633  Pearson Chi-Square 
.000 20 192.463  Likelihood Ratio 
.000 1 74.650  Linear-by-Linear Association 
  683  N of Valid Cases 
 
The main diseases of other malignant neoplasms include Central nervous system, 
Thyroid and Unknown primary (Table (4.709)). 
 
Table (4.70): Main diseases of other malignant neoplasms 
    
1.13 
2.3 
1.27 
24 
48.9 
27.1 
164 
334 
185 
Central nervous system 
Thyroid 
Unknown primary 
4.7 100 683  
4.4. The main malignant diseases in the Sudan according to Stac records 
Similar to the malignant diseases recorded in RIC, incidences of malignant diseases 
were categorized into two groups main malignant diseases and low frequency malignant 
diseases.  The main malignant diseases are similar to that of RIC, namely; neoplasm of 
breast, neoplasms of digestive organs, lymphoma, leukemia, neoplasms of oral cavity 
and pharynx, neoplasms of head and neck and neoplasms of female genital organs.  
Table (4.71) shows the frequencies and percentages of the main malignant diseases 
according to the record of STAC for the period 2000 – 2004. 
Table (4.71): Main malignant diseases according to Stac records (2000 – 2004) 
Cumulative % Valid % % N  
25.1 25.1 25.1 548  Neoplasm of breast  
47.5 22.3 22.3 487  Neoplasms  of digestive organs 
55.2 7.8 7.8 169  Lymphoma  
60.6 5.4 5.4 118  Leukemia  
69.6 8.9 8.9 195  Neoplasms  of oral cavity and pharynx 
79.4 9.8 9.8 214  Neoplasms of head  and neck 
100.0 20.6 20.6 449  Female  genital organ 
 100.0 100.0 2180 Total 
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Neoplasms of breast, neoplasms of digestive organs and neoplasms of female genital 
organs represent the bulk of the malignant diseases in the records of Stac for the period 
2000 – 2004.  They collectively account for about 68% of all the neoplasms.  
 
The geographical distribution of malignant diseases incidences showed the fact that 
patient from Khartoum State represent the majority of the cases of the malignant 
diseases (88.2%), while the other regions of the country (Northern Sudan, Eastern 
Sudan, Central Sudan, Western Sudan and Southern Sudan) account for 11.8%.  Table 
(4.72) shows geographical distribution of malignant diseases according to the records of 
Stac (2000 – 2004). 
 
Table (4.72): Geographical distribution of main malignant diseases (Stac 2000 – 
2004) 
Cumulative Percent Valid Percent Percent Frequency 
88.2 88.2 88.2 1923 khartoum 
91.2 3.0 3.0 65 Central sudan 
93.9 2.7 2.7 59 Northern Sudan 
98.3 4.4 4.4 96 Western Sudan 
100.0 1.7 1.7 37 Eastern Sudan 
 100.0 100.0 2180 Total 
 
 
As far as gender is concerned, the incidences of main malignant diseases occur among 
males and females.  It worth mentioning that there are some malignant diseases are sex 
specific like neoplasms of female genital organs.  Table (4.72) shows the incidences of 
main malignant diseases in relation to sex according to the records of STAC (2000 – 
2004). 
 
Table (4.72): Distribution of main malignant diseases according to sex 
Cumulative Percent Valid Percent Percent Frequency  
28.8 28.8 28.8 627 male 
100.0 71.2 71.2 1553 female 
 100.0 100.0 2180 Total 
 
However, incidences of the main malignant diseases is relatively higher among females 
(71.2%) compared to males (28.8) 
 
Findings of Table (4.73) shows that all the age classes are liable to the incidences of 
main malignant diseases.  Generally, the incidences are low in lower age classes (1- 10 
and 11 – 20) after which it starts to increase sharply where in age class 21 – 30 the 
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percentage of incidences increased to 10.4% and the age class 31 – 40 showed the 
highest level of incidences (20.3%).  In the age classes 41 -50, 51 – 60 and 61 – 70 the 
percentages of incidences is also high (19.6, 18.8 and 18%, respectively.  
 
Table (4.73): Prevalence of main malignant diseases according to age  
Cumulative Percent Valid Percent Percent Frequency  
2.4 2.4 2.4 52 1 10 
5.9 3.5 3.5 77 11-20 
16.3 10.4 10.4 227 21-30 
36.6 20.3 20.3 442 31-40 
56.2 19.6 19.6 428 41-50 
75.0 18.8 18.8 410 51-60 
93.1 18.0 18.0 393 61-70 
100.0 6.9 6.9 151 >70 
 100.0 100.0 2180 Total 
 
In older age classes (over seventies), the incidences of main malignant diseases is higher 
(6.9%) than the incidences in lower age classes (1 – 10 and 11 – 20) and lower than the 
other age classes. 
 
The pattern of distribution of main malignant diseases over the five years (2000 – 2004) 
showed variations in the level of incidences from one year to another being lower in 
2001 (10.4%) and higher in 2003 (31.4%).  Table (4.74) shows the distribution of main 
malignant diseases in the five years (2000 – 2004). 
 
 
Table (4.74): Distribution of malignant diseases during 2000 - 2004 
Cumulative Percent Valid Percent Percent Frequency  
19.5 19.5 19.5 425 2000 
29.9 10.4 10.4 227 2001 
42.5 12.6 12.6 274 2002 
73.9 31.4 31.4 685 2003 
100.0 26.1 26.1 569 2004 
 100.0 100.0 2180 Total 
 
4.4.1. Neoplasms of breast 
Although this neoplasms is not a sex specific diseases, the level of its incidences among 
females is much greater compared to males.  About 548 patients were registered in the 
records of Stac for these diseases representing 25.1% of the main malignant diseases 
and 19.6% of the whole malignant diseases.  Neoplasms of female breast represent 
94.5% of the cases of neoplasms of breast compared to 5.5% for male breast.  Table 
(4.75) shows the distribution of neoplasms of breast according to age groups and sex. 
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However, the peak of the incidences of neoplasms of female breast occurred in the age 
class 31 – 40 and the same is true for the males. 
 
Table (4.75): Distribution of neoplasms of breast according to sex and age 
 Male Female Total 
 N % N % N % 
1 10 2 .4 1 .2 3 .5 
11-20 1 .2 9 1.6 10 1.8 
21-30 1 .2 58 10.6 59 10.8 
31-40 9 1.6 168 30.7 177 32.3 
41-50 5 .9 125 22.8 130 23.7 
51-60 6 1.1 87 15.9 93 17.0 
61-70 6 1.1 51 9.3 57 10.4 
>70   19 3.5 19 3.5 
 30 5.5 518 94.5 548 100 
 
The above table shows clearly, all the age classes are liable to the incidence of 
neoplasms of breast.  The general trend of the incidences of neoplasms of breast follow 
the same trend of the main malignant diseases, lower incidences in the lower age classes 
and high incidences in higher age classes except the older age class which shows higher 
percentage than lower age classes (1 -10 & 11 – 20) and lower than the other age 
classes.  The age class 31 – 40 is the most age range that witnessed high incidences of 
neoplasms of female and male breast. 
 
Pearson Chi-Square shows low relation between age classes and sex for the incidences 
of neoplasms of breast at significance level 0.000 and the likelihood ratio is 15.777 
(Table (4.76 )). 
 
Table (4.76): X2 relationship of age classes and sex for neoplasms of breast 
Asymp. Sig. (2-sided) df Value  
.000 7 28.534  Pearson Chi-Square 
.027 7 15.777  Likelihood Ratio 
1.000 1 .000  Linear-by-Linear Association 
  548  N of Valid Cases 
 
The majority of the cases of neoplasms of breast were from Khartoum State (88%) 
followed by patients from Western Sudan (4.9%).  The other regions showed lower 
incidences compared with the above mentioned regions.  The higher incidences in 
Khartoum State occurred in 2003 and the same is true for Western Sudan.  Table (4.77) 
shows the relationship between the geographical distribution of the incidences of 
neoplasms of breast and the time of incidences. 
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Table (4.77): Geographical distribution of breast neoplasms (2000 – 2004) 
Total 2004 2003 2002 2001 2000 N  
88 22.3 25.0 10.0 9.9 20.8 482 Khartoum 
2.2 .7 .9 .4  .2 12 Central Sudan 
3.6 1.1 1.5 .4 .5 .2 20 Northern Sudan 
4.9 1.3 2.6 .4 .4 .4 27 Western Sudan 
1.3 .4   .4 .5 7 Eastern Sudan 
100 25.7 29.9 11.1 11.1 22.1 548  
 
The time pattern of neoplasms of breast distribution showed high incidences in 2000 
(22.1%) and 2001 and 2002 showed lower incidences (11.1% for each year) compared 
with other years.  Generally, the higher incidences of female and male breast neoplasms 
occurred in 2003 (29.9%) followed by 2004 (25.7%).  No any patient was registered in 
the records of Stac for neoplasms of breast from Eastern Sudan for the years 2002 and 
2003, while no patient was registered from Central Sudan in 2001.  The list of 
neoplasms of breast was deprived from any patient from Southern Sudan. 
 
Pearson X2 showed low relationship between the geographical distribution of breast 
neoplasms and the time of incidences (X2 = 22.061) at significance level 0.141 and the 
likelihood ratio is 26.924 (Table (78)). 
 
Table (4.78): X2 for geographical distribution of neoplasms of breast over time 
Asymp. Sig. (2-sided) df Value  
.141 16 22.061  Pearson Chi-Square 
.042 16 26.924  Likelihood Ratio 
.103 1 2.658  Linear-by-Linear Association 
  548  N of Valid Cases 
 
4.4.2. Neoplasms of digestive organ 
Neoplasms of digestive organ are one of the most common among malignant diseases.  
In the records of RIC it occupied the top of the list of incidences of malignant diseases, 
while it occupied the second rank according to the records of Stac.  The number of 
patients registered for these diseases in the records of stac is 487 representing 22.3% of 
the main malignant diseases and 17.5% of all malignant diseases. 
 
The incidences of neoplasms of digestive organs are higher among females (54.6%) 
compare to males (45.4%).   The higher percentage of incidences among females 
occurred in the age class 51 – 60 (12.9%), while for the males the higher percentage of 
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incidences occurred in the age class 61 – 70 (11.9%).  Table (4.79) shows the cross 
tabulation of sex and age groups for the neoplasms of digestive organs. 
 
Table (4.79): Relationship between sex and age groups for neoplasms of digestive 
organs  
 male female total 
 N % N % N % 
1 - 10 8 1.6 4 .8 12 2.5 
11-20 7 1.4 4 .8 11 2.3 
21-30 25 5.1 26 5.3 51 10.5 
31-40 31 6.4 47 9.7 78 16 
41-50 31 6.4 61 12.5 92 18.9 
51-60 35 7.2 63 12.9 98 20.1 
61-70 58 11.9 48 9.9 106 21.8 
>70 26 5.3 13 2.7 39 8 
 221 45.4 266 54.6 487 100 
 
All the age classes were registered for the neoplasms of digestive organs in the records 
of Stac with variant percentages, being lower in lower age classes and increase steadily 
with the advance of age up to the age class 61 – 70 (21.8%) after which it dropped to 
8% in patients over seventies.   
 
Pearson X2 of neoplasms of digestive organs for the sex and age groups showed low 
relationship at significance level 0.001 where the X2 value is 24.564 and the likelihood 
ratio 24.787 (Table (4.80 )). 
 
Table (4.80): X2 of neoplasms of digestive organs for sex and age groups 
Asymp. Sig. (2-sided) df Value  
.001 7 24.564  Pearson Chi-Square 
.001 7 24.787  Likelihood Ratio 
.290 1 1.121  Linear-by-Linear Association 
  487  N of Valid Cases 
 
The geographical distribution of the incidences of neoplasms of digestive organs is 
almost similar to that of the neoplasms of breast being very high in Khartoum State 
(88.9%) and lower in the other regions.  Also no patients were registered for these 
diseases from Southern Sudan, and in 2002 no patient was registered from Central 
Sudan and Eastern Sudan.  In 2001 no patient was registered for neoplasms of digestive 
organs from Western Sudan.  Table (4.81 ) shows the geographical distribution of the 
incidences of neoplasms of digestive organs for the period 2000 – 2004 according to 
Stac records. 
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Table (4.81): Geographical distribution of neoplasms of digestive organs (2000 – 
2004) 
Total 2004 2003. 2002 2001 2000 N  
88.9 22 24.4 13.1 6.8 22.6 433 khartoum 
3.7 2.1 .8  .4 .4 18 Central sudan 
3.1 .4 1.2 .6 .2 .6 15 Northern Sudan 
3.3 .8 1.2 .8  .4 16 Western Sudan 
1.0 .2 .2  .2 .4 5 Eastern Sudan 
100 25.5 27.9 14.6 7.6 24.4 487  
 
The time trend of the incidences of neoplasms of digestive organs showed a low 
incidences in years 2001 (7.6%) and 2002 (14.6%).  In the other years the percent of 
incidences showed a marked rise in the incidences. 
X2 for the geographical distribution of the neoplasms of digestive organs and the period 
of its incidence show a low relationship at significance level 0.243 where X2 value is 
19.506 and the likelihood ratio is 22.387 (Appendix 10)). 
4.4.3. Lymphoma 
Lymphoma neoplasms is one of the least common diseases among the main malignant 
diseases where only 169 patients were registered in the records of Stac during the period 
2000 – 2004 for these diseases, and this account for 7.8% of the main malignant 
diseases and 6.1% of all malignant diseases registered in Stac records for the above 
mentioned period. 
The incidences of the diseases is relatively higher among females (52.7%) compared to 
males (47.3%).  The highest incidences among females occurred in the age class 31 – 40 
(12.4%), while for the male 51 – 60 (11.8%).  Table (4.82) shows the distribution of 
lymphoma neoplasms among different age groups and sex for the period 2000 – 2004 
according to Stac records. 
Table (4.82): Distribution of Lymphoma in the Sudan (Stac 2000 – 2004) 
 Male  Female  Total  
 N % N % N % 
1 - 10 3 1.8 1 .6 4 2.4 
11-20 3 1.8 4 2.4 7 4.1 
21-30 14 8.3 12 7.1 26 15.4 
31-40 9 5.3 21 12.4 30 17.8 
41-50 12 7.1 15 8.9 27 16.0 
51-60 20 11.8 16 9.5 36 21.3 
61-70 14 8.3 15 8.9 29 17.2 
>70 5 3 5 3 10 6.0 
 80 47.3 89 52.7 169 100 
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Lower age classes showed low percentages, and starting from the age class 21 – 30 the 
percent of incidences start to increase and it reach its peak in the age class 51 – 60 
(21.3%). Similar to the above neoplasms, patients over seventies for lymphoma 
neoplasms are higher compared to lower classes (1 – 10 & 11 – 20) and lower than the 
other age classes. 
The cross tabulation for lymphoma neoplasms in relation to sex and age groups revealed 
a very poor relation (X2 = 6.448) at significance level 0.489 and the likelihood ratio is 
6.615 (Table (4.83)). 
 
Table (4.83):X2 of lymphoma neoplasms for age groups and sex 
Asymp. Sig. (2-sided) Df Value  
.489 7 6.448 Pearson Chi-Square 
.470 7 6.615 Likelihood Ratio 
.815 1 .055 Linear-by-Linear Association 
  169 N of Valid Cases 
 
All the regions showed incidences of lymphoma, being very high in Khartoum State 
(89.3%) followed by Western Sudan (4.1%).  The other regions showed lower 
incidences of lymphoma neoplasms compared to the above mentioned regions.  Table 
(4.84) shows the geographical distribution of lymphoma in relation to the period of 
incidences. 
 
Table (4.84): Geographical distribution of lymphoma in the five years  
Total 2004 2003 2002 2001 2000 N  
89.3 29.0 14.2 10.1 11.2 24.9 151 khartoum 
3.0 1.8 0.6 0.0 0.0 0.6 5 Central sudan 
1.8 1.2 0.0 0.0 0.6 0.0 3 Northern Sudan 
4.1 3.6 0.6 0.0 0.0 0.0 7 Western Sudan 
1.8 .6 1.2 0.0 0.0 0.0 3 Eastern Sudan 
100 36.1 16.6 10.1 11.8 25.4 169  
 
However, Khartoum State is the only region which showed incidences of lymphoma 
neoplasms across the five years (2000 – 2004).  Patients from Western and Eastern 
Sudan were registered only in 2003 and 2004, while patients from Northern Sudan were 
registered only in 2001 and 2004. 
 
X2 of geographical distribution of lymphoma neoplasms over the five years indicated a 
low relationship at significance level 0.187 (X2 = 20.790) and the likelihood ration is 
24.180 at significance level 0.086 (Table (4.85)). 
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Table (4.85): X2 of geographical distribution of lymphoma neoplasms (2000 – 2004) 
Asymp. Sig. (2-sided) Df Value  
.187 16 20.790 Pearson Chi-Square 
.086 16 24.180 Likelihood Ratio 
.002 1 9.477 Linear-by-Linear Association 
  169 N of Valid Cases 
 
4.4.4. Leukemia 
Like lymphoma, leukemia is one of the least common main malignant diseases 
according to the records of Stac for the period 2000 – 2004.  the number of patients 
registered for this disease is only 118 patients representing 5.4% of the main malignant 
diseases and 4.2% of all the malignant diseases registered in Stac records for the above 
mentioned period. 
The records revealed the susceptibility of males and females to the incidences of 
leukemia.  The incidences among females is higher (60.2%) compared to males 
(39.8%).  The peak of the incidences of the diseases occurred in age classes 21 – 30 and 
41 – 50 (12.7% for each), while for males the highest incidences occurred in the age 
class 41 – 50.  Table (4.86) shows the relationship between sex and age groups for the 
neoplasms of leukemia. 
 
Table (4.86): Distribution of leukemia among age groups and sex 
Male Female Total  
N % N % N % 
11-20 4 3.4 3 2.5 7 5.9 
21-30 7 5.9 15 12.7 22 18.6 
31-40 9 7.6 12 10.2 21 17.8 
41-50 10 8.5 15 12.7 25 21.2 
51-60 7 5.9 6 5.1 13 11.0 
61-70 5 4.2 14 11.9 19 16.1 
>70 5 4.2 6 5.1 11 9.3 
 47 39.8 71 60.2 118 100 
 
The trend of leukemia incidences across the five years showed the incidences of the 
diseases at all the age groups, except the first age class (1 – 10) with variant level.  The 
highest percent of incidences of the diseases reported among age group 21 – 30 (18.6%) 
followed by age classes 31 – 40 and 61 – 70 with 17.8 and 16.1%, respectively.  
Patients over seventies are higher than patients of age class 11 – 20 and lower than the 
rest of the age groups. 
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The cross tabulation of the age groups and sex for the neoplasms of leukemia indicated 
a poor relationship at significance level 0.649 where X2 value is 4.204 and the 
likelihood ratio is 4.248 (Table (4.87)). 
 
Table (4.87): X2 of leukemia for age groups and sex (Stac 2000 – 2004) 
Asymp. Sig. (2-sided) Df Value  
.649 6 4.204  Pearson Chi-Square 
.643 6 4.248  Likelihood Ratio 
.813 1 .056  Linear-by-Linear Association 
  118  N of Valid Cases 
 
The geographical distribution of leukemia neoplasm revealed the incidences of the 
diseases in all the regions except Southern Sudan according to the records of Stac.  Like 
all the above mentioned malignant diseases Khartoum State represent the bulk of the 
incidences (87.3%) followed by Northern Sudan (4.2%).  Table (4.88) shows the 
geographical distribution of leukemia neoplasms for the five years (2000 – 2004). 
 
Table (4.88): Geographical distribution of leukemia for the period 2000 - 2004 
Total 2004 2003. 2002 2001 2000 N  
87.3 21.2 33.1 12.7 11.9 8.5 103 khartoum 
3.4 .8 .8 .8 .8 0.0 4 Central sudan 
4.2 2.5 .8 0.0 .8 0.0 5 Northern Sudan 
2.5 0.0 2.5 0.0 0.0 0.0 3 Western Sudan 
2.5 .8 1.7 0.0 0.0 0.0 3 Eastern Sudan 
100 25.4 39.0 13.6 13.6 8.5 118  
 
The above table shows erratic nature of the incidences of neoplasms of leukemia where 
all the regions, except Khartoum Stan, have not registered for this disease in all the five 
years (2000 – 2004).  In 2000, incidences of neoplasms of leukemia were reported only 
in patients from Khartoum State, while in 2002 only patients from Khartoum State and 
Central Sudan were registered for these diseases.  Year 2003 is the only year which 
witnessed incidences of neoplasms of leukemia from all the regions. In the other years 
some regions have not patients for these diseases (Table (4.88)). 
 
X2 of the geographical distribution of leukemia over the five years showed low 
relationship at significance level 0.733 where X2 is 16.567 and the likelihood ratio is 
14.799 (Table (4.89)). 
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Table (4.89): X2 of geographical distribution of leukemia neoplasms (2000 – 2004) 
Asymp. Sig. (2-sided) Df Value  
.733 16 16.567 Pearson Chi-Square 
.539 16 14.799 Likelihood Ratio 
.119 1 2.433 Linear-by-Linear Association 
  118 N of Valid Cases 
 
4.4.5. Neoplasms of oral cavity and pharynx 
According to the records to the records of Stac for the period 2000 – 2004, the 
neoplasms of oral cavity and pharynx is considered as one of less common malignant 
disease compared with the other diseases where only 195 patients were registered for 
these diseases representing 8.9% of the main malignant diseases and 7% of all the 
malignant diseases registered in Stac for the above mentioned period 
 
Table (4.90) shows that males and females were liable to the incidences of neoplasms of 
oral cavity and pharynx.  Incidences of the diseases are relatively higher among males 
(58.5%) compared to females (41.5%).  The highest percent of incidences of the 
diseases for both (males and females) is the age class 61 – 70. 
 
Table (4.90): Relationship of sex and age groups for neoplasms of oral cavity and 
pharynx   
 Male Female Total 
 N % N % N % 
1 10 1 .5 3 1.5 4 2.1 
11-20 5 2.6 6 3.1 11 5.6 
21-30 10 5.1 9 4.6 19 9.7 
31-40 8 4.1 14 7.2 22 11.3 
41-50 21 10.8 13 6.7 34 17.4 
51-60 25 12.8 12 6.2 37 19. 
61-70 29 14.9 18 9.2 47 24.1 
>70 15 7.7 6 3.1 21 10.8 
 114 58.5 81 41.5 195 100 
 
All the age groups were registered for the neoplasms of oral cavity and pharynx in the 
records of Stac for the period 2000 – 2004.  the age class 61 – 70 showed a prominent 
percentage of incidence (24.1%) followed by age class 51 – 60 and 41 – 50 with 19% 
and 17.4%, respectively.  The other age classes showed incidences of the diseases with 
variant level.  It worth mentioning that the level of incidences in patients above 
seventies is higher than the level of incidences in lower age classes (1 – 10, 11 – 20 and 
21 – 30). 
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X2 test revealed a poor relationship between sex and age groups for the neoplasms of 
oral cavity and pharynx at significance level 0.168 and the likelihood ratio at the same 
significance level is 10.386 (Table (4.91)). 
 
 
 
Table (4.91): X2 of the relationship of sex and age for neoplasms of oral cavity and 
pharynx 
Asymp. Sig. (2-sided) Df Value  
.168 7 10.374  Pearson Chi-Square 
.168 7 10.386  Likelihood Ratio 
.012 1 6.295  Linear-by-Linear Association 
  195  N of Valid Cases 
 
 
The geographical distribution of the diseases is almost similar to that of leukemia where 
all the regions, except Southern Sudan, were represented in the patient list for this 
disease.  Khartoum State represented the bulk of the incidences of the neoplasms of oral 
cavity and pharynx.  The level of disease incidences in Northern, Eastern and Western 
Sudan is similar (2.1%), while the percent of incidence of patients from Central Sudan 
is 3.6% (Table (4.92)). 
 
Table (4.92): Geographical distribution of incidences of  neoplasms of oral cavity 
and pharynx (2000 – 2004) 
Total2004 2003. 2002 2001 2000 N  
90.3 15.9 29.7 13.8 8.7 22.1 176 khartoum 
3.6 .5 2.6 .5 0.0 0.0 7 Central sudan 
2.1 0.0 1.0 .5 0.0 .5 4 Northern Sudan 
2.1 .5 1.0 0.0 .5 0.0 4 Western Sudan 
2.1 .5 1.0 .5 0.0 0.0 4 Eastern Sudan 
100 17.4 35.4 15.4 9.2 22.6 195  
 
 
The peak of the incidences of the neoplasms of oral cavity and pharynx occurred in 
2003 (35.4%) followed by 2000 and 2004 with 22.6 and 17.4%, respectively.  The other 
two years (2001 and 2002) showed relatively lower percent of incidences. 
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The cross tabulation of the geographical distribution of neoplasms of oral cavity and 
pharynx over the five years showed a poor relationship at significance level 0.754 and 
the likelihood ratio is 16.811 (Table (4.93)). 
 
Table (4.93): X2 for geographical distribution of neoplasms of oral cavity and pharynx 
(2000 – 2004 
 
Asymp. Sig. (2-sided) Df Value  
.754 16 11.857 Pearson Chi-Square 
.398 16 16.811 Likelihood Ratio 
.097 1 2.746 Linear-by-Linear Association 
  195 N of Valid Cases 
4.4.6. Neoplasms of head and neck 
The neoplasms of head and neck is one of the common diseases of main malignant 
diseases according to the record of Stac where 214 diseases were registered for this 
disease and they represent 9.8% of the main malignant diseases and 7.7% of all the 
malignant diseases. 
Table (4.94) shows the incidences of these disease among sex and age groups.  Males 
and females are susceptible to the incidences of neoplasms of head and neck.  There is 
subtle difference in the level of incidence of neoplasms of head and neck between males 
(49.1%) and females (50.9%).  The highest percent of incidence among males occurred 
in the age class 61 – 70, while for females 41 – 50. 
Table (4.94): Relationship between age groups and sex for neoplasms of head and 
neck  
 Male Female Total 
 N % N % N % 
1 - 10 12 5.6 10 4.7 22 10.3 
11-20 3 1.4 8 3.7 11 5.1 
21-30 6 2.8 16 7.5 22 10.3 
31-40 8 3.7 14 6.5 22 10.3 
41-50 11 5.1 19 8.9 30 14.0 
51-60 24 11.2 17 7.9 41 19.2 
61-70 27 12.6 18 8.4 45 21.0 
>70 14 6.5 7 3.3 21 9.8 
 105 49.1 109 50.9 214 100 
All the age classes were represented in the list of patients for neoplasms of head and 
neck.  The highest level of incidences was registered for patients of age class 61 – 70 
(21%) followed by 51 -60 (19.2%).  Age classes 1 – 10, 21 – 30 and 31 – 40 showed 
similar percentage of incidences of neoplasms of head and neck.  The age class 11 – 20 
showed the least incidences (5.1%).  
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The cross tabulation of the relationship of the incidences of neoplasms of head and neck 
among sex and age groups revealed a poor relationship at significance level 0.025 where 
the X2 value is 16.029 and the likelihood ratio is 16.391 (Table (4. )). 
 
Table (4.95): X2 of neoplasms of head and neck for sex and age groups 
Asymp. Sig. (2-sided) df Value  
.025 7 16.029 Pearson Chi-Square 
.022 7 16.391 Likelihood Ratio 
.011 1 6.422 Linear-by-Linear Association 
  214 N of Valid Cases 
The geographical distribution of the incidences of neoplasms of head and neck is almost 
similar to that of leukemia.  Incidences of the disease were reported from all the regions, 
except Southern Sudan.  Khartoum State showed the highest percent of incidences 
(90.2%).  The percent of incidences in patients from Northern, Western and Eastern 
Sudan is similar (2.3%), while for the Central Sudan is 2.8% (Table (4.96)). 
 
Table (4.96): geographical distribution of neoplasms of head and neck (2000 - 2004 
Total 2004 2003. 2002 2001 2000 N   
90.2 25.7 31.8 12.6 8.4 11.7 193 khartoum 
2.8 .9 1.4 .5   6 Central sudan 
2.3 1.4 .5  .5  5 Northern Sudan 
2.3 1.4 .9    5 Western Sudan 
2.3  1.4 .5  .5 5 Eastern Sudan 
100 29.4 36.0 13.6 8.9 12.1 214  
 
Also incidences of neoplasms of head and neck were reported across the five years 
(2000 – 2004).  In Khartoum State, incidences of the diseases were reported across the 
five years.  In the other regions the pattern of the incidences is erratic in nature where 
two or three years showed incidences of neoplasms of head and neck. 
The cross tabulation of age group and sex for the neoplasms of head and neck indicated 
a poor relationship at significance level 0.722 where X2 value is 12.310 and the 
likelihood ration is 17.405 (Table (4.97)). 
 
Table (4.97): X2 of neoplasms of head and neck for age and sex 
Asymp. Sig. (2-sided) df Value  
.722 16 12.310 Pearson Chi-Square 
.360 16 17.405 Likelihood Ratio 
.317 1 1.000 Linear-by-Linear Association 
 Cases 214 N of Valid  
 
4.4.7. Neoplasms of female genital organ 
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These diseases are common among the main malignant diseases where 449 patients 
were registered for this disease in Stac during the period 2000 – 2004 representing 
20.6% of the main malignant diseases and 16.1% of the malignant diseases registered 
during the same period. Since it is a sex specific diseases, all the patients were females 
of different age groups.  The peak of the incidences occurred among age groups 31 – 40 
and 51 – 60 with 20.5 for each.  Table (4.98) shows the cross tabulation of neoplasms of 
female genital organs and the age groups. 
 
 
 
Table (4.98): Distribution of neoplasms of female genital organs across age groups 
 Female total 
 N % N % 
1- 10 7 1.6 7 1.6 
11-20 20 4.5 20 4.5 
21-30 28 6.2 28 6.2 
31-40 92 20.5 92 20.5 
41-50 90 20 90 20.0 
51-60 92 20.5 92 20.5 
61-70 90 20 90 20.0 
>70 30 6.7 30 6.7 
 449 100 449 100 
 
Incidences of neoplasms of female genital organs were reported in the records of Stac 
for all the age groups.  The levels of incidences were low in lower age classes (1 – 10, 
12 – 20 &21 – 30).  Incidences in patients over seventies are higher than in the above 
mentioned lower age class and far less than the other age groups.  The age range 31 – 70 
showed the highest percent of incidences of neoplasms of female genital organs (81%). 
The cross tabulation of the neoplasms of female genital organs and age groups show a 
low relation at significance level 0.006 where the value of X2 is 19.959 (Table (4.99)). 
 
Table (4.99): X2 of neoplasms of female genital organs and age groups 
Asymp. Sig. (2-sided) df Value  
.006 7 19.959 Pearson Chi-Square 
.049 7 14.133 Likelihood Ratio 
.056 1 3.648 Linear-by-Linear Association 
  449 N of Valid Cases 
The geographical distribution of neoplasms of female genital organs showed high 
incidences of the diseases in Khartoum State followed by Western Sudan (85.7% and 
7.6%, respectively).  The other regions showed lower percent of incidences.  The above 
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mentioned regions showed incidences of the diseases across the five years, while the 
incidences were reported for the other regions in the five years (Table (4. 100). 
 
Table (4.100). Geographical distribution of neoplasms of female genital organs 
Total 2004 2003. 2002 2001 2000 N  
85.7 21.8 30.5 9.6 11.1 12.7 385 khartoum 
2.9 1.6 .9 .4   13 Central Sudan 
1.6 .7 .9    7 Northern Sudan 
7.6 1.8 3.6 .7 .7 .9 34 Western Sudan 
2.2  .9 .4 .7 .2 10 Eastern Sudan 
100 25.8 36.7 11.1 12.5 13.8 449  
 
The time trend of neoplasms of female genital organs revealed the incidences of the 
diseases in the five years.  The percent of incidences are relatively low in the first three 
years and increased dramatically in the last two years (36.7 and 25.8%, respectively). 
 
X2 for the geographical distribution of the neoplasms of female genital organs across the 
five years showed a poor relationship at significance level 0.221 where X2 value is 
19.900 and the likelihood ratio is 26.544 (Table (4.101)). 
 
Table (4. 101): X2 of geographical distribution of female organs neoplasms 
Asymp. Sig. (2-sided) df Value  
.221 16 19.990 Pearson Chi-Square 
.047 16 26.544 Likelihood Ratio 
.592 1 .286 Linear-by-Linear Association 
  449 N of Valid Cases 
 
 
4.5. Low frequency malignant diseases 
The low frequency malignant diseases according to the records of Stac for the period 
2000 – 2004 includes seven neoplasms of malignant diseases, namely; musculoskeletal, 
neoplasms of male genital organs, neoplasms of respiratory organs, neoplasms of 
urinary tract, neoplasms of skin, neoplasms of bone and connective tissue, and other 
neoplasms of malignant diseases.  The low frequency malignant diseases represent 
21.9% of the malignant diseases registered for in the records of Stac for the period 2000 
– 2004.  Table (4.102) shows the low frequency malignant diseases and their 
frequencies. 
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Table (4.102): Frequency and percentages of low frequency malignant diseases 
Cumulative % Valid % % N  
27.4 27.4 27.4167  Neoplasms of musculoskeletal 
46.6 19.2 19.2117  Neoplasms of male genital organs 
49.1 2.5 2.5 15  Neoplasms of respiratory 
57.3 8.2 8.2 50  Neoplasms of urinary tract neoplasm 
67.3 10.0 10.061  Neoplasms of skin 
75.9 8.5 8.5 52 Neoplasms of bone and connective tissue 
100.0 24.1 24.1147 other 
 100.0 100 609 Total 
The most common diseases of the low frequency malignant disease are neoplasms of 
musculoskeletal (27.4%), neoplasms of other malignant diseases (24.1) and neoplasms 
of male genital organs (19.2%).  The other low frequency malignant diseases occurred 
at relatively lower percentages compared to the above mentioned diseases. 
 
The geographical distribution of the malignant diseases indicated that all the regions of 
the country were represented in the records of Stac for the low frequency malignant 
diseases.  Like the main malignant diseases, Khartoum State showed the highest percent 
of patients (88.3%) and Southern Sudan showed the least percent (0.2%).  The other 
regions showed low percent of incidences of low frequency malignant diseases where 
the level of incidences range between 2.1 to 3.6% (Table (4.103)). 
 
Table (4.103): Geographical distribution of low frequency malignant diseases 
Cumulative Percent Valid Percent Percent Frequency  
88.3 88.3 88.3 538 khartoum 
91.0 2.6 2.6 16 Central sudan 
94.6 3.6 3.6 22 Northern Sudan 
97.7 3.1 3.1 19 Western Sudan 
99.8 2.1 2.1 13 Eastern Sudan 
100.0 .2 .2 1 Southern Sudan 
 100.0 100.0 609 Total 
 
Table (4.104) indicates that incidences of low frequency malignant disease are higher 
among males (62.7%) compared with females 37.3%. 
Table (4.104): Distribution of malignant diseases according to sex 
Cumulative Percent Valid Percent Percent Frequency  
62.7 62.7 62.7 382 male 
100.0 37.3 37.3 227 female 
 100.0 100.0 609 Total 
 
Moreover, the records of Stac showed incidences of low frequency malignant diseases 
over all the age groups (Table (4.105).  The percent of incidences is relatively low in the 
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two lower age classes (1 – 10 and 11 – 20), and starting from the third age class the 
percentages of incidences increased sharply.  Percent of old patients (over seventies) is 
higher than the first lower age classes and lowers than the other age classes. 
 
 
 
 
 
 
Table (4.105): Percent of Malignant diseases in the different age groups 
Cumulative Percent Valid Percent Percent Frequency  
2.5 2.5 2.5 15 1 10 
9.7 7.2 7.2 44 11-20 
20.2 10.5 10.5 64 21-30 
31.4 11.2 11.2 68 3.00 
45.2 13.8 13.8 84 31-40 
66.5 21.3 21.3 130 41-50 
88.5 22.0 22.0 134 51-60 
99.8 11.3 11.3 69 61-70 
100.0 .2 .2 1 >70 
 100.0 100.0 609 Total 
 
The time trend of the incidences of the low frequency malignant diseases revealed the 
existence of incidences across the five years with variant levels. The last three years 
(2002, 2003 and 2004, with 22.2, 26.1 and 24%, respectively) showed most of the cases 
of low malignant diseases, while 2001 showed the least percent of incidences (Table 
(4.106)). 
 
Table (4.106): Distribution of low frequency malignant diseases over time 
Cumulative Percent Valid Percent Percent Frequency   
15.8 15.8 15.8 96 2000 
27.8 12.0 12.0 73 2001 
49.9 22.2 22.2 135 2002 
76.0 26.1 26.1 159 2003 
100.0 24.0 24.0 146 2004 
 100.0 100.0 609 Total 
 
4.5.1. Neoplasms of musculoskeletal 
About 167 patients were registered for the neoplasms of musculoskeletal in the records 
of Stac during the above mentioned period representing 27.4% of the low frequency 
malignant diseases and 6% of all the malignant diseases. Table (4.107) shows the 
incidences of neoplasms of musculoskeletal across the different age groups and sex. 
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Incidences of neoplasms of musculoskeletal is higher among males (58.7%) compared 
to females (41.3%).  The age class 41 – 50 showed the highest percent of incidences of 
neoplasms of musculoskeletal for both males and females.  No incidences were reported 
for females in the age class 1 – 10. 
 
 
 
 
Table (4.107 ): Distribution of neoplasms of musculoskeletal among sex and age 
groups 
Total Female Male  
% N % N % N  
2.4 4   2.4 4 1 - 10 
15.0 25 7.2 12 7.8 13 11-20 
12.0 20 6.0 10 6.0 10 21-30 
12.6 21 6.6 11 6.0 10 31-40 
22.2 37 9.6 16 12.6 21 41-50 
15.0 25 6.0 10 9.0 15 51-60 
12.0 20 4.8 8 7.2 12 61-70 
9.0 15 1.2 2 7.8 13 >70 
100 167 41.3 69 58.7 98 Total 
 
The age class 41 – 50 showed the highest incidences of neoplasms of musculoskeletal 
(22.2%) followed by the age classes 11 – 20 and 51 – 60 (15% for each).  The age class 
1 – 10 showed the least percent of incidences followed by patients over seventies. 
The cross tabulation of age groups and sex for the neoplasms of musculoskeletal 
showed a poor relationship at significance level 0.195 where the X2 value is 9.892 
(Table (4.108)). 
 
Table (4.108): X2 of musculoskeletal for age and sex 
Asymp. Sig. (2-sided) df Value  
.195 7 9.892 Pearson Chi-Square 
.098 7 12.075 Likelihood Ratio 
.151 1 2.061 Linear-by-Linear Association 
  167 N of Valid Cases 
 
The geographical distribution of the neoplasms of musculoskeletal is almost similar to 
most of the malignant diseases registered in Stac records, Khartoum State present the 
bulk of patients (85.5%).  The percent of incidences in the other regions is relatively 
low.  No any patient registered for these diseases from Southern Sudan (Table (4.109). 
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Table (4.109): Geographical distribution of musculoskeletal (2000 – 2004) 
 N 2000 2001 2002 2003 2004 Total % 
khartoum 143 13.8 9.6 9.6 24.0 28.7 85.6 
Central sudan 7    1.8 2.4 4.2 
Northern Sudan 4   .6  1.8 2.4 
Western Sudan 9 .6   1.8 3.0 5.4 
Eastern Sudan 4    .6 1.8 2.4 
 167 14.4 9.6 10.2 28.1 37.7 100 
 
Only patients from Khartoum State were registered for the neoplasms of 
musculoskeletal across the five years.  Khartoum State showed the bulk of the percent 
of incidences of neoplasms of musculoskeletal (85.6%).  The incidences among the 
other regions varied between 2.4 to 5.4%. 
 
The cross tabulation for the geographical distribution of the neoplasms of 
musculoskeletal showed a poor relationship at significance level 0.520 (X2 = 15.067).  
Table (4.110) shows X2 of musculoskeletal for geographical distribution and time of 
incidences. 
 
Table (4.110): X2 of musculoskeletal for geographical distribution (2000 – 2004) 
Asymp. Sig. (2-sided) df Value  
.520 16 15.067 Pearson Chi-Square 
.160 16 21.491 Likelihood Ratio 
.008 1 7.034 Linear-by-Linear Association 
  167 N of Valid Cases 
 
4.5.2. Neoplasms of male genital organs 
About 117 patients were registered for the neoplasms of male genital organs in the 
records of Stac for the period 2000 – 2004 representing 19.2% of the low frequency 
malignant diseases and 4.2% of all the malignant diseases.  These diseases are sex 
specific, therefore, only males were registered for these diseases.  Table (4.111) shows 
the distribution of the neoplasms of male genital organs across the different age groups. 
 
Table (4.111): Neoplasms of male genital organs in different age groups 
total Males  
% N % N  
2.6 3 2.6 3 1 10 
1.7 2 1.7 2 11-20 
4.3 5 4.3 5 21-30 
1.7 2 1.7 2 31-40 
7.7 9 7.7 9 41-50 
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25.6 30 25.6 30 51-60 
33.3 39 33.3 39 61-70 
23.1 26 23.1 26 >70 
100 117 100 117 Total 
 
Incidences of neoplasms of male genital organs were reported in the records of Stac for 
all the age groups with variant level.  The last three age classes (51 – 60, 61 – 70 and 
above 70s) the level of incidences are very high, particularly for the age class 61 – 70 
(33.3%). Below the 50s the percent of incidences is relatively low (Table (4.111)).  
 
The cross tabulation of the neoplasms of male genital organs for the different age 
groups showed a poor relationship at significance level 0.286 where X2 value is 9.715 
(Table (4.112)). 
 
Table (4.112): X2 of neoplasms of male genital organs and age groups 
Asymp. Sig. (2-sided) df Value  
.286 8 9.715 Pearson Chi-Square 
.230 8 10.523 Likelihood Ratio 
.100 1 2.706 Linear-by-Linear Association 
  117 N of Valid Cases 
 
The geographical distribution of the neoplasms of male genital organs revealed the 
incidences of the diseases in patients from all the region except Southern Sudan.  
Khartoum State showed the highest level of incidences (88%) followed by Central 
Sudan (6%) and Northern Sudan (3.4%).  In the other regions the level of incidences is 
relatively low.  Table (4.113) shows the geographical distribution of neoplasms of male 
genital organs across 2000 – 2004. 
 
Table (4.113): Geographical distribution of neoplasms of male genital organs (2000 
– 2004) 
 N 2000 2001 2002 2003 2004 Total % 
khartoum 103 10.3 14.5 14.5 29.1 19.7 88 
Central sudan 7  .9 1.7 1.7 1.7 6.0 
Northern Sudan 4  .9 .9 .9 .9 3.4 
Western Sudan 1    .9  .9 
Eastern Sudan 2 .9 .9    1.7 
 117 11.1 17.1 17.1 32.5 22.2 100 
 
Like most of the above malignant diseases, the incidence of neoplasms of male genital 
organs is relatively high (32.5%) in 2003 followed by 2004 (22.2%).  The first three 
years showed low percent of neoplasms of male genital organs incidences. 
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The cross tabulation of incidences of neoplasms of male genital organs over the five 
years showed a poor relation at significance level 0.871 where X2 value is 9.911 (Table 
(4.114)). 
 
 
 
 
Table (4.114): X2 for geographical distribution of neoplasms of male genital 
organs for the five years 
Asymp. Sig. (2-sided) df Value  
.871 16 9.911 Pearson Chi-Square 
.815 16 10.903 Likelihood Ratio 
.326 1 .965 Linear-by-Linear Association 
  117 N of Valid Cases 
 
4.5.3. Neoplasms of respiratory organs  
Only 15 patients were registered for the neoplasms of respiratory organs in the records 
of stac for the period 2000 – 2004 and this represent 2.5% of the low frequency 
malignant diseases and 0.5 of all the malignant diseases registered for in the records of 
Stac.  Females' incidences of neoplasms of respiratory organs account for 53.3% and the 
males (46.7%).  Appendix (11) shows the distribution of neoplasms of male genital 
organs for the different age groups and sex. 
 
The geographical distribution for the neoplasms of respiratory organs showed 
incidences of the neoplasms in four regions where no patient from Southern and 
Western Sudan was registered for these diseases.  The majority of the patients were 
from Khartoum State (80%), while the level of incidences in the other regions is similar 
(6.&%).  Appendix (12) shows the cross tabulation of the geographical distribution of 
neoplasms of respiratory organs and the periods of incidences. 
 
4.5.4. Urinary tract neoplasm 
Few patients were registered in the records of Stack for the neoplasms of urinary tract 
(50 patients) and they represent 8.2% of the low frequency malignant diseases and 2.3% 
of all the malignant diseases registered in Stac for the period 2000 – 2004.  Appendix 
(13) shows the relationship of urinary tract neoplasms for sex and age groups.  
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Incidences of urinary tract neoplasms among males is relatively high (60%) compared 
to females (40%).  However, the incidences among females occurred across all the age 
crops, while for the males the first two age classed did not showed any incidences of the 
diseases.  Moreover, there is no regular trend of incidences across the age groups.  The 
age class 41 – 60 showed the least percent of incidences (4.0%) followed by the two 
lower age classes 1- 10 and 11 – 20 (6% for each).  The age class 51 – 60 showed the 
highest percent of incidences of urinary tract neoplasms. 
 
The geographical distribution of urinary tract neoplasms revealed the distribution of the 
diseases among patients from all the regions of the Sudan, according to the records of 
Stac (2000 – 2004).  Table (4.115) shows the geographical distribution of the neoplasms 
across the five years.  The incidences of the diseases are very high among patients from 
Khartoum State (90%) while the rest of the regions represent the rest of the incidencies. 
 
Table (4. 115): Geographical distribution of urinary tract neplasms (2000 – 2004) 
 N  2000 2001 2002 2003 2004 Total % 
khartoum 45 12.0 6.0 6.0 40 26 90 
Central sudan 1 2.0 0.0 0.0 0.0 0.0 2.0 
Northern Sudan 1 0.0 0.0 0.0 2.0 0.0 2.0 
Western Sudan 2 2.0 0.0 0.0 2.0 0.0 4.0 
Eastern Sudan 1 0.0 0.0 2.0 0.0 0.0 2.0 
Total  50 16. 6. 8 44. 26 100 
 
The time trend of the urinary tract neoplasms showed incidences of the diseases across 
the five years, being very high in 2003 (44.0%) followed by 2004 (26%), while 2001 
showed the least incidencies of the diseases (6.0% followed by 2002 (8.0%). Only 
Khartoum State showed records for the diseases for the five years. 
 
4.5.5. Neoplasms of bone and connective tissue 
The neoplasms of bone and connective tissue is one of the least malignant diseases in 
the records of Stac for the period 2000 – 2004 where 52 patients were registered for this 
disease representing 2.4% of the malignant diseases registered for the diseases. 
 
Appendix (14) shows the relationship between sex and age groups for the neoplasms of 
bone and connective tissue.  The incidences among males is greater (61. 5%) than 
among females (38.5%).  The highest percent of incidences among males occurred in 
the age classes 31 – 40 and 41 – 50, 13.5 and 11.5%, respectively.  While for females 
the highest percent of incidences of the diseases occurred in age class 61 – 70 (11.5%). 
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All the aged groups showed cases of neoplasms of bone and connective tissue except 
the first age class (1 – 10).  However, the highest percent of incidences of neoplasms of 
bone and connective tissues occurred in age class 61 – 70 (21.2%) and the least 
occurred in the age class above seventies. 
 
Table (4.116) shows the geographical distribution of the neoplasms of bone and 
connective tissues and the trend of incidences across the five years.  Khartoum State 
showed the highest level of incidence (94.2%) and the rest of the cases were registered 
for patients from Northern Sudan and Western Sudan (3.8 and 1.9%, respectively). 
 
Table (4. 116): Geographical distribution of neoplasms of bone and connective 
tissues (2000 – 2004)  
 N 2000 2001 2002 2003 2004 Total % 
khartoum 49 3.8 13.5 17.3 30.8 28.8 94.2 
Northern Sudan 1 1.9  1.9   3.8 
Western Sudan 1    1.9  1.9 
 52 3.8 15.4 17.3 34.6 28.8 100 
 
The time trend of the incidences of neoplasms of bone and connective tissues revealed a 
steady increase of the incidences starting from the first year (2000) up to 2003 where 
the percent of incidences reached its peak (34.6%) before dropping in 2004 to 28.8%. 
 
4.5.6. Neoplasms of skin 
Sixty-one patients were registered for these diseases in the records of Stac for the period 
2000 – 2004 representing 2.84% of all the malignant diseases recorded in Stac.  
Appendix (15) shows the distribution of the neoplasms among sex and age groups. 
 
Incidences of neoplasms of skin is high among females (60.7%) compared to males 
(39.3%). The highest percent of incidences among females occurred among the age 
class 61 – 70 while the age class for males which witnessed the highest percent of 
incidences is 51 – 60 (13.1%).  All the age classes showed incidence of neoplasms of 
skin with variant percent.  The age classes 51 – 60 and 61 – 70 showed the highest 
percent of incidences (26.2% for each).  Incidences among patients over seventies is 
higher than in the two lower age classes and lower than the rest of the age classes. 
 
The geographical distribution of the diseases revealed the existence of the incidences in 
all the regions except Central Sudan and Southern Sudan.  Khartoum State showed the 
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highest level of incidences (83.6%) followed by Northern Sudan (9.8%), while Western 
and Eastern Sudan Showed the least percent of incidences (3.3% for each).  Table 
(4.117) shows the geographical distribution of neoplasms of skin during the five years. 
Table (4. 117): Geographical distribution of neoplasms of skin (Stac 2000 – 2004) 
 N 2000 2001 2002 2003 2004 Total % 
khartoum 51 13.1 4.9 39.3 16.4 9.8 83.6 
Northern Sudan 6 4.9 4.9 0.0 0.0 0.0 9.8 
Western Sudan 2 0.0 0.0 1.6 1.6 0.0 3.3 
Eastern Sudan 2 0.0 0.0 3.3 0.0 0.0 3.3 
 61 13.1 9.8 49.2 18 9.8 100 
The time trend of the neoplasms of skin showed the highest percent of incidences 
occurred in 2002 where 49.2% of the diseases were registered in this year.  The other 
four years showed variant level of incidences. 
 
Other malignant diseases 
The other malignant diseases registered in Stac for the period 2000 – 2004 includes 
Central nervous system, Thyroid and Unknown primary.  About 147 patients were 
registered for this disease and representing 6.7% of patients of malignant diseases 
registered in Stac records for the five years. 
 
Appendix (16) shows the relationship between sex and age groups for the neoplasms of 
other malignant diseases. Incidences among females were lower (46.3%) compared to 
males (53.7%).  Incidences among males occurred in the age classes 51 – 60 and 61 – 
70 (15.6% and 13.6%, respectively), while for the females the highest incidences 
occurred in the same age classes with 8.8% for each.  The time trend of the diseases 
revealed the occurrence of the incidences of the diseases in all the age classes being 
lower in the first two age classes and the last age class (2%, 6.1%, and 6.8%, 
respectively).  The highest level of incidences occurred in the age classes 51 – 60 and 
61 – 70. 
 
X2 showed a poor relationship between age and sex for the neoplasms of other 
malignant diseases at significance level 0.526 where X2 value is 6.121 and the 
likelihood ratio is 6.169 (Table (4.118)). 
 
Table (4.118): Relationship between sex and age for neoplasms of other malignant 
diseases 
Asymp. Sig. (2-sided) df Value  
.526 7 6.121 Pearson Chi-Square 
91 
 
.520 7 6.169 Likelihood Ratio 
.077 1 3.138 Linear-by-Linear Association 
  147 N of Valid Cases 
 
The geographical distribution of the neoplasms of other malignant diseases indicated the 
incidences of the diseases in patients from all the regions except Central Sudan.  
Kartourm State represented the bulk of the cases (91.8%) and the rest of the percentages 
distributed among the other regions (Table (4.119)). 
 
 
 
 
Table (4.119): Geographical distribution of neoplasms of other malignant diseases 
 N  2000 2001 2002 2003 2004 Total % 
khartoum 135 22.4 11.6 35.4 11.6 10.9 91.8 
Northern Sudan 4    1.4 1.4 2.7 
Western Sudan 4  .7 .7  1.4 2.7 
Eastern Sudan 3 1.4   .7  2.0 
Southern Sudan 1   .7   .7 
 147 23.8 12.2 36.7 13.6 13.6 100 
 
The time trend of the incidences of neoplasms of other malignant diseases showed 
variation in the incidences of the diseases being relatively high in 2000 (23.8%) and 
higher in 2002 (36.7%).  There is no variation with respect to the percent of incidences 
in 2003 and 2004 (13.6% for each). 
 
X2 for the relationship of geographical distribution of other malignant diseases and the 
time trend of the incidences showed a low relationship at significance level 0.087 where 
the X2 is 24.104 and the likelihood ratio is 24.765 (Table 4.120). 
 
Table (4. 120): X2 of the geographical distribution of neoplasms of other malignant 
diseases over time 
Asymp. Sig. (2-sided) df Value  
.087 16 24.104 Pearson Chi-Square 
.074 16 24.765 Likelihood Ratio 
.257 1 1.286 Linear-by-Linear Association 
  147 N of Valid Cases 
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Chapter V 
Discusions 
 
5.1. Malignant diseases in the Sudan 
As mentioned in Chapter IV the number of malignant diseases cases is more than 
sixteen thousand cancer cases for five years (2000 – 2004).  Two sources of information 
were relied on for the provision of diseases records, namely Radiation and Isotopes 
Centre and Stac laboratories (14521 and 2180, respectively).    This discussion will 
focus on the distribution of the different neoplasms by age, sex and geographical site for 
all registered patients in the records of the above mentioned centres.  The discussion 
attempts to highlight the similarities and differences between and among the various 
subgroups for sake of determining the significance of the incidences of malignant 
diseases with respect to sex, age groups, time series and geographical origin.  It worth 
mentioning that the malignant neoplasms were grouped into two categories, namely; 
high and low frequency malignant diseases.    
 
Site specific incidence rates are considered the most useful single measure of cancer 
occurrence in any community (21).  Despite the reality of this fact, for the most of the 
third world countries it is extremely difficult to conduct like these studies due to 
unavailability of standard records.  In this study considerable number of patients was 
excluded from the study merely due to ttheir incomplete information of the variables 
considered in this study.  (22 – 23) attributed the lack of relevant information to different 
factors like; a deficient and unevenly distributed health and medical service, leading to a 
grossly unequal coverage of the population; scarcity of trained personnel, lack of census 
data, a low priority for cancer as a health problem, lack of funds for adequate cancer 
registration and detection programs, restrictive social habits and practices which 
interfere with detection, diagnosis and follow up of cancer cases, and poor 
communication systems affecting the reporting and follow up of cancer patient.  In this 
discussion the frequency rates will be analysed and discussed in relation to other 
scientists with respect to geographical distribution of the diseases, sex, age group and 
time series of incidences.  
 
5.1.1. Geographical distribution of malignant neoplasms in Sudan 
Doll (24) showed the importance of considering the geographical distribution of diseases 
particularly neoplasm of malignant diseases because it explores the findings regarding 
93 
 
different environment and different habits, customs and working conditions.  He further 
emphasized the importance of such information in provision cclues to the causation of 
diseases.  According to the records of RIC, almost all the country witness cases of 
malignant neoplasms.  As far as the records of Stac labrotary it is almost represents 
cases of incidents of patients of Khartoum State since the bulk of the patients are 
transferred from local hospitals at the State.  Generally, there are significant variations 
in malignant neoplasms among the different regions.  The general pattern of malignant 
neoplasm of this study confirms some of the findings in similar previous studies with 
substantial difference among the different states.  In this study however, Khartoum State 
and Central State showed the dominance of incidences of neoplasm of malignant 
diseases, where Khartoum State occupied the top of ranking of the diseases.  The third 
ranked state is interchangeable between Western Sudan and Northern Sudan. .  
However, incidence of malignant neoplasms in Eastern and southern Sudan is relatively 
low compared to the other regions.  This variation in the incidences of neoplasm of 
malignant diseases agrees with that found by (23) who clearly showed the a gradual but 
definite gradient of change in the pattern of malignant neoplasm among the different 
regions of the country.  However the incidences of the neoplasm of malignant diseases 
in the Khartoum State somehow look similar to the incidences of the diseases in some 
arab countries as indicated by where carcinoma of the breast is the commonst cancer 
and constitutes nealy one third of malignant neoplasm among females.  However, 
neoplasm of digestive organs is the highest disease followed by breast cancer in the 
different region. 
 
5.1.2. Patterns of malignant neoplasms according to age group 
It seems that all age groups are liable to malignant neoplasms.  Table (4.5) shows that 
the percent of incidence in children of 1 – 10 years old, according to RIC records, is low 
where only 4.5% were registered for malignant neoplasms.  The percentages of 
incidences  increase steadily with age up to age groups 51 – 60 years after which the 
percent of incidences start to diminish. Generally patients of malignant neoplasms 
above 31 years represent 80.6% of the total sample.  According to the records of Stac 
laboratory, the incidence of malignant disease in relation to age group is almost similar 
where  the incidences are low in lower age classes (1- 10 and 11 – 20) after which it 
starts to increase sharply with the advance of ages.  In old age classes is also relatively 
high Table (4.73). These findings agree with (23) who showed relatively high ratios of 
cancer are reported among the young age groups in the Sudan.  Similar ratios of 
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incidences of neoplasms were recorded in other developing countries as mentioned by 
(23) On the other hand (25) showed a reverse trend of incidences of malignant diseases in 
developed countries where less than 1% of incidences is reported for cancer in children.  
(22) attributed the disparity of the distribution of neoplasm incidences according to age 
factor between the developed and underdeveloped countries to the marked difference in 
the age structure of populations.  In the developed countries the population have a high 
life expectance, a low ratio of young people and a high ratio of old people.  According 
to Statistical Abstract of 1981, in the Sudan there is a significant differences in the 
distribution of the population into different age groups where children constitute 45% of 
the population while the elderly people represent 2.7%.  As appeared from this study, it 
is clear that the incidences of malignant diseases increase with the advance of age.  This 
fact is supported by the data collected from the both sources of information.  Therefore, 
this fact can be considered as strong correlation between incidences of malignant 
neoplasms and the age factor.  In this study no attempt was made to discover the 
relationship between the ethnic groups and incidences of malignant diseases in the 
country.  This was made simply because recently most of the Sudanese tribes entered in 
crosses regarding marriages.  Therefore, it is clear that comparison between the different 
ethnic groups and the incidences of neoplasm of malignant diseases.    
 
5.1.3. Pattern of malignant diseases according to sex 
The distribution of malignant neoplasms according to sex can be used as a monitor to 
trace the disease and link it to sex.  Some diseases are sex specific like neoplasms of 
male and female genital organs.  Generally, it seems that females are more susceptible 
to cancer diseases compared to males.  According to the records of RIC the number of 
females affected by cancer represents 56.6% of all registered cases compared to 43.4% 
for males.  While according to the records of Stac laboratory female incidences is higher 
(71.2%) compared to incidences among men (28.8%).  This differences is apparent 
across the different years covered by this study.  This results agrees with (23) showing 
that the incidences among female is higher compared to males across eighteen years 
covered in his study.  One of the justifications for the differences in incidences between 
males and females is the fact that there are some diseases which are sex specific and 
their number in females is higher compared to males.  Khiery (26) also arrived to a 
similar conclusion showing that incidences of neoplasms among females are higher than 
in males, an emphasizing this fact despite a lack of disparities in the population census 
of the country in the ratio of males and females.  This variation in incidences among sex 
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is not only common for Sudan, but it seems it is common in most of African countries 
south of the great desert as mentioned by (27).  However, in the Sudan carcinoma of the 
breast is the most important single factor determine the sex ratio of cancer.  Among the 
other factors mentioned by (23) and have effect on the variation in the incidences of 
neoplasm of malignant diseases in the country which have direct relation with the sex.  
This may be the case in the southern Sudan where males appear to have a better 
opportunity to report to far-away medical centers than females.   
 
5.1.4. Incidence of cancer in the five years (2000 – 2004) 
The time trend of cancer diseases in the Sudan, according to RIC and Stac records, 
shows considerable variation in the number of patients.  The general trend indicates that 
the incidences of cancer diseases increase year by year.  The number of cancer cases 
recorded for the year 2000 is about 2190 cases representing 15.1% of all the cases 
recorded in the RIC for the period 2000 – 2004.  in year 2001 the percentage of 
malignant neoplasms incidences increased to 2627 (18.1% of the total sample).  The 
trend of cancer cases showed a continuous increase year after year.  In 2002 the number 
of malignant neoplasm patients raised to 2824 cases (19.4% of the total sample for the 
period 2000 – 2004) and in year 2003 the number of patients increased to 3128 (21.5%). 
18.1year 2001 (398 cases more than the record of year 2000).  The number of cases for 
year 2002 showed 2002 cases, while in 2003 the number of cancer incidences raised to 
2186 and the last year (2004) witnessed the peak of the cancer cases (2315).  Ranking of 
the malignant neoplasms revealed that the neoplasms of digestive organs are the most 
common cancer diseases followed by neoplasms of breast and neoplasms of female 
genital organs.  The other neoplasm are ranked as Leukemia, neoplasms of the oral 
cavity and pharynx, lymphoma and neoplasms of head and neck, respectively. 
 
5.2. Neoplasms of digestive organs 
Neoplasms of digestive organs are not an age group or sex specific diseases.  All the age 
groups are liable for cancers of digestive organs, and the same is true for the sex.  It is 
one of the leading groups of cancers in industrialized countries.  In USA it accounts for 
23.3% of all cancers; and in U.K. it accounts for 24.5% (25).  The total number of 
patients of malignant neoplasms of the digestive organs is about 3126 patients 21.5% of 
the total cancer cases according to the records of RIC for the period 2000 – 2004.  
Incidences of neoplasms of digestive organs is relatively higher among males compared 
to females (61.1 and 38.9%, respectively), and the incidences showed a steadily increase 
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with the advance of age, but there is insignificant difference regarding the incidence of 
the neoplasm of digestive organs and age groups.  After sixty years of age the 
incidences of the neoplasms start to decline.  However, high ratios of cancer of the 
digestive organs are reported from some African countries.  These are mainly due to a 
high frequency of cancers of the oesophagus and liver (28) 
 
5.2.1. Oesophagus 
Carcinoma of the osephagus is the main type of cancer of the digestive organs where it 
represent 25.7% of the cases.  It worth mentioning that in this series the total number of 
patients of malignant neoplasms of the digestive organs is about 3126 patients 21.5% of 
the total cancer cases for the period 2000 – 2004.  This carcinoma was almost unknown 
in the Sudan until the early sixties where only three cases were reported by (29) from a 
sample of 2687 malignant neoplasms.  The trend of carcinoma of the oesophagus 
among different age groups shows a continuous rise in the level of incidence of the 
diseases being low in lower age group (1 – 10 years) and increase steadily up to the age 
of 70 years after which the percent drop.  The number of cases of neoplasms of the 
oesphagus starts to be apparent starting from age 20 years.  As far as sex is concerned, 
the incidence of the neoplasms is much higher in males compared to females 
particularly at age groups of 41-50, 51-60 and 61-70 years.  High serum leptin is 
associated with an increased risk of Barrett’s oesophagus among men but not women. 
This association is not explained simply by higher body mass or gastro-oesophageal 
reflux among cases. The mechanism remains to be determined.  The geographical 
distribution of the neoplasms indicates high ratios at Khartoum State, Central Sudan and 
Western Sudan.   
Until recently, oesophageal adenocarcinoma was a rare disease with an incidence of less 
than five per million person-years; however, the incidence of this cancer has increased 
sharply in the United States, Australia and Europe during the past three decades (30 – 31). 
This has occurred on a background of increasing  incidence of Barrett’s oesophagus, (32- 
33) a metaplastic change in the lining of the oesophagus, which is a precursor for nearly 
all OA (34).  Two recent studies have shown that the association between obesity and the 
risk of Barrett’s oesophagus is mediated via central obesity (35- 36). In these studies, 
adjustment for reflux symptoms did not abolish and in one study (36) increased the 
association between central obesity and Barrett’s oesophagus, suggesting that 
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mechanisms in addition to central obesity-mediated gastro-oesophageal reflux may be 
playing a role in this association.  
It is acknowledged that the serum leptin concentration is strongly associated with the 
risk of Barrett’s oesophagus in men, but not in women. In men, the serum leptin 
concentration was highest in cases with a BMI greater than 35 kg/m2, in which the 
serum concentrations were nearly two times those of BMI-matched controls and 
approached the magnitude of concentrations observed among female cases. Although 
associations between obesity and central obesity and the risk of Barrett’s oesophagus 
have been described previously (35- 39).  
Three factors that potentially confound the association between serum leptin 
concentration and the risk of Barrett’s oesophagus are sex, obesity and gastro-
oesophageal reflux (39). Why is leptin not associated with the risk of Barrett’s 
oesophagus in women? In obese women, peripheral adipocytes secrete significantly 
more leptin than omental adipocytes (40). In contrast, in obese men, the leptin secretion 
by adipocytes is similar at both anatomical sites (40) Given these gender differences in 
leptin secretion, women with central obesity would be expected to have lower serum 
leptin concentrations than women without central obesity, assuming the same BMI. The 
serum leptin concentration would then be negatively associated with central obesity. If 
so, then this would explain the inverse association that we observed between the serum 
leptin concentration and the risk of Barrett’s oesophagus among women (39).  
5.2.2. Stomach 
Stomach, or gastric, cancer incidence is second only to lung cancer worldwide, with an 
estimated 870,000 new cases and 650,000 deaths every year. The high-risk areas are 
East Asia, South America, and Eastern Europe (4).  Incidence rates are twice as high in 
males as in females. Thirty-eight percent of the world’s stomach cancer cases occur in 
China, and it is the most frequent cancer in males in other parts of East Asia. 
Agestandardized incidence rates (ASRs) are the highest in the world in Japan (77.9 per 
100,000 in men; 33.3 in women) (4-40).  The major risk factors for stomach cancer are 
hypothesized to be nutritional, including inadequate intake of fresh fruits and 
vegetables, and high intake of salt, smoked fish, and meat.  Refrigeration of food is 
considered protective. Vitamin C, contained in vegetables and fruits, may be protective 
for stomach cancer.  Other possibly protective nutritional factors are whole-grain cereal, 
carotenoids, allium compounds, and green tea (41).  Smoking carries a slightly increased 
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risk for stomach cancer (42),  and alcohol does not affect risk other than in the gastric 
cardia (43).  Smoking is quite common in countries of the Middle East Cancer 
Consortium (MECC) (44).  Another important risk factor is Helicobacter pylori 
infection.  Other gastric diseases, such as ulcer and atrophic gastritis, elevate gastric pH, 
thus causing anaerobic bacterial colonization in the stomach. H. pylori prevalence 
ranges from 25% in developed countries to 80%-90% in the developing countries (45). It 
is now considered as the principal cause of chronic gastritis and peptic ulcer disease, 
and is a key risk factor for the development of gastric cancer (46). The prevalence of H. 
pylori is thought to be high in MECC countries. In Israel, the prevalence has been 
reported to be 72% in a rural population and 65% in an urban population, which is 
higher than in the United States and Western Europe, but lower than in developing 
countries (47). Another study has reported 33% positive for H. pylori in an elderly 
population in Israel (48), and a case-control study in Israel found 63% positivity among 
the healthy controls (49). In a population of Jordanian endoscopy patients, 82% 
prevalence was reported (50), but there is no information for the general population. 
 
Stomach cancer incidence in the MECC countries during the period 1996-2001 was 
low, compared with the world ASR of 10.3 in females and 22.0 in males (40). The 
incidence was highest in Israeli Jews (8.5), followed by Cypriots (4.9), Jordanians (4.8), 
and Israeli Arabs (4.6). Although a study from Jordan reports that the characteristics of 
gastric cancers diagnosed there resemble those in high-risk countries, it nevertheless 
appears to be a low-incidence country. Egypt had the lowest incidence in the region, 
with 2.9. US SEER incidence was 5.3 for the same years .  These rates are 5 to 15 times 
lower than in Japan, where the overall rate is more than 50 (40).  Worldwide, the 
stomach cancer ASR in males is twice that in females. Cyprus did not show this pattern; 
the male-to-female ratio was closer to 1 (1.44).  The Arab countries in the region had 
low rates, while Israel and Turkey had higher rates. In addition, all of the male-to-
female rate ratios were lower than 2 for Cyprus and the Arab countries, while they were 
approximately 2 for Israel and Turkey. This may be partly due to ethnic differences and 
the more Western lifestyle in Israel and Turkey (43). 
 
The incidence of stomach cancer rises from age 50 years and is highest in the 70-and-
older group. The highest incidence in that group was in Israeli Jews (121.2 in males; 
60.5 in females), and the lowest was in Egyptians (17.5 in males; 5.4 in females).  The 
high incidence in older Israeli Jews, many of whom originated from Europe, could be 
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related to the deprived environmental and nutritional conditions they suffered during the 
Second World War.  This is supported by data showing that Israeli Jews born in Europe 
have a higher stomach cancer incidence than Israeli Jews born elsewhere (51). The low 
rates in Egypt in this oldest age group, among both males and females, strongly 
suggests that older cases have not been diagnosed, perhaps due to elderly patients’ 
underuse of health care services.   The majority of stomach cancers in the MECC and 
US SEER registries were adenocarcinomas. The proportion of adenocarcinomas was 
highest in Cyprus (78.1%) and lowest in Egypt (43.9%). According to US SEER data, 
adenocarcinomas comprised 50.1% of the total cases. The second most common 
histologic type in all MECC populations was signet ring cell carcinoma. This pattern 
was the same in the SEER results (41). 
 
5.2.3. Gall bladder  
Gallbladder cancer is a relatively rare form of malignancy about which our knowledge 
is scant (52).  However, a unique combination of predisposing factors makes this type 
of cancer unique and offers potential for understanding cancer pathogenesis in general.  
Biliary-tract carcinomas (BTCs), which include cancers of the gallbladder and intra- and 
extrahepatic biliary tree — consisting of the various ducts that carry bile are relatively 
infrequent but highly lethal diseases that are notoriously difficult to diagnose and treat.  
Gallbladder cancer (GBC) is the most common type of BTC and the sixth most 
common form of digestive-tract malignancy. However, whereas GBC accounts for 
about 2,000 cases per year in the United States, colorectal carcinoma — the leading 
digestive system cancer — accounts for approximately 150,000 new cases per year. 
GBC is a relatively uncommon neoplasm worldwide, but shows significant geographic 
variation in incidence. Along with the other types of BTC, GBC is associated with late 
diagnosis, unsatisfactory treatment and poor prognosis (53). Five-year survival rates for 
GBC vary from 0 to 12% in most reported series (54). Because the symptoms are seldom 
suggestive of cancer and imaging techniques are usually non-diagnostic, GBC is rarely 
diagnosed before surgical removal.  GBC usually arises in a background of gallstones 
and chronic inflammation of the gallbladder, and patients with cancer usually present 
with symptoms of these related conditions. The incidence rates of GBC in specimens 
obtained during CHOLECYSTECTOMY varies according to geographic location and 
among individual institutions (0.9-6%) (55- 56).  At present, only surgical excision of all 
apparent malignancy is associated with improved 5-year survival (57).  Therefore, urgent 
efforts are needed for identification of reliable tumour markers that will facilitate the 
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early detection of GBC among susceptible populations, as well as the identification of 
cancer-specific cellular targets that might form the basis for novel therapeutic 
approaches. 
Our knowledge of GBC is limited by the relative paucity of published studies compared 
with tumours of other related organs (58). A recent search (July 2004) of the PubMed 
database using the MESH terms 'gallbladder neoplasms' and 'human' yielded only 4,367 
citations. By contrast, similar searches found 7,668 citations for bile-duct neoplasms 
and 28,806 citations for pancreatic cancers. Why has so little attention been paid to 
GBC?  (59 – 60).  Finally, a lack of comprehensive national or international registries for 
information on GBC cases further holds back progress in understanding this disease.  
Despite these gaps in our knowledge, a unique combination of risk factors and large 
variations in geographic distribution distinguish GBC from other biliary-tract tumours 
and might aid our understanding of the pathogenesis of this and other cancers. The main 
focus of this review is a discussion of the available epidemiological and molecular data 
relating to GBC and an analysis of the possible links between the two (61) 
5.2.4. Neoplasms of the bowl 
Several studies have suggested that physical inactivity and obesity increase the risk for 
colorectal neoplasia.  Physical activity is strongly associated with a reduction in the risk 
of large bowel cancer (62), whereas obesity has been linked to an increase in risk (63). 
Results from a number of studies suggest that the inverse association between physical 
activity may be stronger for subgroups of adenomas such as those that are large or 
severely dysplastic (63- 64).  physical activity was associated with a reduced risk of 
advanced colorectal adenomas primarily among men.  Several investigations have 
studied the size or histologic characteristics of adenomas in relation to physical activity, 
with mixed results. Both prospective (63) and case-control studies have reported stronger 
inverse associations between physical activity and large adenomas as opposed to small 
adenomas. Others, however, have reported similar reductions in risk for both large and 
small polyps (65-66).  In a prospective study in which large bowel adenomas were 
observed over a 3-year period, the authors reported a positive association between 
obesity and adenoma growth (67).  Relatively few studies have evaluated the relationship 
between physical activity and risk of hyperplastic polyps. As in our study, these have 
generally found no significant association (68-69). In one report, however, there was a 
nonsignificant 50% lower risk in the highest quartile of activity compared with the 
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lowest, and in three studies a positive relationship has been observed between 
increasing BMI levels and hyperplastic polyps. In one of these, the association was 
confined to men. Although the mechanism(s) by which physical activity protects against 
colorectal neoplasia has not been elucidated, several have been proposed, including 
decreased stool transit time, lower bile acid secretion, and enhanced immune function. 
Still others have suggested that a sedentary lifestyle and obesity may lead to increases in 
insulin levels, which may increase mucosal cell proliferation (62).  
 
5.2.5. Liver 
In evaluating a tumor in the liver, it is important to remember that metastases are by far 
the most frequent type of liver tumor, outnumbering primary hepatic malignancies, by 
as much as 30 to 1.  In patients with cirrhosis, however, primary liver cancer, especially 
hepatocellular carcinoma, is relatively more frequent, (70- 71) outnumbering metastases 
by more than 3 to 1. Among primary liver tumors that come to clinical attention, over 
three-fourths are hepatocellular carcinoma (HCC), while the second most common 
primary malignancy, cholangiocarcinoma (CC).   One of the most striking features of 
HCC is the wide variation in its incidence in different parts of the world (70 – 72).  
Overall, HCC is the fifth most common malignancy among men and the eighth most 
common among women worldwide, but East Asia and Subsaharan Africa have by far 
the greatest number of cases, and in the countries of those regions HCC is among the 
leading causes of death (73).  It is currently the seventh leading cause of cancer deaths in 
the US, but the incidence has been rising, more than doubling between 1975 and 1998 
(74) but even within these areas there is geographic variability.  Hepatitis C infection is 
associated with many cases in countries such as Japan where the prevalence of hepatitis 
B is intermediate but the incidence of HCC is relatively high.  The incidence of HCC 
generally increases with age, although there are geographic differences (72). In Europe 
and the US the peak age-specific incidence is in the seventh decade, while in Qidong 
province in China where the incidence is the highest in the world, the peak is in the fifth 
decade. In South Africa, the average age of patients with HCC is 35 years, and 40% are 
30 or younger, whereas in Taiwan, the majority of patients are 40–60 years old with a 
peak incidence in the eighth decade. Nevertheless, HCC can occur in younger 
individuals and even young children. Regardless of geographic location, HCC occurs 
more frequently in men than women, with male:female ratios in various countries 
ranging from 2:1 to 5:1. The precise reason is not known, but it has been shown that 
many tumors have androgen receptors, (75).  
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The incidence of intrahepatic cholangiocarcinoma (ICC), based on evidence from 
national health statistics and surveys of cancer diagnoses, is reported to be rising in 
several parts of the world, including North America, Europe, Australia, and Japan, 
whereas extrahepatic CC has declined slightly (76-77).  In the US, the SEER program, 
which gathers data from population-based tumor registries in 11 parts of the US, found 
a nearly three-fold increase in the diagnosis of ICC between 1975 and 1999.  No cause 
is apparent, and it remains to be determined whether this is a true increase or merely a 
change in diagnostic trends brought on by advances in imaging techniques. It is 
estimated that CC accounts for approximately 3% of all gastrointestinal cancers 
worldwide and that ICC comprises 10 to 20% of all primary liver cancer (77). 
 
5.2.6. Pancreas 
The pancreas is a rarely diagnosed tumour in the Sudan (78) reported only 4 cases in a 
sample of 2234 cases.  However, surgical experience in recent years indicats many more 
cases.  In the present study the percent of the cases of pancreas tumour is relatively low 
compared to other types of malignant diseases.  Malignant neoplasm of the pancreas has 
become one of the leading causes of death from malignant neoplasm in Japan.  
Mortality from malignant neoplasm of the pancreas tends to be higher in northern Japan 
and in northern European countries. A recent study reported that standardized mortality 
ratios (SMRs) for malignant neoplasm of the pancreas were negatively correlated to 
global solar radiation level. People residing in regions with lower solar radiation and 
lower temperatures may be at higher risk of development of malignant neoplasm of the 
pancreas. Therefore, this study aimed to examine the relationship between SMRs for 
malignant neoplasm of the pancreas and climatic factors, such as the amount of global 
solar radiation and the daily maximum temperature in Japan.   Solar radiation and low 
temperature might relate to the increasing risk of malignant neoplasm of the pancreas.  
Use of group data has a limitation in the case of evaluating environmental factors 
affecting health, since the impact of climatic factors on the human body varies 
according to individual lifestyles and occupations. Use of geographical mesh climatic 
data, however, proved useful as an index of risk or beneficial factors in a small study 
area. Further research using individual data is necessary to elucidate the relationship 
between climatic factors and the development of malignant neoplasm of the pancreas 
(79).   
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In Japan, elderly persons who were born during the period 1890–1930 have a higher 
risk than younger generations. Although the age effect increases similarly for both 
sexes, the cohort effect is higher in males than in females.  Smoking has been regarded 
as a risk factor (80), the cessation of which decreases the risk of developing malignant 
neoplasm of the pancreas (79).  In addition to an individual's lifestyle and medical 
history, geographical factors related to differences among countries have been 
investigated in regard to the occurrence of malignant neoplasm (81). Kato et al. (82) 
reported that mortality from malignant neoplasm of the pancreas tends to be higher in 
northern Japan and in Scandinavian and other northern European countries, and that a 
strong positive correlation exists between mortality and latitude within Japan. 
International comparisons showed that mortality was also positively related to latitude.  
Increasing solar radiation or temperature might decrease mortality from malignant 
neoplasm of the pancreas. Although excessive exposure to ultraviolet (UV) light may be 
harmful to health, moderate exposure helps with the production of vitamin D.  The 
relative risks of mortality related to solar UV-B exposure between the northern and 
southern United States boundary were 1.06 for males and 1.11 for females. Japan is 
located at a latitude similar to the continental United States and an inverse association 
between the solar radiation level and mortality from malignant neoplasm of the pancreas 
was observed, as seen in the continental United States (83).  
SMR values lack stability in thinly populated areas, such as small towns or villages and 
for malignant neoplasm of the pancreas tended to be low in temperate regions. Mean 
SMR values were significantly higher in areas of low maximum temperature, being 
115.31 for males and 108.54 for females, when compared to areas of high maximum 
temperature, which exhibited values of 93.01 for males and 93.18 for females.  Laskin 
et al. (84) reported that ultraviolet light and temperature influenced cell proliferation. 
Holick (85) conducted an animal study and showed that the transformation of previtamin 
D3 to vitamin D3 depended on temperature, and that the process of transformation was 
more enhanced at 25°C than at 5°C. There is increasing evidence that seasonal variation 
is observed for the prognosis of several cancers (86- 87 – 88).  
5.3. Breast cancer disease 
Breast cancer is the second most dominant disease that prevails in the country.  The 
incidences of the disease represent 22.7% of the patients of main malignant neoplasms, 
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and 18.2% of the total sample of patients (14521).  The prevalence of the disease is not 
site specific where all the regions of the country witnessed incidence of breast cancer.  
However, there is significant variation in breast cancer incidences in the different 
regions being higher in Khartoum  and central Sudan.  As far as sex is concerned, 
incidence of female breast cancer disease is the most dominant where 96.7% of the 
patients of this disease are females while the male breast diseases account for 3.3% of 
all the cases of breast cancer disease in the whole country during the period 2000 – 2004 
(RIC records).  Breast cancer is the commonest cancer that afflicts females worldwide. 
In Cancer Statistics 2005, breast cancer remains the leading cancer among American 
women with an estimate of 32% excluding skin cancers (89). Of all the cancers of the 
breast, carcinoma forms the bulk while breast sarcomas are negligible (90 – 91).  
Osteogenic sarcoma of the breast tissue can arise from a pre-existing benign or 
malignant neoplasm of the breast or may arise from previously normal breast tissue as 
non-phylloides sarcoma. It is known to differentiate from the connective tissue elements 
of fibroadenomas and has been reported following intraductal papilloma (91 – 92)].  
Almost all patients with osteogenic sarcoma present like those with other benign or 
malignant breast lesions. Clinically, the breast lump is of varying consistency and may 
be rapidly growing. At the time of presentation, most patients have developed 
metastasis in different parts of the body including the chest and bones, though this was 
not the case with our patient (93).  Osteosarcomas are aggressive tumors with a 
propensity for blood-borne rather than lymphatic spread (94). Because of high risk of 
recurrence, chest wall irradiation and regular follow-up for early detection of loco-
regional recurrence is indicated. The role of combination chemotherapy is uncertain but 
it may be considered in the presence of systemic metastasis. However, these have not 
been proven to offer additional benefits. 
5.4. Neoplasms of female genital organs 
Neoplasms of female genital organs in the Sudan is almost similar to that of some 
Arabic countries and their trend for the period 1956 – 1984 is almost similar), but they 
contrast with those reported from African countries.  However, in this study the 
incidence of malignant neoplasms is relatively high compared to other malignant 
diseases where it represent 11% of the total sample of patients distributed among the 
different age groups except for the age class 1 – 10 years.   The level of cancer 
incidence is higher in Khartoum State (34.1%) followed by Central Sudan Region 
(27.8%), while patients from western Sudan represent 15.5%.  Different malignant 
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neoplasms were registered for female genital organs in RIC for the period 2000 – 2004.  
About 1602 patients were registered for neoplasms of female genital organs.  A total 
number of 60 cases of neoplasms of the female reproductive system were seen. Out of 
these, 1 (1.7%) was of the vagina; 16 (26.7%) were of the cervix of the uterus; none 
were of the endometrium; 20 (33.3%) were of the body of the uterus/uterine muscle ; 16 
(26.7%) were of the ovary, (11 benign, consisting of nine mature cystic tertoma, also 
known as dermoid cyst, one serous papillary cystdenoma and one mucinous 
cystadenoma; and, five malignant, consisting of two serous cystadenocarcinoma, two 
mucinous cystadenocarcinoma and one mixed mucinous and serous 
cystadenocrcinoma); and, 7 (11.6%) were of the breast (95). 
 
There is a worldwide wide variation in the distribution of various neoplasms. These 
international differences appear largely due to exogenous factors rather than due to 
inherited differences between populations (96). On a global basis out of the first eight 
ranking cancers in females, the cancers of the female reproductive system rank as 
follows: 1st breast, 2nd cervix of the uterus , 7th ovary; and, 8th body of the uterus [3rd 
being colon/rectum, 4th stomach, 5th lung; and, 6th oral cavity]2 . This study was done 
to find the relative frequency of various histopathologic type of neoplasms of the female 
reproductive system seen at KUTH, Dhulikhel in comparison to the worldwide 
distribution. On a global basis out of the first eight ranking cancers in females, the 
cancers of the female reproductive system rank as follows: 1st breast, 2nd cervix of the 
uterus , 7th ovary; and, 8th body of the uterus--3rd being colon/rectum, 4th stomach, 5th 
lung; and, 6th oral cavity (97).  However, neoplasms of various parts/organs of the 
female reproductive system (FRS) have a marked international variation of distribution 
according to the parts/organs of the FRS affected.  
 
Primary carcinoma of the vagina is an extremely uncommon cancer accounting for 
about 1% of malignant neoplasms in the female genital tract, and of these, 95% are 
squamous cell carcinomas. Most are associated with HPV. The greatest risk factor is a 
previous carcinoma of cervix or vulva; 1% to 2% of patients with an invasive cervical 
carcinoma eventually develop a vaginal squamous carcinoma (98).  In our study, we had 
one case of cancer of the vagina that was squamous cell carcinoma, papillary variant. 
This patient, a 51-year-old woman, had history of squamous cell carcinoma of the 
uterine cervix and had had transabdominal hysterectomy with bilateral salpingo-
oopherectomy, chemotherapy; and, radiotherapy (97). 
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Cancer of the uterine cervix is surpassed only by breast cancer as the most common 
cause of cancer mortality among women worldwide and it is the most common incident 
cancer among women in developing countries. In the United States, incidence rates of 
invasive cervical cancer have declined steadily over the past few decades, whereas these 
rates continue to rise in many developing countries (97). In 1996 in developed world the 
incidence of carcinoma of the uterine cancer was 102,000 whereas in sharp contrast in 
the developing world it was 421,000.2 This has led to the development of etiologic 
hypotheses implicating inadequate hygienic conditions and infrequent utilization of 
barrier contraception methods (97).  Furthermore, in the United States, the decrease in 
the incidence rate of cancer of the uterine cervix during the last several decades is 
presumably as a result of the widespread use of cervical cytologic screening programs.4 
The reason that Papanicolaou smear screening (PAP) is so effective in preventing 
cervical cancer is that the majority of cancers are preceded by a precancerous lesion (95). 
This lesion may exist in the noninvasive stage for as long as 20 years and shed 
abnormal cells that can be detected on cytologic examination.3 In our series there were 
relatively a large number of cases of advanced stage of the carcinoma of the uterine 
cervix. This could be due to several factors such as lack of early detection due to 
inadequate screening facilities, women not participating in these screening programs, 
false negative rate during screening. Al-Nafussi et al (99) found that cervical smears may 
give false negative results, as seen in 35%, 18% and 3% of their cases of CIN 1, CIN 2, 
and CIN 3 respectively.  Additionally, this could be due to high rate of occurrence of 
cancer of the uterine cervix, which could possibly be due to various factors such as poor 
socio-economic conditions. Also, there is evidence that tobacco smoking increases the 
risk for cervical cancer (98). This could be one of the contributing factors, since in Nepal 
according to estimation by WHO 28.7% of females above 15 years of age smoke (100).   
Larger prospective studies should help in throwing more light on this serious health 
problem, thereby, providing guidelines for better management/prevention of this deadly 
disease in Nepal. 
 
Uterine leiomyomas are perhaps the most common tumour in humans. These benign 
tumours may be present in about 75% of females of reproductive age (98).  Similar to 
this, we found 20 cases of leiomyomas, which accounted for 33.3% of all neoplasms of 
the FRS in our series. Carcinoma of the endometrium is the most common gynaecologic 
malignancy in developed countries (101). Worldwide, of all the malignancies of the 
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female reproductive system, it ranks fourth in frequency after breast, uterine cervix and 
ovary (97). 
 
Tumours of the ovary are common forms of neoplasia in women. Among cancers of the 
female reproductive system , the incidence of ovarian cancer ranks below only 
carcinoma of the breast and uterine cervix (97). Ovarian cancer accounts for 6% of all 
cancers in the female. However, because many of these ovarian neoplasms cannot be 
detected early in their development, they account for a disproportionate number of fatal 
cancers, being responsible for almost half of the deaths from cancer of the female 
genital tract.  Risk factors for ovarian cancer are much less clear than for other genital 
tumours (98). Despite some 30 epidemiologic studies of ovarian cancer, the causes of 
disease remain poorly understood.  New hypotheses as to the cause need to be 
considered. There are numerous types of ovarian tumours, both benign and malignant. 
The majority of ovarian cancers are epithelial carcinomas.1 About 80% are benign, and 
these occur mostly in young women between the ages of 20 and 45 years.  The 
malignant tumours are more common in older women between the ages of 40 and 65 
years.  In our series there were 16 cases of neoplasms of the ovary. Out of these, 11 
were benign and five were malignant. Of the 11 benign neoplasms, nine were mature 
cystic teratomas. The age range for this was between 13 years to 40 years. Of the two 
other benign neoplasm, one was serous papillary cystadenoma in a 20-yearold female; 
and, the other was mucinous cystadenoma in a 22-year-old female. Out of the five 
malignant neoplasm of the ovary, two were serous cystadeno-carcinoma, two were 
mucinous cystadenocarcinoma; and, one was mixed mucinous and serous 
cystadenocarcinoma. The age range was from 27 years to 65 years. 
 
5.5. Leukemia 
Leukemia is one of the most serious diseases and its trend reached an alarming level in 
the country.  In the past few incidences were reported for Leukemia.  Recently the level 
of its incidence is far beyond expectations.  Incidences of Leukemia represent 11.1% of 
the main malignant neoplasms and 8.9% of all cancer cases for the period 2000 – 2004.  
All the age groups are susceptible to Leukemia and the same is true for the sex.  
Incidence of Leukemia is higher in males in comparison with females.  In the age range 
of 51 – 70 years, the incidence of Leukemia is relatively high in males compared to 
other ages where 22.9% of patient males belong to this age range and the same is true 
for females.    As far as the geographical distribution is concerned, Central Sudan 
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showed the highest percentage (32%) of Leukemia followed by Khartoum State 
(28.2%).   Studies from various countries have found an increasing incidence of 
childhood leukemia in recent decades. To characterize time trends in the age- and sex-
specific incidence of childhood acute leukemia during the last 20 years in the Nordic 
countries, a large set of population-based data were analyzed. It is concerning, therefore, 
that studies from different parts of the world have indicated an increase in recent 
decades in the incidence of childhood leukemia (102 – 103), in particular its most common 
subtype, B-precursor acute lymphoblastic leukemia. Leukemias in childhood are rare 
diseases, and trends in incidence are, therefore, sensitive to changes in registration 
procedures. For the few studies (104 -105) that have examined trends in incidence of 
childhood leukemia by immunophenotype, misclassification between leukemia 
subtypes may be a matter of concern, because the leukemia subtype classification rests 
on immunologic and cytologic techniques that have become readily accessible within 
only the past two decades (106).  
 
Analysis demonstrated that incidence rates of childhood leukemias, whether acute 
myeloid leukemia or acute lymphoblastic leukemia, have been remarkably stable 
during the last 20 years in the Nordic countries. These findings extend previous 
incidence surveys from the population-based Nordic Cancer Registries (107 – 108) also 
reporting constant incidence rates, thus, suggesting that the incidence of childhood 
leukemia has been stable for more than 40 years.   Incidence surveys have revealed a 
10-fold variation in the incidence of childhood acute lymphoblastic leukemia 
worldwide, and studies (40 -109) have indicated a geographic correlation between 
socioeconomic status and childhood acute lymphoblastic leukemia incidence. The 
higher acute lymphoblastic leukemia incidence in developed countries reflects a high 
incidence of B-precursor acute lymphoblastic leukemia that makes up the conspicuous 
acute lymphoblastic leukemia incidence peak in children 2–5 years old in industrialized 
countries (109).  The observed incidence of acute lymphoblastic leukemia in the Nordic 
countries is among the highest in the world (110). If exogenous factors are involved in 
the development of childhood acute lymphoblastic leukemia, the constant incidence 
rates observed in the Nordic countries over a 40-year period indicate that the prevalence 
of these elusive risk factors has been constant or that they may have counterbalanced 
over a similar period of time. An alternative explanation is that the relatively high 
childhood leukemia incidence in the Nordic countries might reflect a saturation 
phenomenon, i.e., the number of susceptible individuals and prevalence of risk factors 
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are at their maximum. Thus, the increasing incidence rates of B-precursor acute 
lymphoblastic leukemia reported from the United Kingdom and Northern Italy need not 
conflict with our findings but could reflect the fact that a similar saturation phenomenon 
has not yet occurred in these countries.  
Trend analyses from different parts of the world have provided different and 
inconsistent results, but two recent reports (111) from the United Kingdom have 
suggested an increase of up to 3% per year for this leukemia subtype. In contrast, we 
observed no change in incidence of acute myeloid leukemia in the Nordic countries 
from January 1, 1985, through December 31, 2001. Importantly, the annual incidence 
rate of acute myeloid leukemia in our material did not include children with Down 
syndrome, secondary acute myeloid leukemia, or myelodysplastic syndrome.  
5.6. Neoplasms of the oral cavity and pharynx 
Neoplasms of oral cavity and pharynx represent 9.8% of the main malignant neoplasm 
and 7.8% of the total cancer cases.  The neoplasms of oral cavity and pharynx are higher 
in males compared to females.  The percent of patient males is 56.6% compared to 
43.4% for female.  The percent of patient females for the same age group is much 
higher compared to males (49%).  The incidences of malignant neoplasms of oral cavity 
and pharynx increase with the advance of age.  Regarding the geographical distribution 
of the neoplasms of the oral cavity and the pharynx, the percentages of incidences varies 
among the different regions being high in Khartoum State (31.6%) and Central Sudan 
(30%). The main neoplasms of the oral cavity and pharynx are Lip, Tongue, Salivary 
gland, Mouth, Oropharynx, Nasophrynx and hypopharynx.  The total number of cases 
registered for these neoplasms is 1137 cases.   
5.6.1. Lip 
There are approximately 4,300 cases of lip cancer resulting in 100 to 150 deaths per 
year in the United States. Cancer of the lip is the most frequent site for cancer of the 
oral cavity.  There are, however, several prognostic indicators which may herald an 
aggressive disease and a poor outcome (112). The incidence of lip cancer in the United 
States is 1.8 per 100,000. Patients typically present in their 7th or 8th decade.  All 
reported series demonstrate that the disease occurs more frequently in males. The male 
to female ratio approaches 79-to-1 for cancer of the lower lip and 5-to-1 for the upper 
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lip (113).   The most frequent location of lip cancer is the lower lip where it is reported 
being found between 91.3% and 97.3%. The upper lip is involved between 1.8% and 
7.7% of the time, while the commissure is involved in 1% to 2%.   Almost 95% of lip 
cancers are squamous cell carcinoma. They are most frequently well differentiated. 
Basal cell carcinoma may extend onto the labial surface. Basal cell carcinoma is twice 
as common on the upper lip and is the most frequently neoplasm in that location. 
Approximately 300 cases of salivary gland neoplasms of the lip have been reported. Of 
these, 17% were malignant. Sixty-one percent were of the upper lip and 39% were of 
the lower lip. Melanoma infrequently involves the lips (112). 
Overall, 5% to 15% of patients with lip cancer will present with regional metastasis. An 
additional 15% will subsequently develop nodal metastasis. The five-year survival of 
patients with lip carcinoma and confirmed regional metastasis approaches 50%. The 
literature suggests that the survival rate for treatment of the initial neck metastasis by 
elective neck dissection and for salvage for the subsequent development of neck nodes 
is essentially the same. Due to the fact that less than 10% of patients with T1 or T2 lip 
cancers develop neck metastasis, most authors do not feel that a neck dissection is 
empirically indicated. For T3 and T4 lesions with a clinically negative neck, a node 
sampling procedure should be performed for biopsy (114).  The prognosis for lip cancer 
depends on the extent of disease at the time of presentation. The five-year cure rate for 
T1 and T2 lesions without cervical metastasis approaches 90% with either surgery or 
irradiation. For T3 and T4 lesions, the five-year survival falls to 60% and 40% 
respectively. If cervical disease is present, the five-year survival rate falls to 50% (115). 
5.6.2. Salivary gland 
There are only a few reports available that have reviewed large studies of salivary gland 
neoplasms worldwide (116). Although there have been some reports on salivary gland 
neoplasms as a component of tumors of the oral facial area from Uganda, no specific 
report is available from this part of the world on salivary gland neoplasms.  It must be 
noted in the WHO classification20 salivary gland adenoma comprises a group of 
fourteen tumors. Thus, a combined effort to review African studies is needed to 
establish whether this is an African phenomenon or just a regional one or whether 
reporting is standardized to a specific classification.  Of all cases in a study 53.5% were 
female, 45.1 were specified as male, and 1.4% were unspecified for the neoplasm of 
salivary gland. Thus, an almost equal sex distribution which is in agreement with 
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several other studies (117). The male to female ratio was 1:1.19, thus, no statistically 
significant difference in sex distribution. These statistics differ from those of Jordan 
(118); hence, the question of possible geographical differences in their prevalence. Both 
malignant and benign neoplasms had equal sex distribution. Pleomorphic adenoma had 
a slight preponderance for females with the male to female sex ratio being 1:1.3, which 
is in agreement with other findings. 13 Unlike a report from Nigeria14, for all age 
=groups, female distribution predominated over males. Salivary gland adenoma had 
equal sex distribution, but because no other study we came across recognized this entity 
we had nothing to compare with. All of the three cases of oxyphil cell adenoma were 
female though Cawson1 writes of a female preponderance.  The numbers of salivary 
gland carcinoma, muco-epidermoid carcinoma, and acinic cell carcinoma were too few 
to comfortably establish sex preponderance. Carcinoma ex pleomorphic adenoma had 
only two cases, both being male.  The distribution of the salivary gland neoplasms as 
per site of biopsy is shown in Table 4. Unfortunately, many of the biopsy sites in this 
study’s cases 47.18% were not recorded. Of those recorded, the palate featured greatly 
constituting 45.94%, followed by the parotid area 26.67%, and sub-mandibular area 
16%. These results agree with a few other studies from Africa. The palatal neoplasms 
had a preponderance for females 64.7%, a fact that was reported by Onyango et al.21 
The parotid region was equally affected by both malignant and benign tumors, which is 
in contrast with other reports (116), therefore, geographical differences may exist. 
Though pleomorphic adenoma is known to mainly affect the parotid gland1,17, in this 
study it affected the palate. The lip was affected in just three cases. Of the three lip 
lesions, two were malignant, i.e., adenoid cystic carcinoma and muco-epidermoid 
carcinoma with the third being salivary gland adenoma.  
5.6.3. pharynx 
Between 1979 and 2002, there were 38 263 deaths from pharyngeal cancer in Brazil. 
This corresponds, respectively,  to 1.80% and 1.89% of totaldeaths due to neoplasia in 
this period.  The ratio between the male and female mortality rates was 4:1 for oral 
cancer and 6:1 for pharyngeal cancer.  A study of the trends and spatial distribution of 
oral cancer in the city of São Paulo by Antunes et al. (119) reported stable mortality rates 
for pharynx cancer between 1980 and 1998. However, analysis by specific anatomical 
site found a decrease in gum cancer and lip cancer, and an increase of cancer in the 
unspecified parts of the mouth. In our study we found the same trends for all of these 
sites. Wünsch-Filho (120) has predicted that oral cancer and pharyngeal cancer will 
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become an increasing problem in Brazil in the coming decades. However, according to 
our findings, death rates from oral cancer were stable when the analyzed sites were all 
considered together. When the sites were investigated separately, only tumors of the 
salivary glands and in illdefined and unspecified sites did not show statistically 
significant declines between 1979 and 2002. The same does not apply to pharyngeal 
cancer, where no sites with decreasing rates have been identified. While the Ministry of 
Health’s Mortality Information System stands out for its wide coverage, it still has some 
limitations that must be considered when interpreting these mortality data (121).  When 
analyzing the incidence of and mortality due to oral cancer in Brazil the highest rates of 
mortality from pharyngeal cancer were found in the South and Southeast. However, 
when the regions were grouped into sets, the set including the North, Northeast, and 
Center-West regions showed an increase in the rates of pharyngeal cancer three times 
greater than that found in the South and Southeast regions (122).  The Brazilian phase of 
the World Health Survey found a 22.5% prevalence of smoking among males and of 
14.4% among females in 2003 (123). For alcohol consumption the prevalence was 25.0% 
for males and 6.0% for females. Regional differences in alcohol and tobacco 
consumption patterns have also been reported. The proportion of people aged between 
12 and 65 years old identified as current consumers of alcohol and of tobacco is greater 
in the Southeast and the South than in the Northeast Center-West, and North (124).   
When Matos et al. (125) studied the access that Brazilians over age 60 have to health care 
services, those researchers found a significant relationship between place of residence 
and visits to the dentist. These patterns indicate that the number of cases diagnosed at an 
advanced stage is high, and that inaccurate entry of information on the death certificate 
is common. Diagnosis  ust occur during the initial stages of the disease in order to 
provide the patient a better prognosis, fewer functional problems and social 
consequences (such as peer rejection and a decrease in self-esteem), and a better quality 
of life. Earlier diagnosis also lowers the cost of treatment. Further studies testing the 
hypothesis of an association between the supply of health services and lower mortality 
rates for oral cancer and pharyngeal cancer in Brazil are needed. Such studies could 
clarify the important association suggested in this study and other studies, but which has 
yet to be confirmed (126). 
 
5.7. Lymphoma 
Lymphoma is one of the main malignant neoplasms in the Sudan.  According to the 
records of RIC for the period 2000 – 2004, Lymphoma represent 8.1% of the main 
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malignant neoplasms (6.7% of the total cases of malignant negoplasms).  Almost there 
is no difference in the percent of females and males registered for Lymphoma (50.1 and 
49.9%, respectively.  The main diseases of neoplasm of lymphoma are Non Hodgkin's 
lymphoma, Hodgkin's lymphoma and Axillary LN.  the first two diseases represent the 
bulk of the incidences of neoplasms of lymphoma where 684 patients were registered in 
the RIC records during the period 2000 – 2004 for neoplasm of Non Hodgkin's 
lymphoma representing 73% of the patients of Lymphoma and 4.7% of all the cancer 
cases for the above mentioned periods according to the records of RIC 
5.7.1. Non Hodgkin's lymphoma 
Non-Hodgkin’s lymphoma has become a major health concern in North America. In 
Ontario, Canada, non-Hodgkin’s lymphoma represents the fifth most common cancer 
diagnosed in men and the sixth most common in women (127).  The risk factors 
examined to date, such as dietary fat, protein, fruit and vegetables, alcohol, and 
smoking, are either weakly or inconsistently associated with non-Hodgkin’s lymphoma 
(128). Immunosuppression does not account for all of the increase in the incidence of 
non-Hodgkin’s lymphoma in the general population (129). The majority of the cohorts in 
which non-Hodgkin’s lymphoma rates initially rose were relatively unexposed to 
immunosuppressive agents or to human immunodeficiency virus, particularly since the 
non-Hodgkin’s lymphoma incidence rates were first noted to rise as early as the mid-
1960s, long before the acquired immunodeficiency syndrome epidemic that began in the 
1980s (128).  
No association was apparent between antidepressant medication use and non-Hodgkin’s 
lymphoma risk.  Non-Hodgkin’s lymphoma positively associated with chemical 
exposures, which strengthens the internal validity and generalizability of these findings 
(129 - 130). Depression was not found to be a risk factor for non-Hodgkin’s lymphoma nor 
did it confound the cancer-antidepressant relation in this study. While it has been 
suggested that depression results in immunosuppression, subjecting the individual to a 
greater risk for cancer, to date, the evidence is inconsistent and inconclusive.  
5.7.2. Hodgkin Lymphoma 
It is estimated that 8,190 men and women (4,470 men and 3,720 women) will be 
diagnosed with and 1,070 men and women will die of Hodgkin lymphoma in 20071.  
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The following information is based on NCI’s SEER Cancer Statistics Review2.   From 
2000-2004, the median age at diagnosis for Hodgkin lymphoma was 38 years of age3. 
Approximately 12.1% were diagnosed under age 20; 32.3% between 20 and 34; 18.1% 
between 35 and 44; 12.3% between 45 and 54; 8.5% between 55 and 64; 8.5% between 
65 and 74; 6.3% between 75 and 84; and 1.8% 85+ years of age.  The age-adjusted 
incidence rate was 2.7 per 100,000 men and women per year. These rates are based on 
cases diagnosed in 2000-2004 from 17 SEER geographic areas (131).  From 2000-2004, 
the median age at death for Hodgkin lymphoma was 61 years of age4. Approximately 
2.1% died under age 20; 15.6% between 20 and 34; 11.3% between 35 and 44; 12.8% 
between 45 and 54; 13.2% between 55 and 64; 16.9% between 65 and 74; 19.8% 
between 75 and 84; and 8.3% 85+ years of age.  The age-adjusted death rate was 0.5 per 
100,000 men and women per year. These rates are based on patients who died in 2000-
2004 in the US.     
Based on rates from 2002-2004, 0.22% of men and women born today will be 
diagnosed with Hodgkin lymphoma at some time during their lifetime. This number can 
also be expressed as 1 in 453 men and women will be diagnosed with Hodgkin 
lymphoma during their lifetime. These statistics are called the lifetime risk of 
developing cancer. Sometimes it is more useful to look at the probability of developing 
Hodgkin lymphoma between two age groups. For example, 0.07% of men will develop 
Hodgkin lymphoma between their 50th and 70th birthdays compared to 0.04% for 
women (128).  
5.8. Neoplasms of head and neck 
Neoplasm of head and neck lies in the bottom of the list of the main malignant 
neoplasm in the Sudan according to the records of RIC for the period 2000 – 2004.  it 
represent 7.6% of the main malignant neoplasms and 6.1% of the total patients of 
malignant neoplasms.  There are variations of incidences of neoplasms of head and neck 
among sex.  Neoplasms of head and neck is very high among females (78.2% of the 
patients), while the incidences of neoplasms of head and neck among males is 21.8%.  
Table (4.37) shows the distribution of Neoplasms of head and neck among sex and age 
groups.  However, the highest percentage of female incidences of neoplasms of head 
and neck was 51 – 60 and 41 – 50 age groups, while for the male the incidences of 
neoplasms of head and neck is high in age groups 51 – 60 and 61 – 70.  The time trend 
of the neoplasms of head and neck for the period 2000 – 2004 shows a steady increase 
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in the incidences of neoplasms of head and neck.  In 2000 the patients represent 12.2% 
of the patients and the percentage increased to 18% in 2001 and continued to increase to 
25.5% in 2002.  Year 2003 represent the peak of the incidences of neoplasms of head 
and neck.   The trend of the main neoplasms of head and neck follow different patterns, 
for the neoplasms of the eye the incidences increases steadily with years where in 2000 
the patients represent 3.8% of the patients of this disease and continued to increase until 
it reached its climax in the last year (2004).   
Second primary malignancies such as oral and esophageal cancer frequently develop in 
patients with head and neck cancers (132), and patients with head and neck cancers are at 
high risk of developing synchronous esophageal cancer (133).  Recent studies on 
molecular biology have revealed that genetic instability is one of the most important 
predispositions for human multistep carcinogenesis (134 – 135).  The increased risk of 
head and neck cancer has been attributed to life style, such as heavy smoking and 
excessive consumption of alcohol (136). Tobacco and alcohol were risk factors in the 
etiology with cancers of the oral cavity, pharynx, larynx and esophagus (137).   It was 
reported that head and neck cancer and esophageal cancer exhibited loss of 
heterozygosity at the FHIT gene (3p), p16 gene (9p) and p53 gene (17p) (138).  The head 
and neck cancers that we analyzed were all invasive carcinoma. Staging between the 
double cancer group and the non-double cancer group hardly differed. The frequency of 
LOH of primary head and neck cancer was not associated with development of 
secondary malignant neoplasms. 
An immunohistochemical study revealed that the overexpression of cyclin D1 in the 
head and neck cancers of the double cancer group tended to be more frequent than that 
in the non-double cancer group. Overexpression of cyclin D1 deregulates cell cycle 
control of not only normal cells but also a variety of tumor cells. This might result in the 
accumulation of non-repaired DNA mutations during subsequent cell cycles. Although 
gene amplification and overexpression of cyclin D1 are closely correlated with 
aggressiveness of the esophageal carcinomas and poor prognosis of the patients, this is 
not the case with squamous cell carcinomas of the head and neck (139). However, our 
results suggest that overexpression of cyclin D1 in the head and neck cancers provides 
some information regarding the development of secondary cancer in the esophagus. We 
have to confirm this possibility by analyzing a large number of cases in order to obtain 
statistically significant differences.  In contrast, the incidence of reduced expression of 
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p27, a negative cell cycle regulator, in head and neck cancers was not different between 
the double cancer group and the non-double cancer group. Therefore, 
immunohistochemical detection of p27 may not be an effective biomarker for predicting 
multiple cancers in head and neck and esophageal regions. 
5.9. Musculoskeletal 
The most common disease of the low incidences neoplasm of malignant diseases is 
musculoskeletal diseases; about 2899 patients were registered for this disease in the RIC 
records representing 4% of all neoplasms of malignant diseases registered for the period 
2000 – 2004, and 20.1% of the low incidence neoplasms.  Different proportions of 
males and females of different age classes were subjected to this neoplasm.  The 
incidence of the disease is relatively higher in males (51.6%) compared to females 
(48.4%).  Females of age class 21 – 30 showed the peak of the incidences during the 
period 2000- 2004, while for the males the peak of the incidences occurred among age 
class 11 – 20.  Table (4.42) shows the distribution of the disease according to sex and 
age classes.   Neoplasms of musculoskeletal showed a different trend compared to other 
malignant diseases where the incidences are higher in lower age classes compared to 
higher age classes.  About 56.4% of the patients (males and females) fall within the age 
range of 11 -40 years.  In other malignant diseases the incidence is higher in high age 
classes. 
 
The time trend of musculoskeletal diseases shows a fluctuating pattern during the period 
2000 – 2004 being low (15.4%) in 2000 and raised to 20.9% in 2001 and continued to 
increase in 2002 (24.2%) before dropping to 16% in 2003.  in 2004 the incidence of the 
disease increased again to 23.5% (Table (4.44).  The geographical distribution of the 
disease showed great variations among the regions being high in Khartoum (32.1%) 
followed by patients from Central Sudan (29.5%).  Like most of the incidences of 
neoplasm of malignant diseases, patients from Western Sudan occupy the third position 
in the ranking of percentages of patients where 18.7% of musculoskeletal are from 
Western Sudan.  Northern Sudan and Eastern Sudan there are almost similar as far as 
the percentages of musculoskeletal diseases are concerned ( 9.8 and 7.9%, respectively).  
The percentage of patients from Southern Sudan, as usual, is very low compared to 
other regions (2.1%).  The main diseases of musculoskeletal, according to the records of 
the RIC are; Thigh, Arm, Back, Chromo sarcoma, Fib sarcoa, Knee, Hand, Leg, 
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Leomyosarcoma, Osteag solcoma and shoulder.  Appendix (7) shows the different 
diseases of musculoskeletal neoplasm according to the records of RIC.  The most 
common musculoskeletal neoplasm are Fib sarcoma (28.8%), Osteag solcoma (24%), 
leg (14.9%) and Cromo sarcoma (9.6%), and they collectively accounts for 77.3% of 
musculoskeletal neoplasm.  
5.10. Neoplasms of male genital organs 
Neoplasm of male genital organs is a sex specific disease, all the age classes are liable 
to infection by this disease. However the incidences of this disease become apparent 
with the advance of the age.  Before fifties of age, the incidences of neoplasms of male 
genital organs are relatively low (19.8%).   The time trend of the incidence of 
neoplasms of male genital organs for the period 2000 – 2004 showed a steady increase 
for the period 2000 – 2002 where the percentage of patients reached 19.4% in 2002.  the 
incidences of neoplasms of male genital organs is higher in patients from Central Sudan 
(32.7%) followed by patients from Khartoum State (32.5%).  The main diseases of the 
neoplasms of male genital organs are Prostate, Testis and Penis.  The incidences of 
Prostate represent the bulk of the cases (93.8%), while the rest of the diseases (Testis 
and Penis) account for 6.2%. 
In USA, From 819 patients diagnosed of PCa, 46 (5.6%) presented with focal cancer 
and 23 (2.8%) with stage T1a tumors. None of the patients with incidental cancer (T1a) 
underwent RP opposed to 17 of 46 focal T1c cancers (37%). Although none of these 
cases showed extracapsular extension, seminal vesicle invasion, or lymph node 
invasion, relevant disease (stage pT2b or higher) was found in 15 cases (88.2%) and 
pathological Gleason score > 7 in 2 cases (2.9%). With a mean follow-up time of 37.6 
months, the probability of being free from any progression was, for T1a cancers at 2 and 
5 years, of 75.4% and 57.1% respectively, and 94.4% and 94.4% respectively for T1c 
cases. No PCa deaths were recorded in the presented cases during the mentioned follow-
up period. Therefore, the finding of microscopic or focal cancers in sextant prostate 
biopsy is related to a high proportion of clinically relevant tumors in RP specimens 
(88%). We think that expectant management of patients with such findings in prostate 
biopsy should be questioned (140).  Prostate cancer is the most frequently diagnosed 
cancer in American men. Screening for prostate-specific antigen (PSA) has led to earlier 
detection of prostate cancer, but elevated serum PSA levels may be present in non-
malignant conditions such as benign prostatic hyperlasia (BPH) (141).  The Surveillance 
Research Program of the American Cancer Society's Department of Epidemiology and 
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Surveillance Research reports its annual compilation of estimated cancer incidence, 
mortality, and survival data for the United States in the year 2000. After 70 years of 
increases, the recorded number of total cancer deaths among men in the US declined for 
the first time from 1996 to 1997. This decrease in overall male mortality is the result of 
recent down-turns in prostate cancer deaths (142).  A case-control study was performed 
to estimate the relative risk of developing prostate cancer for men with a positive family 
history. Extensive cancer pedigrees were obtained on 691 men with prostate cancer and 
640 spouse controls. Fifteen percent of the cases but only 8% of the controls had a 
father or brother affected with prostate cancer. Men with a father or brother affected 
were twice as likely to develop prostate cancer as men with no relatives affected. In 
addition, there was a trend of increasing risk with increasing number of affected family 
members such that men with two or three first degree relatives affected had a five and 
11-fold increased risk of developing prostate cancer. Recognizing that 9-10% of U.S. 
men will develop prostate cancer in their lifetime, men with a family history of prostate 
cancer should be advised of their significantly increased prostate cancer risk and should 
undergo appropriate screening measures for this disease (128)  
The magnitude of the relative risk for prostate cancer in sibling- versus parent-affected 
groups was significantly different from that of the comparable relative risk for breast 
cancer. An excess risk of prostate cancer in men with affected brothers compared to 
those with affected fathers is consistent with the hypothesis of an X-linked, or recessive, 
model of inheritance.  The numbers of new cancer cases in 16 common sites for which 
the United Nations produces population estimates. For the world as a whole, the total 
number of new cases was 6.35 million, almost exactly evenly divided between the 
developed and developing countries (143).  In males, the most important sites were lung, 
and prostate, and in females breast, cervix, colon/rectum, stomach, corpus uteri and 
lung. When the two sexes are combined, stomach cancer emerges as the most common 
cancer in 1980, but this estimate is only slightly greater than that of lung cancer, and 
comparisons with earlier estimates for 1975 suggest that, with declining incidence rates 
for stomach cancer and the continuing rise for lung cancer, the latter would become the 
most common cancer in the world by the end of 1981. The implications for cancer 
control in the developed and developing countries of the world are discussed (21). 
 
Recent studies suggest that hereditary prostate cancer is a complex disease involving 
multiple susceptibility genes and variable phenotypic expression.  The strongest 
evidence of linkage was evident with the pedigrees having <5 family members affected 
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with prostate cancer, a later average age of diagnosis, and no male-to-male 
transmission. The group of patients having all three of these characteristics had a 
multipoint NPL score of 3.69. These results demonstrate evidence for a PRCA 
susceptibility locus in a subset of families that is distinct from the groups more likely to 
be linked to previously identified loci (144).  
5.11. Neoplasms of respiratory system 
This neoplasm is one of the low frequency of the neoplasms of malignant diseases.  The 
number of patients registered for these neoplasms in the records of the RIC is about 351 
representing 12.1% of the cases of low frequency neoplasm of malignant diseases and 
2.4% of whole neoplasms of malignant diseases.  All the age groups and sex were 
registered in the records of RIC for the neoplasms of respiratory system for the period 
2000 – 2004.  However, the percentage of males (57.3%) is higher compared to the 
incidence of the disease among females (42.7).  in females the peak of the incidence of 
the disease occurred in age class 51 – 60, while for males the peak of incidence took 
place in age class 61 – 70.  Table (4. 49) shows the distribution of neoplasms of 
respiratory system among the different age classes.  
The above table showed that the incidence of neoplasms of respiratory system is 
relatively high among children of age class 1 – 10 years (16.2%).  In old age classes (51 
– 60 and 61 – 70) the incidences of neoplasms of respiratory system is very high (20.8 
and 19.9%, respectively.  In the other age classes the percentage of incidence is 
relatively low compared to the above mentioned age classes.  As far as the geographical 
distribution of the neoplasm is concerned, there is no variation in the percentage of 
incidences compared with the other neoplasms of malignant diseases.  Table (4.51) 
shows the distribution of the incidences of neoplasms of respiratory system in the 
Sudan.  Khartoum State showed the higher percentage of incidences of neoplasms of 
respiratory system (34.2%) followed by patients from Central Sudan (28.8%) and 
Western Sudan (17.1%), respectively.  The percentages of incidence in Northern and 
Eastern Sudan are 10.3 and 8.8%, respectively, while the level of incidence among 
patients from Southern Sudan is very low (0.9%).  The time series of the disease 
showed a steadily increase during the first three years (2000 – 2002) and in 2003 the 
incidences showed a marked increase in the percentage of the incidences (41.6%) and in 
the fifth year (2004) the percentage of incidence dropped to 19.1.  Therefore, year 2003 
represented the bulk of incidences of neoplasms of respiratory system in all the regions. 
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The main diseases of neoplasms of respiratory system, according to the records of RIC 
for the period 2000 – 2004 include Nasal sinuses, Larynx and lung.  The larynx 
incidence represented the bulk of the (cases 57.5%), while the lung and Nasal sinuses 
were 30.2 and 12.3%, respectively.   
This is one of the lowest neoplasms of malignant diseases where only 313 patients were 
registered for this disease in the RIC records for the period 2000 – 2004.  This 
represents 2.2% of the malignant diseases.  This disease is not a sex specific where both 
males and females are liable for this disease.  According to the records of RIC for the 
period 2000 – 2004, the incidences of neoplasms of urinary system is higher in males 
(54%) compared to females (46%).  For both, males and females, the age class 31 – 40 
represents the climax of the incidence of neoplasms of urinary system (Table (4.53).  
All the age groups were subjected to the incidence of neoplasms of urinary system with 
variant extend.  The geographical distribution of neoplasms of urinary tract system 
revealed that the incidences of the diseases are higher in patients from Central Sudan 
(33.2%) followed by patients from Khartoum State (26.8%).  As in most of neoplasms 
of malignant diseases, patients from Western Sudan ranked third according to their 
percentage (17.6%).  The percentage of patients from Northern Sudan and Eastern 
Sudan is almost similar (10.9 and 10.2%, respectively).  Percentage of patients from 
Southern Sudan occupied the bottom of the list with 1.3%.  The time series of urinary 
tract neoplasms for the five years showed V-shape being high (25.2%) in the first year 
(2000) and declined to 10.9% in the second year (2001) and continue to decline in 2002 
(9.3%) before rising to 21.4% in 2003 and reached the climax in 2004 (33.2%).  In 
2000, 2001 and 2003 there is no any patient of urinary tract neoplasm from southern 
Sudan.  The main diseases of urinary tract neoplasms are kidney, which represent the 
bulk of the urinary tract neoplasms incidence (86.3%) and Bladder (13.7%).   
Several reports indicated that coffee and tea consumption have the risk of human urinary 
tract cancer.  The estimated associations of coffee consumption ranged from moderately 
inverse, (145) through no association to moderately positive.   In addition to residual 
confounding by cigarette smoking, another explanation for a small positive association 
between coffee consumption and cancer of the urinary tract might be that non-coffee-
drinkers are a rather selected population. Non-coffee drinkers may differ also in 
occupation, the consumption of alcohol, tea, vegetables or fruit, or other lifestyle habits 
from the general population of coffee drinkers.   The consumption of tea seems not to be 
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related to an increased risk of urinary tract cancer, although the results are based on only 
a few studies. Evidence from animal experimental studies shows that it is plausible that 
certain compounds present in tea may even protect against the development of cancer 
(146) if an inverse association between tea consumption and urinary tract cancer does 
exist, it is likely to be small. Further research from large epidemiological studies is 
needed is this area.   In accordance with earlier reviews and based on predominantly 
case-control data, we found that coffee consumption increases the risk of urinary tract 
cancer by approximately 20%. The consumption of tea seems not to be related to an 
increased risk of urinary tract cancer. The risk of urinary tract cancer related to the 
amount or type of coffee and tea needs further investigation.  
5.13. Skin neoplasms 
Skin neoplasms are one of the low frequency malignant diseases.  The percentage of 
patients registered in the records of RIC for the period 2000 – 2004 is only 1.65 (239 
patients).  Regarding the incidences of skin neoplasms for sex, the incidences is 
relatively higher among males (62.8%) compared to females (37.2%).  Table (4.58) 
shows the distribution of skin neoplasms among different age classes and sex.  
However, the incidence of the disease among males is high among age class 61 – 70, 
while for the females the age class 31 – 40 showed the higher incidence of skin 
neoplasms.  The incidence of skin neoplasm is low in lower age classes (1 – 10 and 11 – 
20 years, 0.8 and 3.8%, respectively).  There is no big variation in the percent of 
incidence among the age classes 31 – 40 (18.4%), 61 – 70 (18%) and 41 -50 (17.2%).  
In the young youth (21 -30 years) the percentage of patients is 15.9% (Table (4.58)). 
Skin neoplasms including malignant melanomas have been for a long time the 
commonest tumour in Sudan.  The relative frequency of these neoplasm has however 
continued to decrease steadily overtime.  They have recently been surpassed by breast 
cancer as the commonest cancer (146).  The decrease is observed both in relation to 
malignant melanomas and other skin neoplasms.  A similar trend is also observed 
whereby skin neoplasms have decreased in the period 1979 – 84. this continuing 
decrease supports the views of (29 , 147) that the high ratios of skin cancer in the earlier 
reports are a result of easier detection of skin cancer compared to the lesss accessible 
neoplasms.  Early case studies on malignant melanoma were reported by (148).  He 
suggested trauma to the bare foot as a causal factor.  Bates (29)  reported 193 cases, 62% 
of them involving the sole of the foot.  He considered thermal irritation to the bare foot 
an aggravating causal factor.  Away from the foot these tumours arise frequently from 
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pre existing moles.  Over 80% of 108 cases reported by Hickey were located in the foot, 
and so were 70% of the 231 cases reported by Malik et al (149).  Similarly 78% of 139 
cases reported by Yagi et al (150) were on the foot. 
5.14. Bone and connective tissue tumors 
Few cases were registered in the records of the RIC for bone and connective tissue 
tumors during the period 2000 – 2004 where only 149 cases were registered.  The 
incidences of bone and connective tissue tumors among males and females vary 
considerable.   There is no case of bone and connective tissue tumors were registered for 
females in age class 1–10 years.  All the other age classes showed cases of bone and 
connective tissue tumors.  However, the peak of the bone and connective tissue tumors 
occurred in age class 61–70 for the males, while for the females the peak of the 
incidence occurred in the age class 51 – 60.  The geographical distribution of the 
incidences of bone and connective tissue tumors revealed that the incidences of the 
disease is higher in patients from Central Sudan (34.9%), while there is subtle 
difference between patients from Khartoum State and Western Sudan.  There is no any 
case of incidence reported from Northern Sudan and Western Sudan in 2000.   
Incidences of bone and connective tissue tumors for Southern Sudan were reported only 
in the last two years (2003 and 2004).  Moreover, there is no case of bone and 
connective tissue tumors registered for Eastern Sudan.  The time trend of the incidences 
of bone and connective tissue tumors showed a steadily increase in the incidences year 
by year.  The last two years (2003 and 2004) showed a sharp increase in the incidences 
of neoplasms of bone and connective tissue tumors.  The main disease of bone and 
connective tissue tumors includes; bone neoplasms, connective tissue and Kaposi 
sarcoma.   
Epithelioid neoplasms of bone are rare. Those most commonly encountered include 
epithelioid vascular lesions Antonescu CR, Erlandson RA, Huvos AG, adamantinoma, 
epithelioid osteoblastoma, epithelioid osteosarcoma, chordoma, and epithelioid 
chondroblastoma. In addition, rare cases have been reported of epithelioid variants of 
leiomyosarcoma, fibrosarcoma, (151-152) nerve sheath tumors, (153 )  
In 1979 (154) grouped all vascular tumors under the rubric of “histiocytoid 
hemangiomas,” a reflection of the histologic appearance, cytoplasmic enzyme profile, 
and ultrastructural features. Although considerable effort has been expended in the 
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classification of epithelioid vascular tumors in soft tissue with some resulting 
consensus, there is no uniform classification for such lesions arising in bone. In the 
most recent World Health Organization classification of soft tissue tumors, epithelioid 
vascular tumors are categorized as benign, epithelioid hemangioma (EH), malignant, 
epithelioid hemangioendothelioma (EHE), and epithelioid angiosarcoma (EA) (155).  
Epithelioid hemangioma arises in adult patients and is usually solitary, although up to 
25% may be multifocal.  Skeletal distribution is widespread with prevalence in the 
femur followed by the tibia, bones of the hand and foot, and bones of the axial skeleton.  
Epithelioid hemangioendotheliomas of bone occur primarily in adults, although children 
may be affected. Male patients slightly outnumber female, (156) and there is a 
predilection for the appendicular skeleton with a greater prevalence in the lower 
extremity. Radiologically, these tumors arise in the medullary cavity and display 
osteolysis with bony expansion or peripheral sclerosis; however, the appearance is not 
specific. Epithelioid hemangioendothelioma is multifocal in up to 50% of cases and 
may be mono-ostotic or polyostotic. Both widespread disease and restriction to a single 
anatomic region have been described. Campanacci M, Boriani S, Giunti A.   
Chordoma typically has the distinctive presentation of a midline axial lesion in an adult, 
most frequently older than 50 years, although the lesion can be seen rarely in the 
pediatric age group. Ninety percent occur in the sacrococcygeal area or base of skull, 
and, as such, presenting symptoms include pain, nerve compression, incontinence, 
headache, and visual changes. On imaging studies, chordoma appears as a lytic lesion, 
which may suggest the possibility of a metastatic tumor (24).  Chondroblastoma tends to 
occur in the epiphyses of long bones in the second decade of life, frequently prior to 
closure of the epiphyseal plate. It also may occur in small bones of the extremity, the 
pelvis, and in approximately 5% of cases in the bones of the skull and face (157).  
Radiographically the tumor is typically centered in the epiphysis, is radiolucent, and 
displays a well-defined margin and variable calcification. In its classic form the tumor is 
composed of closely packed polygonal mononuclear cells with oval, dark, and clefted 
nuclei. Tumor cells tend to be separated by scant matrix, which may calcify in areas to 
give a characteristic chicken-wire pattern. Well-formed cartilaginous matrix is variable, 
as are giant cells. Occasionally, areas of spindle cell proliferation are present, and cystic 
degeneration mimicking aneurysmal bone cyst may be seen, particularly in lesions of 
the hands and feet.  Variable cellular features include spindle cell differentiation, foam 
cells, and epithelioid cells, the latter present in 31% of cases in one series (158).  
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Chapter VI 
Conclusions and Recommendations 
 
6.1. Conclusions 
• The material under study consists of more than sixteen thousand cancer cases for 
the period 2000 – 2004 (five years) according to the records of Radiation and 
Isotopes Centre and Stac laboratories (14521 and 2180, respectively).    
• The neoplasms of the digestive organs represent the main cases of malignant 
neoplasms according to the records of RIC (21.5%) followed by breast cancer 
(18.2%) and neoplasm of female genital organs (11%).   
• Neoplasms of digestive organs, breast, neoplasms of female genital organs, 
leukemia, neoplasms of the oral cavity and pharynx, lymphoma and head and 
neck represent 80% of the malignant diseases registered in the records of RIC 
for the period 2000 – 2004. 
• The low frequency malignant neoplasms is represented by musculoskeletal, 
neoplasms of male genital organs, neoplasms of respiratory system, urinary tract 
neoplasm, skin neoplasms, bone and connective tissue tumor and other 
malignant neoplasms which collectively represent 20% of the registered cancer 
incidences for the period 2000 – 2004. 
• According to the records of RIC, Khartoum State represents the main source of 
malignant neoplasms where 32.1% of the patients of malignant neoplasms in the 
country followed by patients from Central Sudan (29.3%).   
• The percent of patients of malignant diseases form Western Sudan is relatively 
high (16.2%) compared to other regions (Northern Sudan, Eastern Sudan and 
Southern Sudan).   
• There is insignificant difference (p = 0.073) in distribution of breast, neoplasms 
of male genital organs and neoplasms of respiratory orgasm among the different 
regions in the different regions. 
• Also there is insignificant difference in the incidences of neoplasms of oral 
cavity and pharynx, neoplasms of female genital organs, musculoskeletal, 
neoplasms of digestive organs and Leukemia among the different regions.   
• It seems that all age groups are liable to malignant neoplasms.  The percent of 
incidence in lower age classes (1 – 10 years and 11 -20 ) is very low (4.5% and 
5.8%, respectively).  The incidences of malignant neoplasms increase 
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dramatically with the advance of age.  Patients of malignant neoplasms above 31 
years represent 80.6% of the total sample.  
• As far as the distribution of malignant neoplasms according to sex is concerned, 
it seems that females are more susceptible to cancer diseases compared to males.  
According to the records of RIC the number of females affected by cancer 
represents 56.6% of all registered cases.   
• The time trend of cancer diseases in the Sudan, according to RIC records, shows 
considerable variation in the number of patients.  The general trend indicates 
that the incidences of cancer diseases increase year by year.  The percent of 
cancer cases recorded for the year 2000 is about 15.1% of all the cases recorded 
in the RIC for the period 2000 – 2004.  in year 2001 the percentage increased to 
18.1%, while in 2002 the percent reached 19.4%.  in the last two years 2003 and 
2004 the percent reached 21.5%. 
• The trend of neoplasms of digestive organs among different age groups shows a 
continuous rise in the level of incidence of the diseases being low in lower age 
group (1 – 10 years) and increase steadily up to the age of 70 years after which 
the percent of cancer of digestive organs drop.  
• As far as sex is concerned, the incidence of neoplasms of digestive organs is 
much higher in males compared to females where males' cancer cases represent 
61.1% of the total sample.   
• Regarding the geographical and time trend of the neoplasms of the digestive 
organs, most of the registered cases were from Khartoum State, Central Sudan 
and Western Sudan, respectively.  The percentage of patients from these three 
regions account for 76.8% of patients registered for neoplasms of digestive 
organs.   
• The time trend of neoplasms of digestive organs showed subtle variations in the 
percentages of incidence malignant diseases for the period 2000 – 2004.  
• the main malignant neoplasms affecting the digestive organs are Oesphagus, 
Stomach, Gall bladder, Large bowel, Rectum, Sarcoma, Colon, Liver, and other 
neoplasms of digestive organs (Pancreas, Carcinoma, Characinoid and anal)  
• Breast cancer is the second most dominant disease that prevails almost in the 
whole country and it represent 18.2% of the total sample of patients.  The 
prevalence of the disease is not site specific where all the regions of the country 
witnessed incidence of breast cancer being higher in Khartoum (10% of all the 
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cancer cases for the period 2000 – 2004) followed by patients from Central 
Sudan.  The number of breast cancer incidence in the Northern Region is also 
high (364 cases), while in southern, western and eastern Sudan the percent of 
breast cancer incidence is relatively low compared to the above-mentioned 
regions.   
• Female breast cancer disease is higher in Khartoum, Central Sudan, Northern 
Sudan and Western Sudan, and low in Eastern and Southern Sudan and the 
distribution of male breast disease follows the same trend.  
• The time trend of breast cancer diseases shows that the percentage of incidences 
increases year after year being least in 2000 (15.4%) and maximum in 2004 
(24.9%) 
• The neoplasms of female genital organs distribute among the different age 
groups except the age class 1 – 10 years and the percent of neoplasms of female 
genital organs in the second age class (11 – 20) is relatively low (2.5%) 
compared to other age classes.   
• Starting from the age class 21 – 30 years, the level  of neoplasm of female 
genital organs increase and after thirties, the level of cancer incidence increase 
dramatically.  
• Regarding the time series of neoplasms of female genital organs in the different 
regions, the level of cancer incidence is higher in Khartoum State (34.1%) 
followed by Central Sudan Region (27.8%), while patients from western Sudan 
represent 15.5%.  Incidences of neoplasm of female genital organs are almost 
similar in patients from Northern and Eastern Sudan (10.7 & 9.9%, 
respectively).  
• As far as the time trend is concerned, the percentages of incidence of neoplasms 
of female genital organs in general showed a steadily increase in cancer cases 
and the main diseases of the female genital organs includes; Cervix, ovary 
cancer, uterus cancer , chorion carcinoma , and vagina and vulva  
• According to CIR records for the period 2000 – 2004, all the age groups are 
susceptible to Leukemia and the same is true for the sex.  The incidence of 
Leukemia is higher in males in comparison with females.  In the age range of 51 
– 70 years, the incidence of Leukemia is relatively high in males compared to 
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other ages.  The same is true for females where the same age range represent the 
crest of Leukemia incidence.   
• The geographical distribution of theses diseases showed Central Sudan has the 
highest percent of leukemia incidences during the period 2000 2004.  There is 
subtle difference in the percentages of Leukemia incidence in Northern and 
Western Sudan, and the level of Leukemia incidences in Eastern and Southern 
Sudan is relatively low. 
• The incidences of Leukemia showed a declining trend compared to other 
malignant diseases which showed ascending trend and the main diseases of 
Leukemia include lymphatic leukemia, Meyloid leukemia, CML, CLL, AML 
and ALL with different frequencies.  The other Leukemia diseases are 
Lymphatic leukemia and Meyloid leukemia which have lesser weight compared 
to the other diseases of Leukemia.   
• Incidences of neoplasms of oral cavity and pharynx are higher in males 
compared to females.  Males of age 51 – 70 years represent 29.5% of the 
patients.  The percent of patient females for the same age group is much higher 
compared to males (49%).  Generally, incidences of malignant neoplasms of oral 
cavity and pharynx increase with the advance of age.   
• Regarding the geographical distribution of the neoplasms of the oral cavity and 
the pharynx, the percentages of incidences varies among the different regions 
being high in Khartoum State (31.6%) and Central Sudan (30%), while the 
percentage of incidence is relatively low in Southern and Eastern Sudan (7.6 & 
1.7%, respectively).  
• The trend of the incidence of neoplasms of oral cavity and pharynx in the 
different regions showed significant variations.  In Khartoum the peak of 
incidences recorded in year 2002 and for Central Sudan the peak was 2004 
where more than half of the patients registered in RIC for this disease were from 
Central Sudan. Generally, 2004 showed the high incidences of neoplasms of oral 
cavity and pharynx in patients of all the regions except Khartoum State. 
• The main neoplasms of the oral cavity and pharynx according to the records of 
RIC for the period 2000 – 2004 are Lip, Tongue, Salivary gland, Mouth, 
Oropharynx, Nasophrynx and hypopharynx.  
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• Almost there is no difference in the percent of females and males registered for 
Lymphoma.  Female of age group 41 – 60 represent the bulk of the Lymphoma 
patients, while for male incidences of Lymphoma is high in age group 51 – 70.     
• As far as the age group is concern the trend of lymphoma shows a fluctuating 
trends being very low in lower age classes and declined to 8.8% in age class 21 
– 30, but after thirties, the incidences of lymphoma start to increase steadily until 
it reached its climax at age class 51 – 60 (18.1%).  
• Khartoum State and Central Sudan showed the highest percentages of 
Lymphoma patients.  Patients form Northern Sudan (8.2%) showed lower 
percentage than that of patients from Eastern Sudan (9.2%).  As usual 
Lymphoma patients from Southern Sudan showed the least percentage (2.7%). 
• The time trend of Lymphoma incidences over the five years showed a steady 
increase of percentages where in year 2000 the percent of patients is 13.6% and 
in 2004 is 25.8%.  The main diseases of neoplasm of lymphoma are Non 
Hodgkin's lymphoma, Hodgkin's lymphoma and Axillary LN.  the first two 
diseases represent the bulk of the incidences of neoplasms of lymphoma 
• There are variations of incidences of neoplasms of head and neck among sex 
being very high among females (78.2% of the patients), and low among males. 
However, the highest percentage of female incidences of neoplasms of head and 
neck was 51 – 60 and 41 – 50 age groups, while for the male the incidences of 
neoplasms of head and neck is high in age groups 51 – 60 and 61 – 70.   
• Khartoum State, Central Sudan and Western Sudan represent the main regions 
for the incidences of neoplasms of head and neck (76.9%).  For this neoplasm, 
the percent of patients from Eastern Sudan (9.7%) is higher than the cases from 
Northern Sudan (9.6%).   
• The time trend of the neoplasms of head and neck for the period 2000 – 2004 
shows a steady increase in the incidences of neoplasms of head and neck and the 
main diseases includes; Buccal, Cheek, Ear, Eye, Face, Gingira, Jaw, Mandible, 
Maxillary, neck, Nose, Palate, Parotid, Post cricoids and tonsil.  However, the 
most common cancer diseases are; eye, Parotid, Mandible and maxillary, and 
collectively they represent more than half the cases of neoplasm of head and 
neck. 
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• Different proportions of males and females of different age classes were 
subjected to the neoplasms of musculoskeletal; the incidences are relatively 
higher in males compared to females.  Females of age class 21 – 30 showed the 
peak of the incidences, while for the males the peak of the incidences occuirred 
among age class 11 – 20.   
 
• Neoplasms of musculoskeletal showed a different trend compared to other 
malignant diseases where the incidences are higher in lower age classes 
compared to higher age classes. Generally, the trends of the diseases showed a 
fluctuating pattern across the period 2000 – 2004. 
• The geographical distribution of the disease showed great variations among the 
regions being high in Khartoum followed by Central Sudan.  Like most of the 
incidences of neoplasm of malignant diseases, patients from Western Sudan 
occupy the third position in the ranking.  Northern Sudan and Eastern Sudan 
there are almost similar as far as the percentages of musculoskeletal diseases are 
concerned ( 9.8 and 7.9%, respectively).  
• The main diseases of musculoskeletal, according to the records of the RIC are; 
Thigh, Arm, Back, Chromo sarcoma, Fib sarcoa, Knee, Hand, Leg, 
Leomyosarcoma, Osteag solcoma and shoulder.   
• Neoplasm of male genital organs become apparent with the advance of the age.  
Before fifties of age, the incidences of neoplasms of male genital organs are 
relatively low (19.8%).  After the fifties, the incidences of neoplasms of male 
genital organs start to occur at alarming rate.   
• The time trend of the incidence of neoplasms of male genital organs for the 
period 2000 – 2004 showed a steady increase for the period 2000 – 2002 where 
the percentage of patients reached 19.4% in 2002.  In 2003 the percentage of 
patients dropped to 17.6 before rising to 32.7% in 2004.  The main diseases of 
the neoplasms of male genital organs are Prostate, Testis and Penis.  
• All the age groups and sex were registered in the records of RIC for the 
neoplasms of respiratory system for the period 2000 – 2004.  However, the 
percentage of males (57.3%) is higher compared to the incidence of the disease 
among females (42.7).  In females the peak of the incidence of the disease 
occurred in age class 51 – 60, while for males the peak of incidence took place 
in age class 61 – 70.   
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• As far as the geographical distribution of the neoplasm is concerned, Khartoum 
State showed the higher percentage of incidences followed by patients from 
Central Sudan and Western Sudan, respectively.   
• The time series of the disease showed a steadily increase during the first three 
years (2000 – 2002) and in 2003 the incidences showed a marked increase in the 
percentage of the incidences before dropping to 19.1 in 2004.  The main diseases 
of neoplasms of respiratory system includes; Nasal sinuses, Larynx and lung.   
• According to the records of RIC, the incidences of neoplasms of urinary system 
is higher in males (54%) compared to females (46%).  For both, males and 
females, the age class 31 – 40 represents the climax of the incidence of 
neoplasms of urinary system.   
• All the age groups were subjected to the incidence of neoplasms of urinary 
system with variant extend.  The age class 31 – 40 showed the peak of the 
incidences (22.4%) followed by age class 21 – 30 (17.3%) and 11 – 20 (14.4%), 
respectively.  The other percentages are distributed for the other five age classes.  
• The geographical distribution of neoplasms of urinary tract system revealed that 
the incidences of the diseases are higher in patients from Central Sudan (33.2%) 
followed by patients from Khartoum State (26.8%).  As in most of neoplasms of 
malignant diseases, patients from Western Sudan ranked third according to their 
percentage (17.6%).  The percentage of patients from Northern Sudan and 
Eastern Sudan is almost similar (10.9 and 10.2%, respectively).  Percentage of 
patients from Southern Sudan occupied the bottom of the list with 1.3% (Table 
(4.55)). 
• The time series of urinary tract neoplasms for the five years showed V-shape 
being high (25.2%) in the first year (2000) and declined to 10.9% in the second 
year (2001) and continue to decline in 2002 (9.3%) before rising to 21.4% in 
2003 and reached the climax in 2004 (33.2%).  In 2000, 2001 and 2003 there is 
no any patient of urinary tract neoplasm from southern Sudan. 
• The main diseases of urinary tract neoplasms are kidney, which represent the 
bulk of the urinary tract neoplasms incidence (86.3%) and Bladder (13.7%).   
• Regarding the incidences of skin neoplasms for sex, the incidences is relatively 
higher among males compared to females, and the incidence is low in lower age 
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classes (1 – 10 and 11 – 20 years.  There is subtle variation in the percent of 
incidence among the age classes 31 – 40, 61 – 70 and 41 -50.  
• The geographical distribution of skin neoplasms showed subtle variation in the 
incidence of skin neoplasms for Khartoum State and Central Sudan (28.9 and 
28%, respectively).  The percentage of patients from Western Sudan is 18.4 
while for the patients from Northern Sudan is 14.6%.  
• The time trend of skin neoplasms showed a steadily increase in the percentages 
of patients for the period 2000 – 2002 where it reached 22.6% after which it 
dropped to 19.2% in 2003 before rising to the maximum level of percentages 
(31.8%).  The highest incidences of skin neoplasm took place in 2004 in all the 
regions except in Khartoum State where the peak of the incidence occurred in 
2002.   
• There is no case of bone and connective tissue tumors were registered for 
females in age class 1 – 10 years.  All the other age classes showed cases of 
bone and connective tissue tumors.  The peak of the bone and connective tissue 
tumors occurred in age class 61–70 for the males, while for the females occurred 
in the age class 51–60. 
• The geographical distribution of the incidences of bone and connective tissue 
tumors revealed that the incidences of the disease is higher in patients from 
Central Sudan, while there is subtle difference between patients from Khartoum 
State and Western Sudan.   
• The time trend of the incidences of bone and connective tissue tumors showed a 
steadily increase in the incidences year by year.  The last two years showed a 
sharp increase in the incidences of neoplasms of bone and connective tissue 
tumors. 
• The main disease of bone and connective tissue tumors includes; bone 
neoplasms, connective tissue and Kaposi sarcoma.   
• According to Stac records, neoplasm of breast is significantly higher among 
females compared to males (94.5 and 5.5%, respectively).  However, all the age 
classes are liable to the incidence of neoplasms of breast.  The majority of the 
cases of neoplasms of breast were from Khartoum State (88%) followed by 
patients from Western Sudan (4.9%).  
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• The incidences of neoplasms of digestive organs are higher among females 
(54.6%), particularly among age class 51 - 60, while for males the higher 
percentage of incidences occurred in the age class 61 – 70. 
• The time trend of the incidences of neoplasms of digestive organs showed low 
incidences in years 2001 and 2002.  In the other years the percent of incidences 
showed a marked rise in the incidences.  The incidences of the diseases is 
relatively higher among females compared to males.  The highest incidences 
among females occurred in the age class 31 – 40, while for the male 51 – 60, 
according to Stac records. 
• All the regions showed incidences of lymphoma, being very high in Khartoum 
State followed by Western Sudan.  The other regions showed lower incidences 
of lymphoma neoplasms compared to the above mentioned regions.   
• However, Khartoum State is the only region which showed incidences of 
lymphoma neoplasms across the five years (2000 – 2004).  Patients from 
Western and Eastern Sudan were registered only in 2003 and 2004, while 
patients from Northern Sudan were registered only in 2001 and 2004. 
• The records of stac revealed the susceptibility of males and females to the 
incidences of leukemia.  The incidences among females is higher compared to 
males, incidences among females is high in age classes 21 – 30 and 41 – 50 , 
while for males the highest incidences occurred in the age class 41 – 50.   
• The trend of leukemia incidences across the five years showed the incidences of 
the diseases at all the age groups, except the first age class.  The highest percent 
of incidences of the diseases reported among age group 21 – 30 followed by age 
classes 31 – 40 and 61 – 70.  Patients over seventies are higher than patients of 
age class 11 – 20 and lower than the rest of the age groups. 
• The geographical distribution of leukemia neoplasm, according to Stac records, 
revealed the incidences of the diseases in all the regions except Southern Sudan 
and Khartoum State represent the bulk of the incidences followed by Northern 
Sudan.   
• According to the records of Stac for the period 2000 – 2004, the neoplasms of 
oral cavity and pharynx incidences are relatively higher among males compared 
to females.   
• The geographical distribution of the diseases is almost similar to that of 
leukemia where all the regions, except Southern Sudan, were represented in the 
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patient list for this disease.  Khartoum State represented the bulk of the 
incidences of the neoplasms of oral cavity and pharynx.   
• The geographical distribution of the incidences of neoplasms of head and neck is 
almost similar to that of leukemia.  Incidences of the disease were reported from 
all the regions, except Southern Sudan.  Khartoum State showed the highest 
percent of incidences.  The percent of incidences in patients from Northern, 
Western and Eastern Sudan is similar (2.3%), while for the Central Sudan is 
2.8%. 
• Incidences of neoplasms of female genital organs were reported in the records of 
Stac for all the age groups.  The levels of incidences were low in lower age 
classes.  Incidences in patients over seventies are higher than in the above 
mentioned lower age class and far less than the other age groups.  The age range 
31 – 70 showed the highest percent of incidences of neoplasms of female genital 
organs (81%). 
• The time trend of neoplasms of female genital organs, according to Stac records, 
revealed the incidences of the diseases in the five years.  The percent of 
incidences are relatively low in the first three years and increased dramatically in 
the last two years. 
• According to Stac records, the age class 41 – 50 showed the highest incidences 
of neoplasms of musculoskeletal (22.2%) followed by the age classes 11 – 20 
and 51 – 60 (15% for each).  The age class 1 – 10 showed the least percent of 
incidences followed by patients over seventies. 
• The geographical distribution of the neoplasms of musculoskeletal is almost 
similar to most of the malignant diseases registered in Stac records, Khartoum 
State present the bulk of patients (85.5%).  The percent of incidences in the 
other regions is relatively low.  No any patient registered for these diseases from 
Southern Sudan. 
• Incidences of neoplasms of male genital organs were reported in the records of 
Stac for all the age groups with variant level.  The last three age classes (51 – 60, 
61 – 70 and above 70s) the level of incidences are very high, particularly for the 
age class 61 – 70  
• The geographical distribution of the neoplasms of male genital organs revealed 
the incidences of the diseases in patients from all the region except Southern 
Sudan.  Khartoum State showed the highest level of incidences (88%) followed 
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by Central Sudan (6%) and Northern Sudan (3.4%).  In the other regions the 
level of incidences is relatively low.   
• The geographical distribution for the neoplasms of respiratory organs showed 
incidences of the neoplasms in four regions.  No patients from Southern and 
Western Sudan were registered for these diseases.  The majority of the patients 
were from Khartoum State (80%), while the level of incidences in the other 
regions is similar.   
• Few patients were registered in the records of Stack for the neoplasms of urinary 
tract (50 patients) and they represent 8.2% of the low frequency malignant 
diseases and 2.3% of all the malignant diseases registered in Stac for the period 
2000 – 2004.  Appendix (13) shows the relationship of urinary tract neoplasms 
for sex and age groups.  
• Incidences of urinary tract neoplasms among males is relatively high (60%) 
compared to females (40%).  However, the incidences among females occurred 
across all the age crops, while for the males the first two age classed did not 
showed any incidences of the diseases.  Moreover, there is no regular trend of 
incidences across the age groups.  The age class 41 – 60 showed the least 
percent of incidences (4.0%) followed by the two lower age classes 1- 10 and 11 
– 20 (6% for each).  The age class 51 – 60 showed the highest percent of 
incidences of urinary tract neoplasms. 
• The geographical distribution of urinary tract neoplasms revealed the 
distribution of the diseases among patients from all the regions of the Sudan, 
according to the records of Stac (2000 – 2004).   
• The geographical distribution of the neoplasms across the five years indicated 
the fact that the incidences of the diseases are very high among patients from 
Khartoum State (90%) while the rest of the regions represent the rest of the 
incidences. 
• The time trend of the urinary tract neoplasms showed incidences of the diseases 
across the five years, being very high in 2003 (44.0%) followed by 2004 (26%), 
while 2001 showed the least incidences of the diseases (6.0% followed by 2002 
(8.0%). Only Khartoum State showed records for the diseases for the five years. 
• The neoplasms of bone and connective tissue is one of the least malignant 
diseases in the records of Stac for the period 2000 – 2004 where 52 patients 
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were registered for this disease representing 2.4% of the malignant diseases 
registered for the diseases. 
• All the aged groups showed cases of neoplasms of bone and connective tissue 
except the first age class (1 – 10).  However, the highest percent of incidences of 
neoplasms of bone and connective tissues occurred in age class 61 – 70 (21.2%) 
and the least occurred in the age class above seventies. 
• The geographical distribution of the neoplasms of bone and connective tissues 
and the trend of incidences across the five years indicated Khartoum State had 
the highest level of incidence (94.2%) and the rest of the cases were registered 
for patients from Northern Sudan and Western Sudan (3.8 and 1.9%, 
respectively). 
• The time trend of the incidences of neoplasms of bone and connective tissues 
revealed a steady increase of the incidences starting from the first year (2000) up 
to 2003 where the percent of incidences reached its peak (34.6%) before 
dropping in 2004 to 28.8%. 
• Sixty-one patients were registered for these diseases in the records of Stac for 
the period 2000 – 2004 representing 2.84% of all the malignant diseases 
recorded in Stac.   
• The geographical distribution of the diseases revealed the existence of the 
incidences in all the regions except Central Sudan and Southern Sudan.  
Khartoum State showed the highest level of incidences (83.6%) followed by 
Northern Sudan (9.8%), while Western and Eastern Sudan Showed the least 
percent of incidences (3.3% for each).   
6.2. Recommendations 
This study recommends the followings: 
- With the advancement in the field of technology there is an urgent need 
for establishing database encompassing all the relevant information that 
would enhance research. 
- Importance of training to personnel who indulge with data entry and 
record keeping 
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Appencix 1 
Table (1): neoplasms of digestive organs (RIC 2000 – 2004) 
 N % of digestive organs % of the total sample 
Oesphagus 807 25.7 5.6 
Stomach 435 13.9 3.0 
Gall  bladder 386 12.3 2.6 
Large bowel 333 10.6 2.3 
Rectum 330 10.5 2.3 
Sarcoma 290 9.2 2.0 
Colon 223 7.0 1.5 
Liver 161 5.1 1.1 
Others 171 5.4 1.2 
Total  3136 100 21.5 
Appendix 2 
Table (2): Incidence of female genital organs neoplasm (RIC 2000–2004)  
% of total % of female genital 
organs 
Frequency Neoplasms of female genital 
organs 
5.75 
0.08 
1.2 
3.57 
0.41 
52.1 
0.7 
11 
32.3 
3.7 
835 
12 
177 
518 
60 
Cervix 
Chorion carcinoma 
Body  uterus 
Ovary   
Other  female genital organs 
11 100 1602  
 
Appendix 3 
Table (3): Main Leukemia diseases in the Sudan (RIC 2000 – 2004) 
% of the total sample % of  Leukemia N  
0.1 
0.16 
1.38 
1.67 
3.3 
2.27 
1.2 
1.8 
15.5 
18.8 
37.3 
25.5 
15 
23 
200 
243 
482 
330 
Lymphatic  
leukemia  
Meyloid leukemia 
CML 
CLL 
AML 
ALL 
8.9 100 1293  
Appendix 4 
Table (4):  Main neoplasms of the oral cavity and pharynx (RIC 2000 -2004) 
% of the total sample % of oral cavity and pharynx N  
0.8 
0.6 
0.4 
0.3 
1.6 
3.0 
1.1 
10.6 
7.7 
5.9 
3.8 
20.6 
36.9 
13.8 
120 
87 
67 
43 
234 
429 
157 
Lip 
Tongue 
Salivary  gland 
Mouth  
Oropharynx  
Nasophrynx  
hypopharynx  
7.8 100 1137  
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Appendix (5) 
Table (5): Main incidences of lymphoma in the Sudan (RIC 2000 – 2004) 
% of total sample % of Lymphoma Frequency % of the total sample 
4.7 
1.48 
0.26 
73 
22.9 
4.1 
684 
215 
38 
Non Hodgkin's lymphoma 
Hodgkin's lymphoma 
Axillary LN 
6.5 100 937  
 
Appendix (6) 
Table (6): Main neoplasms of head and neck (RIC 2000 – 2004) 
% of the total sample % of head and neck Frequency  
0.1 
0.2 
0.13 
1.4 
0.08 
0.28 
0.4 
0.67 
0.6 
0.12 
0.33 
0.32 
0.79 
0.37 
0.23 
1.6 
3.2 
2.1 
23.6 
1.4 
4.6 
6.7 
11 
10.1 
2.0 
5.5 
5.5 
12.9 
6 
3.7 
14 
29 
19 
209 
12 
41 
59 
98 
90 
18 
49 
48 
114 
54 
33 
Buccal 
Cheek 
Ear 
Eye 
Face 
Gingira 
Jaw 
Mandible 
Maxillary 
Neck 
Nose 
Palate 
Parotid 
Post cricoids 
tonsil 
6.1 100 887 Total  
 
Appendix (7) 
Table (7 ): Main musculoskeletal diseases in the Sudan (RIC 2000 – 2004) 
% of neoplasm 
malignant 
% of musculoskeletal patients Musculoskeletal 
disease 
0.13 
0.15 
0.08 
0.39 
1.16 
0.13 
0.08 
0.60 
0.15 
0.96 
0.18 
3.3 
3.8 
2.0 
9.6 
28.8 
3.3 
2.2 
14.9 
3.6 
24 
4.5 
19 
22 
12 
56 
168 
19 
13 
87 
21 
140 
26 
Thigh 
Arm 
Back 
Chromo sarcoma 
Fib sarcoma 
Knee  
Hand  
Leg  
Leomyosarcoma  
Osteag  solcoma  
Shoulder  
4.1 100 583 Total  
Appendix (8) 
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Table (8): Main diseases of neoplasms of male genital organs 
% of total neoplasms of 
malignant diseases 
% of male 
genital organs 
patients Neoplasms of male 
genital organs 
3.75 
0.12 
0.12 
93.8 
3.1 
3.1 
545 
18 
18 
Prostate 
Testis 
Penis  
3.99 100 581 Total  
 
Appendix (9) 
Table (9): Main diseases of neoplasms of respiratory system 
    
0.3 
1.4 
0.7 
12.3 
57.5 
30.2 
43 
202 
106 
Nasal  sinuses 
Larynx 
Lung 
2.4 100 351  
 
Appendix 10 
Table (10):X2 of neoplasms of digestive organs for geographical distribution of 
incidences and time trend 
Asymp. Sig. (2-sided) df Value  
.243 16 19.506 Pearson Chi-Square 
.131 16 22.387 Likelihood Ratio 
.426 1 .635 Linear-by-Linear Association 
  487 N of Valid Cases 
 
 
Table (11 ): Neoplasms of respiratory organs for sex and age groups (Stac 2000 – 
2004) 
total female male  
% N % N % N 1 10 
6.7 1   6.7 1 11-20 
13.3 2 6.7 1 6.7 1 21-30 
6.7 1   6.7 1 31-40 
20.0 3 13.3 2 6.7 1 41-50 
13.3 2 6.7 1 6.7 1 51-60 
33.3 5 26.7 4 6.7 1 61-70 
6.7 1   6.7 1 >70 
100 15 53.3 8 46.7 7 Total 
 
Table (12): geographical distribution of neoplasms of respiratory organs (Stac 
2000 – 2004) 
 N 2000 2001 2002 2003 2004 Total % 
Khartoum 12 26.7 13.3 6.7 20 13.3 80 
Central Sudan 1     6.7 6.7 
Northern Sudan 1 6.7     6.7 
Eastern Sudan 1 6.7     6.7 
 15 40 13.3 6.7 20 20 100 
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Table (13): Cross tabulation of sex and age groups for urinary tract neoplasms 
Total  Female  Male   
% N % N % N  
6.0 3 6.0 3   1 10 
6.0 3 6.0 3   11-20 
14.0 7 4.0 2 10 5 21-30 
10.0 5 6.0 3 4.0 2 31-40 
4.0 2 2.0 1 2.0 1 41-50 
26.0 13 10.0 5 16.0 8 51-60 
20.0 10 6.0 3 14.0 7 61-70 
14 7 2.0 1 12.0 6 >70 
100 50 40 20 60 30 Total 
 
Table (14 )Neoplasms of bone and connective tissue among sex and age groups 
Total  Female  Male   
% N % N % N  
7.7 4 3.8 2 3.8 2 11-20 
19.2 10 9.6 5 9.6 5 21-30 
19.2 10 5.8 3 13.5 7 31-40 
13.5 7 1.9 1 11.5 6 41-50 
15.4 8 5.8 3 9.6 5 51-60 
21.2 11 11.5 6 9.6 5 61-70 
3.8 2   3.8 2 >70 
100 52 38.5 20 61.5 32 Total 
 
15 
Total  Female  Male   
% N % N % N 1 10 
3.3 2 3.3 2   11-20 
8.2 5 4.9 3 3.3 2 21-30 
14.8 9 9.8 6 4.9 3 31-40 
8.2 5 4.9 3 3.3 2 41-50 
26.2 16 13.1 8 13.1 8 51-60 
26.2 16 21.3 13 4.9 3 61-70 
13.1 8 3.3 2 9.8 6 >70 
100 61 60.7 37 39.3 24 Total 
16 
Total  Female  Male   
% N % N % N  
2.0 3 .7 1 1.4 2 1 10 
6.1 9 4.1 7 2.0 3 11-20 
10.2 15 5.4 8 4.8 7 21-30 
13.6 20 8.2 12 5.4 8 31-40 
14.3 21 7.5 11 6.8 10 41-50 
24.5 36 8.8 13 15.6 23 51-60 
22.4 33 8.8 13 13.6 20 61-70 
6.8 10 2.7 4 4.1 6 >70 
100 147 46.3 68 53.7 79 Total 
 
